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Summary 
To determine the expression pattern of XPAT (Xenopus primordial germ cell associated 
transcript) protein in Xenopus oocytes, XPAT-GFP fusion proteins were generated. When 
XPAT was amino-terminally tagged with GFP it became localised to the nuclei of stage VI 
Xenopus oocytes. However, when carboxy-terminally tagged with GFP, XPAT also 
translocated to the vegetal pole of stage VI oocytes. XPAT-GFP formed particles (1 to 
2.5µm in diameter) which aggregated into large (10 to 50µm) granular structures at the 
vegetal pole. These particles looked exactly like those seen after in situ hybridisation to 
germ plasm RNAs. The granules of XPAT-GFP were larger than endogenous germ plasm 
granules seen in stage VI oocytes; they were more consistent with those observed in 2-cell 
embryos during germ plasm aggregation. Studies involving the use of the anticytoskeletal 
drugs colcemid, nocodazole and cytochalasin D and the microtubule stabilising agent taxol 
indicated that microtubular transport was important in the localisation of XPAT-GFP. 
Several attempts were made to raise antibodies to XPAT peptides, but at present the 
endogenous expression pattern of XPAT protein is unresolved. 
To investigate possible domain structure of XPAT, one carboxy-terminal and three amino- 
terminal deletion variants of XPAT-GFP were constructed. An N-terminal deletion protein 
lacking the first 61 amino acids of XPAT was able to form small particles, but none of the 
deletion proteins exhibited vegetal localisation or formed large aggregates in Xenopus 
oocytes. The N-terminal deletion proteins all became predominantly localised to the 
nucleus; protein motif analysis revealed that XPAT contains a putative bipartite NLS in its 
carboxy-terminal region. The C-terminal deletion protein, which lacked the putative NLS, 
was evenly distributed throughout the nucleus and cytoplasm of Xenopus oocytes. 
XPAT was shown to be able to bind to homopolymeric RNAs in vitro. When Xpat mRNA 
was depleted from stage VI Xenopus oocytes (by injection of an antisense oligo) levels of 
DEADSouth and XVLG1 mRNAs decreased substantially. Overexpression of Xpat in 
oocytes caused increased levels of DEADSouth and XVLG1 and more particles of 
DEADSouth were detected by in situ hybridisation in Xpat-injected oocytes than in controls. 
A statistically significant difference between the diameter of Xcat-2 RNA expression 
domain and that of Xdazl and Xpat in control (uninjected) oocytes was also observed. These 
results suggest that there are distinct sets of granules within the germ plasm. However, it 
will be necessary to perform double in situ hybridisation to clarify this point. 
X111 
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Chanter 1: Introduction 
1.1 Germ plasm and primordial germ cells 
All sexually reproducing organisms arise from the fusion of two gametes. In turn, all 
gametes are formed from primordial germ cells (PGCs), which segregate from 
somatic cell lineages during early embryonic development. Ultimately germ cells 
give rise to all tissues in an animal; they are pluripotent. Thus, the study of germ-line 
development allows both the propagation of species and the differentiation of a 
highly specialised cell type to be investigated. 
Differentiation of germ cells is often directly dependent upon the asymmetric 
inheritance of maternal germ cell determinants. In Drosophila, Caenorhabditis and 
Xenopus, such determinants are localised to a specialised region of cytoplasm, the 
germ plasm. Germ plasm is assembled from germ-line specific factors deposited in 
the egg during oogenesis. It is distinguished by the presence of specialised 
organelles, termed germinal granules in Xenopus, polar granules in Drosophila and P 
granules in Caenorhabditis. These granules are exclusive to germ plasm and 
incorporate into forming PGCs. The germinal (polar) granules are visualised by 
electron microscopy as electron-dense fibrillar organelles which are not bound by 
membranes. Germ plasm is rich in mitochondria and ribosomes and also contains 
RNA, protein and pigment granules (reviewed by Houston and King, 2000a). The 
germ granules have not been comprehensively characterised, although it is known 
that they contain specific RNAs that are generally not found elsewhere in the germ 
plasm (Strome and Wood, 1983; St. Johnston, 1995). 
Many ablation, overexpression and transplantation studies have been performed 
which provide evidence that germ plasm is critical in the development of PGCs in 
Drosophila and Xenopus. Rather than discuss these experiments here, the reader is 
directed to a recent comprehensive review elsewhere (Houston and King, 2000a). 
1.1.1 Primoridal germ cell development and migration in Drosophila 
PGCs arise in Drosophila as a cluster of cells (termed pole cells) at the posterior of 
the blastoderm, approximately 90 to 120 minutes post-fertilisation. The arriving 
nuclei associate with pole plasm and are thus directed to a germ cell fate. Pole cells 
1 
cellularise in advance of the rest of the syncitial blastoderm, this process being 
triggered by centrioles (Raff and Glover, 1989). Pole plasm contains maternal RNAs 
and proteins, which are localised to the posterior pole during oogenesis by an active 
process requiring microtubules, and possibly microfilaments (Clark et al., 1994; 
Pokrywka and Stephenson, 1995; Erdelyi et al., 1995; Glotzer and Ephrussi, 1996). 
During gastrulation, pole cells become attached to the presumptive endoderm and are 
carried inside the embryo by the invaginations of the posterior embryo, to become 
located in the posterior midgut lumen. The pole cells then actively migrate 
posteriorly and laterally across and then along the surface of the endoderm through 
the gut wall and towards the developing overlying gonadal mesoderm tissue. The 
pole cells and somatic gonadal precursor cells then coalesce to form the gonads, 
which eventually contain -20 pole cells (reviewed in Saffman and Lasko, 1999). 
1.1.2 The development and migration of PGCs in Xenopus 
The movement of germ plasm and PGCs in Xenopus has been followed by staining 
the germ plasm with lipophilic and nuclear dyes (Whitington and Dixon, 1975; 
Ressom and Dixon, 1988; Heasman et al., 1984; Savage and Danilchik, 1993; Robb 
et al., 1996), and using antibodies directed against cell surface antigens (Heasman 
and Wylie, 1983). 
In the fertilised egg, germ plasm is distributed in hundreds of small cytoplasmic 
islands, which are distributed over a wide cortical area of the vegetal hemisphere 
(Whitington and Dixon, 1975; Ressom and Dixon, 1988). These islands appear to be 
attached to the vegetal yolk mass and they rotate with it during the first cell cycle 
after fertilisation (Savage and Danilchik, 1993). After cortical rotation, the islands 
are suddenly released from the yolk mass and begin coalescing locally and moving 
towards the vegetal pole (Savage and Danilchik, 1993). This aggregation continues 
throughout early embryonic cleavage and is dependent on microtubules (Ressom and 
Dixon, 1988; Savage and Danilchik, 1993). Also required is a Xenopus kinesin-like 
protein (Xklp-1), a motor protein which is found in the germ plasm throughout 
aggregation (Robb et al., 1996). This process is not dependent on cleavage, as 
artificially activated eggs also show normal aggregation (Savage and Danilchik, 
1993). Germ plasm thus becomes aggregated into large patches at the vegetal pole. 
From the 4-cell stage onwards, germ plasm ingresses into the interior of the embryo 
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along the cleavage furrows. Thus, by the 32-cell stage few patches of germ plasm 
remain at the vegetal pole and one mass of germ plasm is inherited by each of the 
four vegetal pole blastomeres. Ingression is dependent on cleavage, microfilaments 
and microtubules (Savage and Danilchik, 1993). 
As cleavage continues, each patch of germ plasm becomes unequally segregated into 
only one of the daughter cells. By the blastula stage, the germ plasm is found in 2-6 
presumptive PGCs (pPGCs) within the endodermal mass (Figure 1.1). Early in 
gastrulation the germ plasm becomes relocated perinuclearly (Whitington and Dixon, 
1975), thereby ensuring that as cell divisions continue both daughter cells receive 
germ plasm and the number of pPGCs increases (Whitington and Dixon, 1975). 
During gastrulation and neurulation, PGCs stay in the vegetal hemisphere and follow 
the normal morphogenic movements of the endodermal mass, thus becoming 
concentrated posteriorly in the endoderm (Whitington and Dixon, 1975; Figure 1.1). 
Between stages 17 and 28 (staging, according to Nieuwkoop and Faber, 1967) all 
PGCs coalesce into one or two clusters of cells which are located below the 
archenteron cavity of the endoderm. The PGCs then migrate laterally (at stage 28) 
and dorsally in the endoderm (between stages 31 and 36) until they reach the dorsal 
crest of the endoderm by stage 40. PGCs exit the endoderm and incorporate into the 
dorsal mesentery, which develops in the coelom at stage 41 (Whitington and Dixon, 
1975). They then migrate to the gonads via the mesentery which connects the gut to 
the region where the mesodermal organs are forming. From stage 44 to 46, the PGCs 
migrate laterally from the mesentery along the abdominal wall and into the forming 
genital ridges (Wylie and Heasman, 1976). During migration the PGCs divide 
approximately 2-3 times so that 20-30 cells populate the genital ridges (Dziadek and 
Dixon, 1977). PGCs then migrate up the genital ridge until they reach the developing 
gonads, where gametogenesis then proceeds. 
1.2 The intracellular localisation of mRNAs 
RNA localisation is an important and common strategy used by cells to localise 
proteins to subcellular domains, to control protein synthesis regionally and is 
particularly important to asymmetrically distribute regulatory proteins into different 
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Figure 1.1: Schematic representation of the movement of PGCs through 
development in Xenopus 
PGCs were followed by using a cell surface antigen. 1-4 represent longitudinal 
sections, 6-13 transverse sections through the hindgut region. Stages are given below. 
B- blastocoel, A- archenteron, C- coelom. The black dots represent PGCs. Mesoderm is 
represented by black shading. The PGCs are present in the endodermal mass until 
neurula stages. They then migrate laterally (9), and then dorsally (10-11) before leaving 
the endoderm and entering the mesentery (12). By stage 46 they have migrated to the 
genital ridges (13). Taken from Heasman and Wylie (1983). 
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cells during cleavage, thereby generating regional and cellular identity within the 
embryo (reviewed in St. Johnston, 1995; King, 1996; King et al., 1999; Schnapp, 
1999). There are four known methods for RNA localisation: spatial control of mRNA 
stability, vectorial nuclear transport, anchorage to localised binding sites and directed 
transport along microtubules or microfilaments (St Johnston, 1995). Whichever 
mechanism is used, it is critical that the localised mRNA is immobilised or anchored 
at the site of localisation and that its translation is coordinated with its localisation. 
Significantly, initial evidence for the existence of specific localised RNAs was 
obtained from Ascidian eggs, where actin mRNA is enriched in the myoplasm 
(Jeffery et al., 1983). Subsequently, many other maternal mRNAs have been shown 
to localise to specific regions of eggs or oocytes (for example, King and Barklis, 
1985; Rebagliati et al., 1985). It is now understood that RNA localisation is essential 
for normal embryonic development and is also used by many somatic cells to deliver 
proteins to discrete sites. Recently, it has been shown that the budding yeast 
Saccharomyces cerevisiae localises RNA encoding cell-fate determinants to the 
distal tip of daughter buds, suggesting that this mechanism is evolutionary conserved 
(Long et al., 1997). The phenomenon of RNA localisation has been examined most 
extensively in oocytes and eggs. Generally oocytes and eggs are considerably larger 
than somatic cells, making them an easier experimental model to use, and the 
majority of known asymmetrically distributed RNAs localise during oogenesis and 
early embryogenesis (Bashirullah et al., 1998). Some of the most dramatic examples 
of asymmetric RNA distribution during oogenesis are the specific localisation of 
several maternally transcribed RNAs to the anterior and posterior poles of 
Drosophila (Micklem, 1995) and C. elegans (Seydoux and Strome, 1999), and to the 
animal and vegetal poles of Xenopus (Smith and Williams, 1975). 
The following sections summarise the steps in development and the localisation of 
RNAs occurring during oogenesis in Xenopus laevis, the species investigated in this 
work. 
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1.2.1 Morphological, subcellular and molecular changes occur during oogenesis 
in Xenopus 
The development of a newly formed Xenopus oocyte into a fertilisable egg usually 
lasts 3 years, but can take as little as 9 months, During this time the oocyte undergoes 
a series of morphological, subcellular and molecular transformations. This process 
was first examined in detail and divided into six consecutive stages by Dumont 
(1972). Stage I oocytes arrest in diplotene and are transparent, have centrally located 
nuclei and do not exhibit any external signs of polarity. There is in fact only one axis 
that is polarised prior to fertilisation, the animal-vegetal (A-V) axis, which is set up 
before the onset of meiosis (Coggins, 1973). In pre-diplotene stages of oogenesis, 
several large mitochondrial aggregates surround the nucleus (al-Mukhtar and Webb, 
1971; Kloc et al., 1996) and these coalesce by stage I into a single mass called the 
mitochondrial cloud or Balbiani body (Balinsky and Devis, 1963) that is positioned 
against the future vegetal side of the nucleus (Figure 1.2). From late stage II of 
oogenesis, oocytes accumulate pigment and yolk and the mitochondrial cloud 
fragments into many islands, which move towards, and anchor at, the vegetal cortex 
of the oocyte (Balinsky and Devis, 1963; Tourte et al., 1984; Heasman et al., 1984). 
During this process of migration and dispersal at the vegetal pole, the mitochondrial 
cloud associates with granular fibrillar components of the germ plasm (Heasman et 
al., 1984), several vegetally localised RNAs (Forristall et al., 1995; Kloc and Etkin, 
1995), vesicles and endoplasmic reticulum (ER) (al-Mukhtar and Webb, 1971; Billett 
and Adam, 1976; Tourte et al., 1984). Shortly after dispersal of the mitochondrial 
cloud at the vegetal cortex, an ER subcompartment forms in the wedge-shaped area 
of the vegetal pole (Deshler et al., 1997), where the components of the mitochondrial 
cloud were previously localised. This ER subdomain also plays a role in localisation 
of RNAs during oogenesis (discussed in Etkin, 1997). 
Eventually, when wild-type Xenopus oocytes are fully grown (at stage VI), they 
show a striking external polarity with a dark, pigmented animal half and a light, less 
pigmented, vegetal hemisphere. The differences in pigmentation reflect a complex 
internal asymmetry at the subcellular and molecular levels. There is polarisation 
along the AN axis in the distribution of organelles, with the nucleus located in the 
animal hemisphere. The vegetal half and/or cortex contains large yolk platelets, germ 
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plasm, Golgi apparatus and specialised regions of ER (Gerhart et al., 1986; Hausen 
and Riebesell, 1991). At the molecular level, several RNAs and proteins are 
differentially distributed along the AN axis. 
Proteins encoded by localised maternal mRNAs are believed to direct cell-fate 
specification. Asymmetric cell divisions in the embryo cause localised maternal 
mRNAs to become segregated to particular cell groups (Forristall et al., 1995), where 
they contribute to patterning of the mesoderm along both AN and D-V axes 
(Lemaire and Gurdon, 1994). D-V axis specification also contributes to 
establishment of left-right asymmetry (Danos and Yost, 1995), which may also 
involve localised maternal factors (Lohr et al., 1997). As already stated, several 
vegetally localised RNAs are transported with the germ plasm as part of the 
mitochondrial cloud in oocytes (Forristall et al., 1995; Kloc and Etkin, 1995). In the 
embryo germ plasm is segregated into a small number of cells, which develop into 
PGCs (Whitington and Dixon, 1975; Ressom and Dixon, 1988; Savage and 
Danilchik, 1993); thus, vegetally localised RNAs in the oocyte could function as 
germ cell determinants (Smith and Williams, 1975). This is discussed further in 
Section 1.3. 
1.2.1.1 Structure and function of the oocyte cytoskeleton in Xenopus 
As mentioned previously, stage VI Xenopus oocytes are polarised along the AN 
axis. AN polarity also extends to the cytoskeleton, which is composed of the three 
major filamentous systems: microtubules (Palecek et al., 1985; Gard, 1991), actin 
microfilaments (F-actin) (Roeder and Gard, 1994) and intermediate filaments 
composed of cytokeratins (Godsave et al., 1984; Klymkowsky et al., 1987; Torpey et 
al., 1992; Gard et al., 1997). These systems may contribute to maintenance or 
establishment of oocyte polarity (reviewed in Gard, 1995; Gard et al., 1995; 
Klymkowsky, 1995). Indeed disruption of the oocyte microtubule array using 
nocodazole or colcemid during formation of the AN axis blocks the vegetal 
localisation of maternal RNAs (Yisraeli et al., 1990), and disruption of microtubules 
or F-actin in stage VI oocytes displaces the germinal vesicle (GV) from its normal 
animal pole location (Colman et al., 1981; Gard, 1991,1993; Roeder and Gard, 
1994). This section details how the cytoskeleton is structured and becomes polarised 
during oogenesis in Xenopus. 
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Microtubules are found throughout the cytoplasm of stage I oocytes, but they are 
poorly ordered and there is no evidence of a microtubule organising centre (MTOC) 
at this stage (Gard, 1991). Starting from stage III of oogenesis, microtubules become 
oriented more radially, extending from the GV to the cortex of the oocyte. By stage 
VI the animal cytoplasm contains loose microtubule bundles which link the GV to 
the animal cortex, while there are fewer, less ordered microtubules extending 
towards the vegetal cortex (Gard, 1991). It has been suggested that the GV acts as an 
MTOC during the later stages of oogenesis (Gard, 1991; 1994). From stage III of 
oogenesis onwards, the majority of microtubules have their minus ends oriented 
towards the oocyte cortex and their plus ends towards the GV (Pfeiffer and Gard, 
1999). 
Unlike most animal cells, Xenopus oocytes lack centrioles and recognisable 
centrosomes (Gard, 1991). The maternal centrosomes are inactivated during early 
stage I of oogenesis before the microtubule array is polarised and prior to the 
establishment of AN axis polarity (Gard, 1991). However, Xenopus eggs do contain 
a substantial amount of centrosomal components, including y-tubulin (Stearns et al., 
1991). y-tubulin was found to be concentrated near the GV surface and in the cortex 
of stage VI oocytes (Gard, 1994). Furthermore, y-tubulin is asymmetrically 
distributed between animal and vegetal cortices of stage IV oocytes, with foci of y 
tubulin concentrated at the vegetal cortex (Gard, 1994; Gard et al., 1995). This 
polarisation in y-tubulin distribution coincides temporally with AN axis formation 
and polarisation of the microtubule array during stage IV of oogenesis (Gard, 1994). 
There could, therefore, be a population of microtubules nucleated by y-tubulin at the 
vegetal cortex with their minus ends at the cortex from stage IV onwards (Pfeiffer 
and Gard, 1999). Thus, y-tubulin could be involved in RNA localisation to the 
vegetal cortex via the late pathway (see Section 1.2.2.2). 
In early stage I oocytes, F-actin is found in the cortex, the GV and in a disorganised 
network of cables in the cytoplasm. In larger stage I oocytes, the GV and 
mitochondrial cloud are linked to the cortex via a dense network of actin 
microfilaments, but there is no evidence of a polarised distribution of F-actin (Roeder 
and Gard, 1994). A network of microfilaments surround the GV of stage VI oocytes 
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and radially oriented actin microfilaments link the animal cortex to the GV. A loose 
three-dimensional network of microfilaments forms in the vegetal hemisphere 
surrounding the yolk platelet clusters of stage VI oocytes (Roeder and Gard, 1994). 
Intermediate filaments first become associated with the GV and the mitochondrial 
mass in previtellogenic stage I oocytes. By late stage I, they form complex networks 
which surround the GV and mitochondrial cloud and connect them to a network of 
intermediate filaments in the oocyte cortex (Godsave et al., 1984; Gard et al., 1997). 
During stage III to early stage N, a highly interconnected network of radially 
oriented intermediate filaments forms, which links the cortical and perinuclear 
intermediate filament networks (Godsave et al., 1984; Gard et al., 1997). Between 
mid-stage N and stage V, this network becomes polarised (Gard et al., 1997), with 
first the animal and then the vegetal intermediate filaments becoming reoriented. 
Stage VI oocytes therefore contain a continuous and polarised network of 
intermediate filaments in their cortex. In the animal cortex, intermediate filaments 
form a network that is thicker and distributed in a finer mesh than the network visible 
at the vegetal cortex (Klymkowsky et al., 1987; Gard et al., 1997). 
Although microtubules, microfilaments and intermediate filaments all have a distinct 
organisation in Xenopus oocytes, there is a great deal of overlap in their cytoplasmic 
distribution (reviewed in Gard, 1995; Gard et al., 1995; Klymkowsky, 1995). 
Networks of all three surround the GV, are present in the cortex and link the GV to 
the animal cortex (Godsave et al., 1984; Palacek et al., 1985; Klymkowsky et al., 
1987; Gard, 1991; Roeder and Gard, 1994). This complex network of interactions 
has led to suggestions that the three cytoskeletal networks may interact or be 
physically associated in Xenopus oocytes (Gard, 1995; Klymkowsky, 1995). Indeed, 
confocal immunofluorescence microscopy, in combination with cytoskeletal 
inhibitors, was employed to demonstrate that a hierarchy of interactions between 
microtubules, microfilaments and intermediate filaments is necessary for A-V 
polarity of the oocyte cytoskeleton (Gard et al., 1997). 
1.2.2 RNA localisation in Xenopus laevis oocytes 
Rebagliati et al. (1985) investigated how cells in different regions of embryos 
acquire different developmental fates by determining whether this was due to the 
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asymmetric distribution of specific mRNAs along the AN axis. They demonstrated 
the existence of the first set of differentially localised RNAs in Xenopus. While most 
maternal RNAs were equally distributed, four were identified as being concentrated 
in either the vegetal (Vgl) or animal (An), An2, Ana) hemispheres. Subsequent 
studies revealed that although Vgl mRNA is uniformly distributed in stage I oocytes, 
it is localised to a vegetal cortical disc in stage IV oocytes (Melton, 1987). This 
vegetal distribution is not accompanied by any change in the RNA (Melton, 1987) 
and persists until oocyte maturation when Vg1 is released from the cortex, but 
remains concentrated in the vegetal cytoplasm (Weeks and Melton, 1987). Vgl 
mRNA is highly enriched in a detergent insoluble fraction (Pondel and King, 1988) 
and is associated with the cortical cytoskeleton (Yisraeli and Melton, 1988). Vgl 
protein has been implicated in the establishment of both dorsal identity (Thomsen 
and Melton, 1993; Joseph and Melton, 1998) and left-right asymmetry of the embryo 
(Hyatt et al., 1996; Hyatt and Yost, 1998). 
Several additional mRNAs that are either vegetally or animally localised have been 
described since (An4,8TrCP, G -proteins, Oct60, PABP, PKCa X121, Xlan4 and 
Xlcaax-1 in the animal hemisphere [reviewed by Bashirullah et al., 1998]; 8TrCP2, 
, 
BTrCP3 (Hudson et al., 1996), VegT (Zhang and King, 1996), Xcat-2, Xcat-3 
(DEADSouth), Xcat-4 (Mosquera et al., 1993), Xlsirt (Kloc et al., 1993), Xwnt-11 
(Ku and Melton, 1993), Xdazl (Houston et al., 1998) and Xpat (Hudson and 
Woodland, 1998) in the vegetal hemisphere. The VegT gene was independently 
identified as Xombi (Lustig et al., 1996), Antipodean (Stennard et al., 1996) and Brat 
(Horb and Thomsen, 1997) in differential or expression screens designed to isolate 
mesodermal patterning genes). 
The animal-pole localisation of mRNAs has not been thoroughly investigated, 
mainly as the relative concentration of mRNAs in that hemisphere is poor (2-fold 
compared to >50-fold for the vegetally localised). Furthermore, unlike vegetal 
messages, which are cortically localised, animal localisation is rather diffuse which 
renders in situ hybridisation analysis of mRNAs technically challenging. 
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The first two vegetally localised clones isolated, Vgl and Xcat-2, were subjected to 
extensive further characterisation (Mosquera et al., 1993; Forristall et al., 1995; Zhou 
and King, 1996b). These studies showed marked differences to exist between the 
localisation of Xcat-2 and Vgl during oogenesis. Unlike Vgl, Xcat-2 is not uniformly 
distributed in stage I oocytes but is localised to the mitochondrial cloud. Xcat-2 
transcripts then move with the mitochondrial cloud to form a small patch at the 
vegetal pole at stage II. Subsequently Xcat-2 RNA forms islands, consistent with its 
being a component of the germ plasm. Xcat-2 remains cortically localised during 
oogenesis, its distribution being more restricted than Vgl (Figure 1.2). Moreover, 
Xcat-2, unlike Vgl, is retained in the vegetal cortex after oocyte maturation 
(Mosquera et al., 1993). Xcat-2 remains in a stippled pattern at the vegetal pole, in 
contrast to the broad ubiquitous vegetal hemisphere distribution of Vgl, until it 
disappears at blastula stages (Mosquera et al., 1993; Forristall et al., 1995). 
These observations led to the suggestion that there are two distinct pathways for the 
localisation of RNAs to the vegetal cortex of Xenopus oocytes (Forristall et al., 1995; 
Kloc and Etkin, 1995): the early mitochondrial cloud pathway, which localises Xcat- 
2 (see Section 1.2.2.2) and a late stage III pathway which Vg1 utilises (Melton, 1987; 
Yisraeli et al., 1990) (see Section 1.2.2.3). These pathways are illustrated in Figure 
1.2. Other RNAs which are distributed at the vegetal pole also appear to localise via 
one of these pathways. Transcripts which utilise the early pathway also appear to be 
able to localise via the late pathway (see Section 1.2.2.4). 
1.2.2.1 The early pathway for vegetal RNA localisation - the METRO 
The early pathway is established prior to and during stage I of oogenesis and occurs 
mainly during the first two stages of oogenesis. It involves the transport of various 
RNAs within a specific area of the mitochondrial cloud, termed the message 
transport organiser (METRO). The METRO-mediated localisation pathway has been 
divided into three steps: transport of RNAs from their site of synthesis in the GV into 
the mitochondrial cloud, sorting of the transcripts to specific regions within the 
cloud, and translocation of the entire structure to the vegetal cortex of the oocyte 
where the different transcripts appear to become anchored in the order Xcat-2, Xlsirt 
and finally Xwnt-11 (Kloc and Etkin, 1995; Kloc et al., 1996). Vegetal localisation of 
RNAs via the METRO is not dependent on microtubules or microfilaments. 
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Figure 1.2: Vegetal RNA localisation pathways in Xenopus oocytes 
Lateral views. GV, germinal vesicle; MC, mitochondrial cloud. Early pathway: RNAs localised via the early 
pathway include Xcat-2, Xwnt-11 and Xlsirts, and are shown in blue in this diagram. These transcripts first 
associate with the mitochondrial aggregates surrounding the nucleus (GV) in pre-stage I oocytes. As the 
mitochondrial aggregates coalesce to form the mitochondrial cloud during stage I, early pathway RNAs localise to 
its future vegetal side. At late stage II of oogenesis, coincident with the fragmentation of the mitochondrial cloud, 
early pathway RNAs move towards the vegetal cortex in a wedge-shaped pattern and disperse in a disc-shaped 
region at the vegetal pole. Late pathway: Vgl RNA is localised by the late pathway and is depicted in red in this 
figure. Vgl is ubiquitously expressed in the cytoplasm of stage I and II oocytes, but is excluded from the 
mitochondrial cloud. During stage II-III of oogenesis, Vgl colocalises with an ER-subcompartment in a wedge- 
shaped region of the vegetal hemisphere also occupied by METRO RNAs. Vg 1 moves to the vegetal pole during 
stages II-III and becomes distributed along the entire vegetal cortex during stage IV of oogenesis. (Adapted from 
Schnapp et al., 1997; King et al., 1999). 
Microfilaments are, however, necessary for tight anchorage at the vegetal cortex 
(Kloc and Etkin, 1995; Kloc et al., 1996). 
1.2.2.1.1 Localisation of Xcat-2 mRNA. 
Microinjected Xcat-2 mRNA localises to the mitochondrial cloud of stage I oocytes 
within 22 hours of injection (thou and King, 1996a). It appears to be localised by 
entrapment as it becomes concentrated in the cloud and depleted in the cytoplasm, 
yet a gradient is never detected (Zhou and King, 1996a). Exogenous Xlsirts are also 
able to localise into the mitochondrial cloud (Kloc et al., 1996). 
The minimum cis-localisation element necessary to direct Xcat-2 localisation to the 
mitochondrial cloud was mapped to a 227 nt region at the proximal end of the 3' 
UTR (403-630 nt). This therefore served as a mitochondrial cloud localisation 
element (MCLE; Zhou and King, 1996a). This region includes a 150 nt proximal 
domain shown to be required (in addition to the last 120 nt of the 3' UTR) for 
cortical localisation (Zhou and King, 1996b). Also, when fused to a luciferase 
reporter the MCLE directed this mRNA to the cloud. 
Kloc et al. (2000a) utilised Xcat-2 as a molecular marker in conjunction with in situ 
hybridisation and electron microscopy to identify a cis-acting element on Xcat-2 
mRNA that targets it to the germinal granules. This was achieved by the creation of a 
series of constructs that deleted various regions of the Xcat-2 mRNA 3' UTR. 
Targeting of Xcat-2 to the germinal granules was shown to be achieved by the distal 
164 nt of the Xcat-2 3' UTR (631-795 nt) termed the GGLE (germinal granules 
localisation element). The GGLE is distinct from the MCLE, which is capable of 
targeting Xcat-2 to the mitochondrial cloud, but not to the germinal granules (Zhou 
and King, 1996a, b; Kloc et al., 2000a). Thus, the 3' UTR of Xcat-2 possesses a 
compound localisation element in which the proximal 227 nt contain a cis-acting 
element (MCLE) responsible for localisation of the RNA to the mitochondrial cloud 
and a distal 164 nt GGLE that is necessary and sufficient to target it to the germinal 
granules within the cloud. The GGLE was sufficient to target a non-granule 
mitochondrial cloud associated RNA to the germinal granules (Kloc et al., 2000a). 
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1.2.2.2. The late pathway for RNA localisation to the vegetal cortex 
The late pathway of vegetal localisation was initially described for Vgl mRNA 
(Rebagliati et al., 1995; Melton, 1987; Kloc and Ftkin, 1995; Forristall et al., 1995) 
and subsequently for Xcat-4,09, $12, VegT and fatvg (King, 1995; Lustig et al., 
1996; Stennard et al., 1996; Zhang and King, 1996; Horb and Thomsen, 1997; Zhang 
et al., 1998; Chan et al., 1999). However, since only the former has been extensively 
investigated, the pathway is also referred to as Vgl-like localisation. Other RNAs 
from this group behave in a similar fashion to Vgl. 
RNAs normally localised by the late pathway are distributed homogeneously 
throughout the cytoplasm of stage I oocytes and are excluded from the mitochondrial 
cloud. In late stage II oocytes, Vgl mRNA aggregates into a crescent-shaped body 
located between the vegetal pole and the nucleus. The crescent consists of a 
concentration of mitochondria and ER and also contains spectrin and tubulin 
(Palacek and Ubbels, 1997; Kloc and Etkin, 1998; Chan et al., 1999). The onset of 
Vg1 localisation involves its microtubule-independent binding to an ER subdomain 
(Kloc and Etkin, 1998). At late stage II to early stage III, Vg1 mRNA aggregates into 
a wedge-shaped structure that forms between the crescent and the vegetal cortex 
(Kloc and Etkin, 1995). Spatially and temporally the formation of the wedge 
overlaps with movement of the mitochondrial cloud (Yisraeli and Melton, 1988; 
Kloc and Etkin, 1994,1995,1998; Forristall et al., 1995). From stage IV onwards, 
Vg1 migrates to the vegetal cortex of the oocyte and anchors there. The localisation 
of Vgl is first limited to the tip of the oocyte's vegetal pole but over time it spreads 
toward the equator and becomes distributed over the entire vegetal cortex (Melton, 
1987; Pondel and King, 1988; Yisraeli et al., 1990; Elinson et al., 1993). Thus, in 
comparison to the METRO RNAs, localised Vg1 occupies a broader region of the 
vegetal cortex (Kloc and Etkin, 1995). 
The translocation of Vgl to the vegetal hemisphere was shown, using cytoskeletal 
inhibitors and immunohistochemistry, to be dependent on cytoplasmic microtubules. 
Conversely, the anchoring of Vgl at the vegetal cortex, is achieved with the 
involvement of cortical actin microfilaments (Yisraeli et al., 1990). Thus, the oocyte 
cytoskeleton is critical in the localisation of transcripts by the Vgl-like pathway 
(Yisraeli et al., 1990). 
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The anchoring step has also been demonstrated to depend upon the correct 
localisation of the formerly anchored Xlsirts transcripts (Kloc and Etkin, 1994). This 
dependence of Vgl (but not Xcat-2) on Xlsirts localisation was shown by disruption 
of Xlsirts with antisense oligodeoxynucleotides, which resulted in release of Vgl 
from the vegetal cortex. 
Light and electron microscopy in situ hybridisation have been used to show that 
RNAs localised by the late pathway are excluded from the germ plasm in oocytes 
and embryos (1{loc et al., 1998). 
1.2.2.2.1 The localisation of Vgl RNA 
After Yisraeli and Melton (1988) demonstrated that exogenous Vg1 mRNA localises 
in the same way as endogenous Vgl in middle stage oocytes, sequences present in 
Vgl RNA that are required for its localisation became the subject of extensive 
searches. A 340 nt sequence from the Vgl 3' UTR was found to be both necessary 
and sufficient to direct localisation of Vgl to the vegetal cortex (Mowry and Melton, 
1992). Subsequently, sequence elements and protein binding sites have been 
discovered in this localisation element (LE) (Schwartz et al., 1992; Gottlieb, 1992; 
Elisha et al., 1995; Mowry, 1996; Deshler et al., 1997; Gautreau et al., 1997). 
Mutational analysis of the Vgl LE identified an 85 nt subelement from the 5' end of 
the 340 nt sequence, which when duplicated is sufficient to direct vegetal localisation 
(Gautreau et al., 1997). Furthermore, a repeated 6 nt sequence motif (UUUCUA) 
called VM1 (Vg1 motif 1) was identified within the subelement that is vital for 
localisation (Gautreau et al, 1997). \ Point mutations within VM1 abolish Vgl 
localisation in vivo. VM1 is believed to act as a binding site for an essential trans- 
acting localisation factor (Gautreau et al., 1997). 
Transport of Vgl RNA is thought to begin with recognition of the RNA LE by 
proteins involved in localisation (Melton, 1987; Yisraeli et al., 1990; Mowry, 1996). 
Vgl RNA-binding proteins (VgRBPs) with potential roles in the localisation process 
have been identified by their ability to specifically bind to the Vg1 LE. There are 6 
polypeptides that become cross-linked to the Vgl LE upon UV irradiation, named 
according to their molecular weights as p78, p69, p60, p40, p36 and p33 (Mowry, 
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1996). Two of the cross-linked proteins have been identified. p69 is Vg1RBP/Vera 
(Schwartz et al., 1992; Havin et al., 1998; Deshler et al., 1998). Vg1RBP and Vera 
were separately isolated as two proteins, but have now been shown to be identical. 
This protein is highly homologous to the rnicrofilament- and RNA-binding Zipcode 
binding protein (ZBP-1). ZBP-1 is involved in ß-actin mRNA localisation in chick 
embryonic fibroblasts (Ross et al., 1997). The predicted amino acid sequences of 
ZBP-1 and Vg1RBP/Vera contain five putative RNA-binding motifs: one RRM and 
four KH domains. p60 is a homologue of human hnRNPI and is referred to as 
VgRBP60 (Cote et at, 1999). 
Vg1RBP1Vera associates with both Vgl RNA and microtubules and is necessary for 
their association (Elisha et al., 1995). This protein also binds to a Vg1RBP binding 
site present in the rat tau RNA 3' UTR which, upon injection, localises to the vegetal 
pole of stage III-IV oocytes in a distribution indistinguishable from Vg1 RNA 
(Litman et al., 1996). Tau RNA is localised in rat axons and cell bodies in a 
microtubule-dependent manner. This is strong evidence that Vg1RBP is involved in 
vegetal localisation of RNAs in oocytes. Apart from its microtubule association, an 
ER association of Vg1RBP was suggested by Deshler et al. (1997,1998) based on 
the colocalisation of Vgl mRNA with a marker of the rough ER. Sequences 
necessary for Vg1RBP binding were also required for RNA localisation, implying a 
link between these processes (Deshler et al., 1997). ER vesicles have been shown to 
be transported along microtubules (discussed in Deshler et al., 1997), and the ER is 
found near to the cytoskeleton at the vegetal cortex (Elinson et al., 1993). 
VgRBP60 is an essential trans-acting localisation factor which, like Vg1RBP, 
directly interacts with Vgl's VM1 motif and colocalises with Vgl in the vegetal 
cytoplasm. The base modifications within VM1 which specifically block VgRBP60 
binding were shown to abolish Vgl RNA localisation in vivo (Cote et al., 1999). 
Recently, Prrp (proline-rich RNA-binding protein; Zhao et al., 2001a) has been 
identified, which colocalises with Vgl at the vegetal cortex in stage IV oocytes and 
also interacts with Vgl's LE. 
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Vg1RBP/Vera, VgRBP60 and Prrp all colocalise with Vgl RNA in the vegetal cortex 
in oocytes, and Vg1RBP/Vera and VgRBP60 share distribution patterns with Vgl 
RNA during localisation, These results indicate that these 3 proteins are likely to be 
in a complex with Vgl during translocation to the vegetal cortex. They could all be 
involved in cortical anchoring, RNA targeting and/or translational control. 
1.2.2.3 Continuity between the early and late RNA localisation pathways 
Kloc and Etkin (1998) first proposed a model in which the establishment of the late 
localisation pathway is a sequential process that involves interaction with the 
METRO. This proposal was based upon the observations that the initial step in Vgl 
localisation in stage II oocytes involves microtubule-independent association with 
the wedge-shaped subdomain of the ER, closely associated with movement of the 
mitcochondrial cloud. The mitochondrial cloud was also seen to overlap with a y- 
tubulin-containing body that may function as an MTOC during stage III and IV of 
oogenesis (Kloc and Etkin, 1998). 
The two vegetal localisation pathways in the Xenopus oocyte are not exclusive in 
their choice of RNA targets. Therefore, in stage III/IV oocytes, where endogenous 
Xcat-2 has already localised to the vegetal cortex via the METRO, injected Xcat-2 
can also localise to the vegetal pole in a similar manner to, though not as efficiently 
as, Vgl mRNA. This process is sensitive to microtubule depolymerisation (Zhou and 
King, 1996b). Similarly, when Xpat mRNA is injected into stage III oocytes it 
localises in a broader domain than the germ plasm at the vegetal pole, appearing 
much like Vgl. This is in contrast to endogenous Xpat which localises, via the 
METRO, to the germ plasm (Hudson and Woodland, 1998). This indicates that there 
are cis- and trans-acting factors common for the two localisation pathways. 
However, it is not clear if there might be some long-term maintenance of Xcat-2 and 
Xpat mRNAs in the germ plasm via continual synthesis and transport by the Vgl 
pathway. 
Chan et al. (1999) defined a 25 nt element (FVLE 1) present in the fatvg 3' UTR that 
could direct localisation of fatvg through the late pathway. This element is different 
from any of the Vgl LEs. fatvg mRNA exhibits a localisation pattern similar, though 
not identical, to Vgl. However, somefatvg mRNA associates with the mitochondrial 
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cloud in stage II oocytes immediately before the late pathway functions. Electron 
microscopy in situ hybridisation revealed that fatvg RNA is localised in the germ 
plasm matrix, but is excluded from the germinal granules (Chan et al., 2001). Thus, 
fatvg demonstrates the overall characteristic of a late pathway RNA, but also 
associates with the mitochondrial cloud and germ plasm, as METRO RNAs do. 
Thus, fatvg localisation also suggests there is continuity between the METRO and 
late pathways (Chan et al., 1999,2001). 
1.3 Molecules localised to the germ plasm 
The following sections summarise what is known about molecules localised to the 
germ plasm in the two most extensively examined species: Drosophila (reviewed in 
Gavis, 1997; Houston and King, 2000a) and Xenopus laevis, the system investigated 
in this work (Reviewed by Schnapp et al., 1997; King et al., 1999; Houston and 
King, 2000a). There are also several known genes which affect germ cell 
development in Caenorhabditis elegans. Rather than discuss these here, the reader is 
instead directed to recent reviews elsewhere (Wylie, 1999; Seydoux and Strome, 
1999). 
1.3.1 Genes involved in Drosophila pole cell development 
The pathway of genes involved in pole cell development in Drosophila is 
summarised in Figure 1.3. 
1.3.1.1 - oskar 
oskar (osk) is the inducer of pole plasm assembly in Drosophila and is critical for 
germ-line formation. osk RNA is localised to the posterior pole of the oocyte when 
germ plasm forms (Ephrussi et al., 1991). The amount of osk at the posterior pole 
determines the number of pole cells formed (Ephrussi and Lehmann, 1992; Smith et 
al., 1992). Replacement of the osk 3' UTR with that of bicoid (bcd), an RNA which 
localises to the anterior pole, causes osk to be mislocalised to the anterior of the 
oocyte. Ectopic pole plasm and functional pole cells form at the anterior pole and a 
second abdomen forms in mirror image to the posterior abdomen (Ephrussi and 
Lehmann, 1992). 
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Figure 1.3: The hierarchy of genes involved in the assembly of pole plasm and abdominal segmentation in 
Drosophila 
The diagram illustrates the majority of genetic interactions discussed in Section 1.3.1. Proteins are in normal type, 
RNAs in italics and putative and proven germ granule components are in red. Lines ending with arrowheads indicate 
positive interaction, activation or localisation, whereas lines ending with a vertical bar indicate translational 
repression by a trans-acting factor. The question mark adjacent to dIF2 is because it is unknown whether this protein 
is directly involved in activation of gurken translation by Vasa. Valois, orb and homeless have not been included in 
the figure as their roles in germ plasm formation are, as yet, unclear. (Adapted from Rongo and Lehmann, 1996). 
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Osk protein directs the localisation of Vasa (vas) and Tudor (tud) proteins and nanos 
(nos) RNA and the protein it encodes to the ectopic site. The activity of these genes 
is necessary for the formation of ectopic germ cells and abdomen. These experiments 
indicate that the site at which osk is localised within the oocyte determines where the 
germ plasm will form (Ephrussi and Lehmann, 1992). 
The initial orientation of the cytoskeleton during early oogenesis is critical to the 
positioning of osk. Direct observation of the oocyte cytoskeleton and studies with 
microtubule depolymerising agents and mutant embryos lacking tropomyosin II 
implicate a role for the microtubule network in the localisation of osk to the posterior 
pole (Theurkauf et al., 1992,1993; Clark et al., 1994; Pokrywka and Stephenson, 
1995; Erdelyi et al., 1995; Glotzer et al., 1997). The colocalisation of osk with a 
microtubule plus end-directed motor protein also suggests that osk localisation 
depends on intact microtubules (Clark et al., 1994). Likewise, the mislocalisation of 
osk to the centre of oocytes with MTOCs at both anterior and posterior poles 
supports this notion (Glotzer and Ephrussi, 1996). Shulman et al. (2000) identified 
the Drosophila homologue of C. elegans PAR-1, which localises to the posterior 
pole of oocytes. osk is mislocalised to the centre of oocytes lacking par-1. This 
phenotype results from disorganisation of the oocyte microtubule network. Thus, in 
wild-type Drosophila, PAR-1 could play a role in the microtubule-dependent 
polarisation of the A-P axis and thus define the posterior pole as a site for osk 
localisation (Shulman et al., 2000). A domain in Staufen necessary for the 
microtubule-dependent localisation of osk has also been discovered recently 
(Micklem et al., 2000). 
Osk protein is produced, by alternative codon usage, as two isoforms, of which the 
shorter is the functional protein (Markussen et al., 1995; Rongo et al., 1995). In the 
embryo, the two Osk species show different localisation patterns. Long Osk is 
detected just until pole cell formation whereas short Osk persists and is incorporated 
into the pole cells. Short Osk can rescue the defects of osk pole plasm mutants, 
whereas long Osk cannot (Markussen et al., 1995). Osk protein directly interacts 
with both Vas and Staufen proteins in a yeast two-hybrid assay (Breitwesser et al., 
1996) and only the functional short Osk can recruit these proteins to the posterior 
pole. They in turn, along with Tud and Osk itself, aid the accumulation of Osk 
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protein at the posterior pole (Markussen et al., 1995). One of Vas's functions is in 
the phosphorylation of short Osk (ßreitwesser et al., 1996). 
The correct localisation of ask is required for its translation (Gavis and Lehmann, 
1994; Markussen et al 1995; Rongo et al., 1995). Indeed osk remains translationally 
repressed in mutants that prevent ask RNA localisation to the posterior pole 
(Markussen et al., 1995; Rongo et al., 1995). Premature translation of ask outside the 
posterior pole is prevented by Bruno, which recognises and binds specifically to a 
conserved repeated sequence (the Bruno response element - BRE) in the 3' UTR of 
osk (Kim-Ha et al., 1995; Webster et al., 1997; Lie and Macdonald, 1999). 
Translation of localised osk is specifically activated via an element present in the 5' 
region of the mRNA. The element is only needed when the transcript is repressed via 
the BRE and only active at the posterior pole. Thus, the 5' region of osk functions as 
a translational derepressor element. A direct correlation has been demonstrated 
between the derepression of osk translation and the binding of two proteins to this 
element. One of the proteins which binds to the 5' end of osk also interacts with the 
BRE in the 3' UTR. This binding is necessary for complete repression of osk 
translation. It has been shown that the BRE-mediated translational regulation of osk 
occurs independently of the 5' cap in vitro. This suggests that Bruno interferes with a 
step in translation other than recognition of the cap (Lie and Macdonald, 1999). 
Saffman et al. (1998) discovered that in Drosophila oocytes lacking Bicaudal-C, 
translation of osk commenced before the localisation of osk to the posterior pole. 
Since Bicaudal-C is an RNA-binding protein, these results when taken together 
indicate it may act directly to repress osk translation during oogenesis (Saffman et 
al., 1998). Recently, a domain in Staufen has been shown to be necessary for the 
derepression of osk mRNA translation after it is localised (Micklem et at., 2000). 
1.3.1.2 Genes required for the localisation of oskar 
The localisation of osk to the posterior pole of the oocyte and thus assembly of pole 
plasm material there is dependent on the activity of the following genes: cappuccino 
(capu), spire (spir), staufen (stau), valois (vls), mago nashi (mago), orb, homeless 
and tropomyosin II. These genes and their products will not be discussed further 
21 
here, but have been reviewed extensively elsewhere (Rongo and Lehmann, 1996; 
Rongo et at., 1997). 
Recently, another gene required for the localisation of osk mRNA has been 
described, barentsz (van Eeden et at., 2001). In contrast to other defined mutations 
that affect this process, oocytes lacking barentsz exhibit no posterior localisation of 
osk, but have wild-type bicoid and gurken localisation and microtubule organisation 
and show no alteration in subsequent steps in pole plasm assembly. Barentsz protein 
colocalises with osk to the posterior pole and this localisation is dependent on osk 
mRNA. However, Barentsz, unlike Staufen, does not remain in the posterior pole and 
only colocalises with osk during the stages when it is being transported. Thus, 
Barentsz is essential for the movement of osk from the anterior to the posterior pole 
and it acts like a specific component of the osk localisation complex (van Eeden et 
al., 2001). 
1.3.1.3 Nanos 
In Drosophila, the apparatus which localises the germ plasm also localises the 
posterior determinant in embryonic patterning, Nanos (Nos) (Wang and Lehmann, 
1991; Rongo and Lehmann, 1996). In fertilised eggs, only nos mRNA at the 
posterior pole is translated (Gavis and Lehmann, 1994), which creates a gradient of 
Nos protein emanating from the posterior (Gavis and Lehmann, 1994; Dahanukar 
and Wharton, 1996). 
Nos is a zinc-finger protein, which together with another protein Pumilio (Pum), acts 
to repress translation of maternal hunchback (hb) in the posterior pole allowing 
development of the abdomen (Barker et al., 1992; Tautz and Pfeifle, 1989). Pum is 
an RNA-binding protein which can specifically bind the nos response elements 
(NREs) in the 3' UTR of hb (Wharton and Struhl, 1991; Murata and Wharton, 1995; 
Zamore et al., 1997). Pum is distributed throughout the embryo, yet is only able to 
repress hb translation in the posterior pole, thus it has been suggested that interaction 
of RNA-bound Pum with posteriorly localised nos mediates translational repression 
(Murata and Wharton, 1995). A Xenopus Pumilio homologue has recently been 
cloned and shown to bind Xcat-2 mRNA, a homologue of nos (Nakahata et al., 2001) 
(see Section 1.3.2.2). 
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Nos protein localised at the posterior pole of fertilised eggs incorporates into forming 
germ cells. Nos is present in germ cells throughout embryogenesis, but is absent 
from the rest of the embryo (Wang et al., 1994). Nos protein is also detected in germ- 
line stem cells and developing cystoblasts in the adult ovary (Wang et al., 1994). 
While not necessary for pole cell formation, maternal Nos protein is essential for the 
migration of germ cells to the gonads, after their exit from the posterior midgut 
(Forbes and Lehmann, 1998), and to prevent premature gene expression in pole cells 
(Kobayashi et al., 1996). 
In pum mutants, ovaries fail to maintain stem cells and all germ-line cells 
differentiate into egg chambers. However, Nos appears to function in differentiation 
of the cytoblast, the stem cell progeny (Forbes and Lehmann, 1998). Thus, it has 
been suggested that in germ-line development, in contrast to embryonic patterning, 
Nos and Pum may interact with different partners. 
nos RNA is localised to the posterior pole by a large cis-acting signal in the nos 3' 
UTR (Gavis and Lehmann, 1992,1994; Gavis et al., 1996). Translation of 
unlocalised nos RNA is repressed by a 90 nt translational control element (TCE) 
located at the proximal end of the 3' UTR (Gavis et al., 1996; Dahanukar and 
Wharton, 1996; Smibert et al., 1996). Only a small proportion of all nos RNA in an 
embryo is localised to the posterior pole, thus indicating that restriction of Nos 
protein to the posterior pole must occur by translational repression (Gavis and 
Lehmann, 1994; Bergsten and Gavis, 1999). Bergsten and Gavis (1999) increased the 
number of potential sites in nos available for binding of translational repressors and 
localisation factors by using multiple copies of nos 3' UTR elements in transgenes. 
They determined that localisation of nos and its translational repression are mutually 
exclusive; indeed RNA localisation of nos activates its translation by preventing nos 
RNA from interaction with translational repressors. This is achieved by a 180 nt 
region of the nos localisation element, which contains the TCE (and the +2' element, 
see later; Dahanukar and Wharton, 1996; Bergsten and Gavis, 1999). 
Smaug protein is distributed uniformly throughout the early Drosophila embryo and 
can bind to the nos TCE (in vitro and) in vivo and prevent its translation outside of 
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the posterior pole (Smibert et al., 1996; Dahanukar et al., 1999). Smaug was also 
shown to physically interact with Osk, which is critical for the activation of nos 
RNA. These observations indicate that Smaug is important in restricting Nos protein 
to the posterior of the embryo (Dahanukar et al., 1999). 
Genetic analysis implicates Osk, Vas and Tud in a localisation complex which 
anchors nos RNA to the posterior pole (reviewed by Gavis, 1997). Bergsten and 
Gavis (1999) suggested that the binding of nos 3' UTR localisation elements by 
distinct factors promotes association of nos RNA with germ plasm components. 
Recently, Evans-Bergsten et al. (2001) dissected the minimal requirements for 
function of the nos localisation signal by focusing on the 88 nt +2' element, which is 
located directly adjacent to the TCE (at its proximal side) within the nos 3' UTR. A 
protein (p75) present in ovaries and embryos was found to specifically recognise a 41 
nt domain within the +2' element, that is highly conserved between D. melanogaster 
and D. virilis. Mutations disrupting binding of p75 to the +2' element also disrupted 
in vivo localisation, thus implicating p75 in nos RNA localisation. 
1.3.1.4 Aubergine 
Aubergine (Aub) is a cytoplasmic protein that is related to eukaryotic translation 
initiation factor 2C (eIF2C) and thus may have a direct role in translational 
activation. Aub accumulates in pole plasm in a vas-dependent manner and is itself a 
component of the polar granules, whilst aub mRNA is not localised in the oocyte 
(Harris and Macdonald, 2001). aub mutants do not demonstrate efficient translation 
of osk and thus have defective pole cell formation and posterior patterning. Aub 
protein has a role in the posterior localisation of nos (Wilson et al., 1996), as well as 
in pole cell formation (Harris and Macdonald, 2001). However, Aub's role in pole 
cell formation appears to be independent from its role in the activation of osk 
translation (Harris and Macdonald, 2001). This was demonstrated as osk translation 
begins before accumulation of Aub at the posterior pole, and can occur even if the 
Aub concentration is reduced at the posterior pole. Using aub ` embryos and an osk- 
bcd transgene, which localises anteriorally, Aub was shown to be necessary for 
ectopic pole cell development and therefore also likely to be involved in this process 
at the posterior pole (Harris and Macdonald, 2001). 
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There are a number of localised mRNAs that affect Drosophila germ cell formation, 
but not that of the abdomen (via nanos). These are discussed in the following 
sections. 
1.3.1.5 germcell-less 
germcell-less (gcl) encodes a protein that specifically associates with the nuclei 
which migrate into pole plasm and become incorporated into pole cells. Reduction of 
maternal gcl mRNA levels causes the resulting embryos to lack pole cells, yet they 
have a normal posterior axis (Jongens et al., 1992). Similarly, transgenic mothers 
which overexpress gcl produce progeny with increased numbers of pole cells. 
However, these pole cells undergo fewer divisions or die before or during the 
formation of the cellular blastoderm, Mislocalisation of gcl RNA to the embryo's 
anterior pole causes the ectopic initiation of events similar to those seen during 
normal pole cell formation (Jongens et al., 1994). These effects did not occur as a 
result of ectopic localisation of any other pole cell components but solely as a result 
of gcl concentration. Mutant embryos completely lacking gcl failed to establish a 
germ-line. gcl activity was shown to be required for formation of proper pole buds 
and pole cells and survival of pole cells (Robertson et al., 1999). High-resolution, 
three-dimensional wide-field microscopy and immunoelectron microscopy was used 
to analyse the subcellular localisation of Gcl. Gcl protein was seen to associate 
specifically with the nuclear pores of pole cells (Jongens et al., 1994). The correct 
localisation of Gcl to the nuclear envelope was found to be critical for formation of 
pole cells, but was not required to initiate and form proper pole buds (Robertson et 
al., 1999). 
1.3.1.6 polar granule component 
An untranslated RNA, termed polar granule component (pgc) was identified and 
found to localise to polar granules. pgc is expressed only in female germ cells 
(Nakamura et al., 1996). Transgenic female flies expressing antisense pgc RNA 
contained pole cells which failed to complete migration or populate the embryonic 
gonads; and their nos and gcl RNA and Vas protein signals were reduced in intensity. 
Furthermore, females that developed from these embryos frequently had ovaries 
which completely lacked gametes. Thus, pgc RNA has an essential role in the 
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differentiation of pole cells into functional germ cells in females (Nakamura et al., 
1996). 
1.3.1.7 indora 
indora (ind) mRNA is expressed specifically in pole cells within embryonic gonads. 
Antisense reduction of Or mRNA in embryos causes failure of pole cells to develop 
into functional germ cells in females. Thus, induction of Or in pole cells is, like pgc, 
necessary for correct germ-line development in females (Mukai et al., 1999). 
1.3.1.8 mitochondrial rRNAs 
Mitochondrial large ribosomal RNA (mtlrRNA) localises to Drosophila pole plasm 
and injection of mtlrRNA into UV-sterilised embryos restores pole cell (though not 
functional germ cell) formation (Kobayashi and Okada, 1989). Because mtlrRNA is 
exclusively encoded by the mitochondrial genome, it appears that it is transported out 
of mitochondria to reach polar granules in germ plasm (Kobayashi and Okada, 
1989). A combination of light and electron microscopy in situ hybridisation has 
shown that mtlrRNA is present outside mitochondria and localises to the polar 
granules within the pole plasm of early cleavage embryos. However, it does not 
localise to the granules of pole cells (Kobayashi et al., 1993,1994,1995; Amikura et 
al., 1996). The localisation of mtlrRNA is dependent on the function of osk, vas and 
tud genes (Ding et al., 1994; Kobayashi et al., 1994; 1995). The injection of anti- 
mtlrRNA ribozymes into cleavage embryos reduces mtlrRNA in germ plasm and 
inhibits pole cell formation (Lida and Kobayashi, 1998). osk and gcl mRNAs and Vas 
and Tud proteins are not affected in these embryos. Thus, while mtlrRNA has an 
essential role in pole cell formation (Iida and Kobayashi, 1998), it is not required for 
the differentiation of pole cells into functional germ cells (Kobayashi and Okada, 
1989; Amikura et al., 1996). 
Mitochondrial small ribosomal RNA (mtsrRNA) has also been identified as a 
component of polar granules (Kashikawa et al., 1999). The temporal and spatial 
distribution of mtsrRNA is essentially identical to that of mtlrRNA, and mtsrRNA 
localises on polar granules of cleavage stage embryos. As for mtlrRNA, mtsrRNA 
localisation is dependent on the function of osk vas and tud genes (Kashikawa et al., 
1999). It has recently been shown that mtsrRNA and mtlrRNA both localise in 
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mitochondrial-type ribosomes formed on the surface of the polar granules for a short 
time prior to pole cell formation (Amikura et al., 2001b). Ultrastructural analysis 
indicates that at least two mitochondrial ribosomal proteins are found in these 
ribosomes, as well as in mitochondria. These mitochondrial-type ribosomes are 
smaller than cytosolic ribosomes and are integrated into polysomes (active sites of 
translation) on the polar granules. Furthermore, ribosomes were only seen on polar 
granules when the mtrRNAs and proteins were present on the granules. Amikura et 
al. (2001b) proposed that translation from these mitochondrial-type ribosomes is 
important in formation of the Drosophila germ-line. 
1.3.1.9 Vasa 
Vas protein is detected throughout the development of the germ-line in Drosophila. 
Maternal Vas incorporates into pole cells and is distributed in embryonic gonads and 
in the germ-line throughout oogenesis. During mid-oogenesis, Vas protein localises 
to the pole plasm at the posterior pole of the oocyte, and its localisation depends 
upon the functions of capu, spar, osk and stau (Hay et at., 1988a, b, 1990; Lasko and 
Ashburner, 1990; Liang et al., 1994). The recruitment of other molecules to the pole 
plasm later in oogenesis (including nos, pum, gel, mtlrRNA and Tud protein) depends 
on vas function, vas null embryos are defective in many aspects of oogenesis, 
including oocyte differentiation; vas females produce few or no eggs (Lasko and 
Ashburner, 1988). Furthermore, vas-null oocytes cannot efficiently accumulate orb, 
Bicaudal-D, osk or nos, but are still able to accumulate gurken mRNA. However, 
Gurken protein accumulation is severely reduced in vas ovaries. vas mutants show 
AT and D-V axis polarity defects which appear to be linked to the reduction in 
Gurken protein levels (Tomancak et al., 1998). Vas functions in activating gurken 
translation early in oogenesis and aids accumulation of gurken mRNA later in 
oogenesis (Styhler et al., 1998; Tomancak et al., 1998). 
Vas is a member of the DEAD-box family of putative RNA helicases, similar to 
eukaryotic initiation factor 4A (eIF4A) (Hay et al., 1988b). Vas has been shown to 
function as an ATP-dependent RNA helicase in vitro, and vas mutants that cannot 
bind RNA do not form polar granules (Liang et al., 1994). Recruitment of Vas to the 
pole plasm is dependent on protein-protein interactions, but after localisation Vas 
binds RNA to mediate formation of germ cells (Liang et al., 1994). The posterior 
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accumulation of Vas is mediated by its interaction with Osk protein (Breitwesser et 
al., 1996). Recently Vas protein has been shown to directly interact with the 
Drosophila homologue of yeast translation initiation factor 2, encoded by dIF2, in 
vitro and in vivo (Carrera et al., 2000). Therefore, Vas may regulate translation of 
germ-line mRNAs by interacting specifically with dIF2 (Carrera et al., 2000). 
1.3.1.10 Tudor 
Vas protein is necessary for the recruitment of Tud to the polar granules. tud RNA is 
not found in the oocyte, thus the protein is apparently transported from the nurse 
cells (Golumbeski et al 1991), Tud protein is found in the mitochondria present in 
pole plasm and around cleavage stage nuclei, as well as in germ granules (Bardsley 
et al,, 1993). tud mutants do not form polar granules or pole cells, thus tud, like osk 
and vas, is absolutely required for determination and formation of pole cells (Boswell 
and Mahowald, 1985). Furthermore, as with osk, the number of pole cells that form 
in embryos is proportional to the amount of Tud protein that accumulates at the 
posterior pole (Bardsley et al,, 1993), It has recently been discovered that embryos 
derived from tud females exhibit reduced localisation of mtlrRNA and mtsrRNA. In 
normal embryos, Tud protein colocalises with the two mtrRNAs at the boundaries 
between polar granules and mitochondria, when mtrRNA transport occurs. Thus Tud 
appears to be required for mediating transport of mtrRNAs from mitochondria to 
polar granules (Amikura et al., 2001 a). 
1.3.2 Xenopus germ plasm localised RNAs 
Over the last decade, a number of RNAs that localise to the germ plasm of Xenopus 
have been identified (reviewed in Wylie, 1999; King et al., 1999). However, only 
recently have functional studies allowed the roles of some of these RNAs to be 
determined (reviewed in Houston and King, 2000a; Kloc et al., 2001). 
1.3.2.1 Xcat-2 
Xcat-2 (Xenopus aytoskeletal associated transcript 2) was originally isolated and 
characterised by Mosquera et al. (1993) (see Section 1.2.2). Xcat-2 mRNA was seen, 
by in situ hybridisation, to localise to the mitochondrial cloud and it moves with the 
cloud material to the vegetal cortex early in oogenesis (Forristall et al., 1995). Xcat-2 
mRNA has a distribution pattern entirely consistent with it being a germ plasm 
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component (Forristall et al., 1995; Kloc et al., 1998). Indeed Kloc et al. (1998) 
showed that, at the ultrastructural level, Xcat-2 mRNA is localised on the germinal 
granules themselves. 
Xcat-2 encodes a protein that is a member of the CCHC RNA-binding family of Zinc 
finger proteins, and is closely related to Nos (Mosquera et at., 1993). Xcat-2 protein 
is able to bind RNA in an in vitro assay (MacArthur et at., 1999). Using an Xcat-2 
specific antibody, MacArthur et at. (1999) showed that Xcat-2 is translationally 
repressed during oogenesis and is not expressed until early embryogenesis. Indeed, 
Xcat-2 RNA was found to be tightly associated with a dense complex in oocytes, 
consistent with its translationally repressed state. Replacing the Xcat-2 3' UTR with 
that of ß-globin did not alleviate this translational inhibition, thus the 3' UTR does 
not appear to be involved in the translational repression of Xcat-2 mRNA. Xcat-2 
protein is expressed during blastulation and gastrulation, which coincides temporally 
with the movement of germ plasm to a perinuclear location and subsequent 
symmetric segregation of germ plasm and increase in pPGC numbers (MacArthur et 
al., 1999). 
1.3.2.2 Xpum 
The Xenopus homologue of Pumilio has been recently identified (Nakahata et al., 
2001). Nakahata et al. (2001) isolated a cDNA clone encoding a protein homologous 
(78% identity) to Drosophila Pumilio in the domain defining this family. A 
monoclonal antibody was raised against the Pumilio domain, and it was able to cross 
react with the Xenopus homologue of Pumilio (Xpum) in oocytes and eggs. This 
protein can bind to the NRE of Drosophila hb mRNA, as can Drosophila Pum. 
Using UV-crosslinking studies it was shown that, like Pum, Xpum can specifically 
bind to the 3' UTR of cyclin B1 mRNA. Furthermore, Xpum physically associates 
with Xcat-2 (the Xenopus Nanos homologue) in an in vitro protein pull-down assay 
(Nakahata et al., 2001). However, as Xcat-2 protein is absent from oocytes and eggs 
(MacArthur et al., 1999), Xcat-2 was undetectable in anti-Xpum immunoprecipitates 
from oocytes extracts. Thus, it is not yet known whether Xpum acts together with a 
Nanos homologue to control mRNA translation in oocytes. Although the role of 
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Xpum is unknown at present, Nakahata et al. (2001) hypothesised that Xpum is 
important in translational control of cyclin a1 mRNA, as in Drosophila. 
1.3.2.3 DEADSouth 
DEADSouth (Xcat-3) was originally isolated in a screen for vegetally localised 
maternal RNAs (Elinson et al., 1993; Moquera et al., 1993). It was later shown, by in 
situ hybridisation analysis of oocytes and early embryos that DEADSouth RNA 
localises to the vegetal cortex via the mitochondrial cloud early in oogenesis, is 
expressed in a pattern characteristic of germ plasm and is a germ-line specific RNA 
(MacArthur et al., 2000). Multiple sequence analysis of DEADSouth indicated that it 
is more like the RNA-dependent helicase eIF4A than other developmentally 
important DEAD-box proteins (MacArthur et al., 2000). Preliminary experiments 
suggest that DEADSouth. unlike Xcat-2, is not localised to the germinal granules 
themselves but is found in the cytoplasm surrounding them (M. L. King unpublished 
observations, cited in Houston and King, 2000a). 
1.3.2.4 Xdazl 
Xdazl mRNA is expressed in the germ plasm from early oocytes until the neurula 
stage (Houston et at., 1998). Xdazl mRNA localisation in the oocyte is restricted first 
to the mitochondrial cloud and then to the vegetal cortex (Houston et al., 1998). 
Xdazl protein is first detected in blastulae (Houston and King, 2000b) and is seen in 
PGCs in the endoderm until early tailbud stages (stage 22). Within the cell, Xdazl 
protein is cytoplasmic and localised to the germ plasm (Houston and King, 2000b). 
Xdazl RNA must therefore be under translational control, like Xcat-2 (Houston and 
King, 2000b; MacArthur et al., 1999). Xdazl is an RNA-binding protein homologous 
to the human Deleted in Azoospermia (DAZ) and related proteins in many species 
and contains a consensus RNP domain (Houston et al., 1998). As Xdazl encodes an 
RNA-binding protein (Houston et al., 1998) and the protein is cytoplasmic (Houston 
and King, 2000b), possible roles for Xdazl include regulation of translation, RNA 
transport, RNA storage or regulation of RNA stability. Xdazl mRNA was depleted 
from stage VI Xenopus oocytes and these oocytes fertilised by the host-transfer 
technique. Xdazl-depletion caused PGC numbers to be greatly reduced; this loss of 
PGCs occurs at the late tailbud stage, at or near the time when PGCs normally begin 
their dorsal migration. PGCs lacking Xdazl appear laterally but do not migrate 
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dorsally. Xdazl can act as the functional homologue of Drosophila boule, a protein 
required for meiotic entry during spermatogenesis (Houston et al., 1998). 
1.3.2.5 mitochondrial rRNAs 
Mitochondrial large rRNA (mt1rRNA) was shown to be a component of the germ 
plasm 'in Xenopus from 4-cell to blastula stage (Kobayashi et al., 1998). Electron 
microscopy in situ hybridisation revealed that the mtlrRNA signal was present within 
the germinal granules during these stages (Kobayashi et al., 1998). 
Recently, mtsrRNA has also been identified as a common component of the germinal 
granules in Xenopus embryos (Kashikawa et al., 2001). mtsrRNA has a distribution 
pattern identical to that of mtlrRNA, namely it is localised on the surface of the 
germinal granules from 4-cell to blastula stage and then disappears until the end of 
gastrulation. Kloc et al. (2000b) re-examined the distribution of mtlrRNA and 
mtsrRNA and found that, contrary to the findings of Kobayashi et al. (1998), the 
mitochondrial rRNAs are located in close proximity to the germinal granules but are 
not major components of the granules themselves. In fact the majority of mtlrRNA 
and mtsrRNA was found to be present within mitochondria and, to a lesser extent, the 
germ plasm matrix (Kloc et al,, 2000b). The temporal distribution of the 
mitochondrial rRNAs (4-cell to blastulae) coincides with the inheritance of germ 
plasm by only one daughter cell, This may indicate a role for mtlrRNA or mtsrRNA in 
restricting the association of germ plasm to one pole of the mitotic spindle during 
cleavage at these stages. However, this is purely speculative and it is not yet known 
whether these RNAs are functional in germ plasm. 
1.3.2.6 Xlsirts 
Xlsirts are a family of interspersed repeat transcripts from Xenopus laevis that have 
in common a 79- to 81- nucleotide sequence tandemly repeated 3-13 times. Each of 
the Xlsirts possesses unique flanking sequences on each side of the tandem repeat 
unit. The transcripts do not contain start codons and do not appear to be translated 
(Kloc et al., 1993). Xlsirt RNA is first localised in the mitochondrial cloud in early 
stage II oocytes and is then distributed in island-like structures at the vegetal pole by 
stage III, thus colocalising with the germ plasm. At the ultrastructural level, Xlsirts is 
detected within the germ plasm, but is not associated with germinal granules in stage 
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II-IV oocytes (Kloc et al., 1998). In embryos Xlsirts remains associated with the 
germ plasm. Recently four proteins were shown, using UV-crosslinking studies, to 
interact with the Xlsirts localisation signal in the vegetal cortex of stage V-VI 
oocytes. The evidence suggests that one of the proteins is Vg1RBP/Vera (Bubunenko 
and King, 2001). 
1.3.2.7 XVLGI 
Besides Xdazl, the only other molecule with a defined role in germ plasm in Xenopus 
is the Xenopus Vasa-like gene-1 (XVLG-1) (Komiya et al., 1994; Ikenishi et al., 
1996; Ikenishi and Tanaka, 1997). XVLG1 shares 8 highly conserved amino acid 
regions (with the exception of 1 amino acid in 1 of these regions), with the DEAD- 
box family of proteins, and it is most similar to Drosophila Vasa (Komiya et al., 
1994). XVLG-1 RNA is expressed in adult testis and ovaries, as well as in pPGCs 
from late gastrula (stage 12) to hatching tadpole stage (stage 33/34) and in some of 
the PGCs at stages 49-50 (Komiya et al., 1994; Ikenishi and Tanaka, 2000). In situ 
hybridisation analysis of Xenopus oocytes reveals that XVLG-1 RNA is present in 
stage I-III oocytes, but is barely detectable in stage IV-VI oocytes. It was detected 
throughout the cytoplasm except in the mitochondrial cloud of stage I oocytes. 
XVLG-1 protein is present in the germ plasm from gastrula stage 12, but is also 
found around the somatic cell nuclei (Ikenishi et al., 1996). The protein remains in 
association with PGCs until stage 46 and in somatic cells until stage 42, although the 
amount of protein is much greater in germ-line cells than in somatic cells (Ikenishi et 
al., 1996). Injection of an anti-XVLG1 antibody revealed that the presence of 
XVLG-1 protein is necessary for the differentiation of germ plasm-containing cells 
into PGCs during and after stages 37/38 (Ikenishi and Tanaka, 1997). However, 
injection of antibody into somatic cells had no effect on their development. 
Therefore, like its homologue in Drosophila, XVLG-1 is important in germ-line 
development. 
1.3.2.8 Xwnt-11 
Xwnt-11 encodes a secreted protein related to the Wnt family and its mRNA is 
vegetally localised (Ku and Melton, 1993). Xwnt-11 RNA is translocated to the 
vegetal cortex via the METRO pathway during stage I of oogenesis and is found in 
the germ plasm during oogenesis and embryonic development. However, like Xlsirts 
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and DEADSouth, Xwnt-11 is not detected on the germinal granules (Kloc et al., 
1998). The presence of Xwnt-11 in the germ plasm led Kloc et al. (1998) to suggest 
that a Writ-directed signalling pathway could aid specification of the germ cell 
lineage. 
1.3.2.9 Xpat 
Xpat (Xenopus primordial germ cell associated transcript) encodes a novel protein 
and its RNA is localised to the germ plasm and PGCs of Xenopus throughout 
oogenesis and early embryogenesis. Xpat mRNA expression persists longer than any 
other known Xenopus germ plasm transcripts, and can be detected by in situ 
hybridisation in PGCs of stage 40 tadpoles (Hudson and Woodland, 1998). Xpat 
RNA has been demonstrated, using electron microscopy in situ hybridisation, to be 
localised on the germinal granules (Etkin, 2000). Xpat is discussed further in Section 
1.4. 
1.3.3 The role of localised molecules in germ plasm 
The maternal localisation of RNAs coding for RNA-binding proteins appears to be a 
common theme in germ cell determination. RNAs for nanos and vasa are well 
known components of Drosophila pole plasm, and they encode proteins that are 
implicated in RNA-binding. Specifically in Xenopus, Xcat-2 (a nanos-like gene, 
Mosquera et al., 1993), DEADSouth (a translation initiation factor-like putative RNA 
helicase, MacArthur et at, 2000) and Xdazl (which contains an RNP domain and is 
the functional homologue of Drosophila boule, Houston et al., 1998) are also 
expressed in the germ plasm and have putative RNA-binding roles. 
How the inheritance of RNAs coding for RNA-binding proteins establishes the germ- 
line is still unclear, but it has been hypothesised that the mechanism may involve 
germ cell-specific regulation of mRNA stability or splicing, or translational 
repression. There appears to be a role for translational control (activation or 
repression) of maternal mRNAs in germ-line specification. For example, the 
Nanos/Pumilio complex is involved in translational repression of hunchback RNA in 
Drosophila (Murata and Wharton, 1995), and translational suppression by Nanos is 
necessary for entry of PGCs into the Drosophila gonad (Kobayashi et al., 1996). 
Germ plasm components also appear to be subjected to this translational control 
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mechanism, Nanos protein is never detected in Drosophila oocytes, and injected 
nanos RNA is not translated in the oocyte (Gavis and Lehmann, 1994). Different cis- 
elements in the 3' UTR of nanos are responsible for localisation and control of 
translation (Gavis et al., 1996; Dahanuka and Wharton, 1996). Like nanos, Xcat-2 is 
also translationally repressed during oogenesis and is not translated until early 
embryogenesis (MacArthur et al., 1999). The recent discovery of a Pumilio 
homologue in Xenopus indicates that its function as a translational regulator could 
also be conserved in Xenopus. 
The germ plasm may act as a protective enclave from signals involved in somatic 
cell lineage determination (Dixon, 1994). Transcriptional repression in PGCs may 
act to protect these cells from a somatic cell fate. Germ-line blastomeres in C. 
elegans, in contrast to somatic cells, were found to be lack newly transcribed 
mRNAs during early cleavage stages (Seydoux et al., 1996). This transcriptional 
suppression was demonstrated to require PIE-1 protein, a germ-line specific factor 
which, when ectopically expressed in somatic blastomeres, could also repress 
transcription in these cells (Seydoux et al., 1996). PIE-1 was found to specifically 
block phosphorylation of RNA polymerase II large subunit carboxy-terminal domain 
(CTD), which is normally phosphorylated during eukaryotic mRNA transcription 
(Seydoux and Dunn, 1997). A sequence element in PIE-1 that is required for PIE-1 
to function as a transcriptional repressor in vitro resembles the CTD of RNA 
polymerase II (Batchelder et al., 1999). PIE-1 may therefore act to block 
transcription in germ-line blastomeres by targeting factors that can bind to the CTD 
(Batchelder et al., 1999). A period of transcriptional repression has also been 
observed in Drosophila pole cells (Seydoux and Dunn, 1997; Van Doren et al., 
1998), which indicates that a general block in transcription may be a conserved 
feature of germ cell specification. 
1.4 The germ granule mRNA Xpat 
Xpat (Xenopus primordial germ cell associated transcript) was isolated from a 
cDNA library screen designed to isolate mRNAs specific to vegetal poles of Xenopus 
gastrula embryos (Hudson and Woodland, 1998). In situ hybridisation analysis of 
Xpat revealed that it is localised at the vegetal pole of early stage I oocytes and 
associates with the mitochondrial cloud during oogenesis. Xpat mRNA is specifically 
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localised to the germ plasm throughout oogenesis and embryogenesis (see Figure 
1.4) and, unlike any other known germ plasm RNAs, Xpat's expression persists after 
gastrulation until stage 40 (Figure 1.4). Thus, the expression of Xpat mRNA ceases 
at the time when PGCs are known to enter the dorsal mesentery (Hudson and 
Woodland, 1998). It is thought that all the Xpat mRNA localised in embryos is 
purely maternal, as Northern blots indicate that no zygotic transcription of Xpat 
occurs (Hudson and Woodland, 1998). 
Hudson and Woodland (1998) also demonstrated that the large -3 kb 3' UTR of Xpat 
is both necessary and sufficient to localise injected Xpat mRNA to the vegetal pole in 
stage III oocytes. The injected Xpat mRNA, unlike endogenous Xpat, localised in a 
domain that was broader than the germ plasm at the vegetal pole, appearing similar 
to the distribution of Vgl. Furthermore, exogenous Xpat mRNA did not localise to 
the vegetal pole in stage V or VI oocytes, thus it only localises at stages where the 
late pathway has been shown (by Yisraeli and Melton, 1988) to be active. Thus, 
whilst endogenous Xpat localises via the METRO, exogenous Xpat can localise via 
the late pathway of RNA localisation (see Section 1.2.2). Exogenous XPAT protein 
was shown to have no effect on the localisation of injected Xpat mRNA (Hudson and 
Woodland, 1998). 
Xpat is a novel clone which encodes a predicted protein of 303 amino acids, with a 
molecular weight of 35kDa. When it was isolated, Xpat was found to have no 
convincing homology to any known proteins (Hudson and Woodland, 1998). Recent 
searches, performed in November 2001 using the NCBI BLAST database, revealed 
that the 3'UTR has a 140 bp region (a repetitive element) which appears in the 
Silurana tropicalis Zinc-finger transcription factor Slug gene and smaller parts of this 
region are present in the X. laevis cerberus 3' UTR, the X. borealis type I 
cytoskeleton actin mRNA and the X. laevis VhVI gene for immunoglobulin heavy 
chain as well as many other Xenopus mRNAs. Small 20 bp regions of the 5' UTR 
have homology to various clones of human DNA sequences and others, but nothing 
of note in the EST databases (other than X. laevis clones and various short sequence 
matches). The nucleotide sequence of the ORF has only limited regions of homology 
- over -20-30 bp regions - to various human and Drosophila genomic DNA 
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Figure 1.4: Localisation of Xpat mRNA assessed by in situ hybridisation 
AdU-- 
(A-D) Stage I-III oocytes (Dumont, 1972); Xpat transcripts are localised to the vegetal pole from stage I (A), remaining 
there during stages II (B, C) and III (D). (E, F) In cleavage stage embryos the signal takes on a granular appearance in a 
small disc at the vegetal pole. During gastrulation (stage 10.5, G) the cells that contain Xpat move inside, and remain 
there through neurulation (stage 14, H) until tailbud (stage 26, I). At stage 35 (J) they have begun to move anteriorly and 
dorsally in the endodermal mass. This continues through stage 37 (K), until they are most dorsal by stage 40 (L). (G-L) 
Embryos are cleared. Scale bar = 100µm. (Taken from Hudson and Woodland, 1998). 
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sequences and other clones. However, when the XPAT protein sequence was used to 
search the BLAST protein database, different regions of the protein show 34 % 
identity (over 50 amino acids) with a Bacillus subtilis protein similar to phage- 
related protein, 34 % identity (over 84 amino acids) with Superoxide dismutases 
from sweet potato (Ipomoea batatas), pepper (apsicum annuum) and quaking aspen 
(Populus tremuloides). XPAT also shared 25 % identity over 116 amino acids with 
DNA topoisomerase IV Par C subunit A from Caulobacter crescentus, but not to 
other topoisomerases. None of these homologies are very convincing or shed light on 
Xpat function. 
Despite screens of chick and mouse genomic libraries (R. Harnes, unpublished data) 
and database searches of the now complete Drosophila and C. elegans genomes, no 
homologue of Xpat has been found in these organisms. Bradley et al. (2001) claim to 
have discovered the cricket homologue of Xpat, but the sequence of this clone is not 
yet on the BLAST database and the evidence is not very convincing. 
To date, the spatial and temporal distribution of XPAT protein has not been 
investigated. There is no doubt that establishing the distribution of the protein that it 
encodes will be critical in delineating the role of the Xpat gene. It will also be 
important to determine whether destruction of Xpat affects the localisation of other 
transcripts and, if so, where Xpat lies within the hierarchy of localisation proposed by 
Kloc and Etkin (1995). Lastly, it will be vital to find out how ablation of Xpat affects 
PGC differentiation and behaviour. 
1.5 Aims of this study 
" To determine the expression pattern and localisation properties of XPAT protein in 
Xenopus. 
" To investigate the effect that destruction of Xpat mRNA has on other germ plasm 
components in vivo. 
" To determine the effect that overexpression of Xpat mRNA has on other germ 
plasm transcripts. 
" To determine the role ofXpat in development of the amphibian germ-line. 
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Chapter 2: Materials and Methods 
2.1 DNA manipulation 
All enzymes were purchased from Gibco BRL unless otherwise stated. 
DNA was stored either in water or in EB buffer (10 mM Tris-HCI, pH 8.5) at -20°C. 
2.1.1 Agar plates and cultures 
Cells were plated on LB agar (10 g bacto-tryptone, 5g bacto-yeast extract, 10 g 
NaCl, 15 g bacto agar per litre) and grown in LB cultures as above (with no agar). 
Ampicillin was used at a final concentration of 0.1 mg/ml where appropriate. 
2.1.2 Agarose gels 
Agarose gels were made using 1x TBE (89 mM Tris, 89 mM boric acid, 10 mM 
EDTA pH 8.0) using between 0.6 and 2% agarose, depending upon the size 
separation required. DNA was stained by addition of ethidium bromide to 0.1 µg/ml. 
Loading dye (6 x TBE, 5% (v/v) glycerol; bromophenol blue and xylene cyanol 
were added to achieve desired colour) was used at 1: 6 concentration. 1 Kb DNA 
Ladder (Gibco BRL) was used to observe size separation, typically 0.5 tg was 
loaded per lane on a gel. 
2.1.3 Restriction digestions and ligations 
DNA was digested with restriction enzymes according to the manufacturer's 
recommendations. Double digestions were carried out with the React Buffers (Gibco 
BRL) recommended. Restriction digestion was used to check all constructs made. 
DNA was quantified using an Ultraspec III spectrophotometer (Pharmacia) and 
associated software. 
Ligations were carried out using T4 DNA ligase according to Sambrook et al. 
(1989). A molar ratio of 3: 1, insert: vector was used for all ligations. Approximately 
200 ng of vector DNA was used and the amount of insert adjusted accordingly. In 
cases where the amount of insert was limited, the amount of vector was reduced to fit 
the ratio above. Vector was dephosphorylated using bacterial alkaline phosphatase (1 
U/µ1, Boehringer Mannheim). Generally, 0.5 U was added for the final 1 hour of 
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digestion and then another 0.5 U was-added for the final 30 minutes of digestion. 
DNA was then gel purified (see Section 2.1.5). Insert DNA was also isolated by gel 
purification. 
2.1.4 Transformations 
2.1.4.1 The RbC1 Transformation Procedure 
DNA transformations were made into Escherischia coli DH5a (ý80dlacZAM 15, 
recAl, endAl, gyrA96, thi-1, hsdR17 (rK-, mK+), supE44, relAl, deoR, A[lacZYA- 
argFJU169) cells, unless otherwise stated. 
A single colony was inoculated from an LB plate into 10 ml of LB broth. This was 
shaken overnight at 37°C. The overnight was then subcultured 1: 100 in LB+ 20 mM 
MgSO4 (typically 250 ml). Cells were grown to OD590=0.4-0.6 (-2-3 hours). They 
were then centrifuged at 5,000 rpm for 5 minutes at 4°C. The pellet was gently 
resuspended in 0.4 of the original volume (100 ml for a 250 ml subculture) in ice 
cold TFBI (30 mM KOAc (potassium acetate), 100 mM RbCl, 10 mM CaC12,50 mM 
MnCl2,15 % glycerol, final pH 5.8). This was incubated on ice for 5 minutes, 
centrifuged at 5,000 rpm for 5 minutes at 4°C and the pellet gently resuspended in 
1/25 original volume cold TFB2 (10 mM MOPS, 75 mM CaCl2,10 mM RbCl, 15 % 
glycerol, final pH 6.5). For 250 ml subculture 10 ml of TFB2 was used. This was 
then incubated on ice for 15-60 minutes, aliquoted 100 p /tube and quick frozen on 
dry ice and stored at -70°C. 
To transform, an aliquot was thawed on ice, the DNA was added and the cells 
incubated for 30-120 minutes on ice. The reaction was then heat shocked at 42°C for 
90 seconds, incubated on ice for 5-10 minutes, and then diluted 6-fold in LB medium 
and grown for 30 minutes at 37°C. The transformation was then plated on LB 
medium containing ampicillin and grown overnight at 37°C. 
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2.1.4.2 The calcium chloride method for transformation 
For cells other than DH5a, competency was obtained by use of the calcium chloride 
method (from Sambrook et al., 1989). For example, BL21 (F-, ompT, hsdSB [re, ms 
]dcm, gal) and AD202 (F-, araD139, DE(argF-lac)U169, ompTl000:: kan, LAM-, 
flhD5301, fruA25, relAl, rpsL150(strR), rbsR22, deoCl) cells were treated in this 
way for bacterial expression of proteins (Section 2.7). 
2.1.5 Gel purifications and DNA preparations 
Gel purification was carried out upon gel slices, excised with a clean razor blade, 
using a Qiagen QlAquick Gel Extraction kit. 
DNA minipreps were performed from 5-10 mis of culture using Qiagen Qiaprep 
plasmid minipreparation kit, according to manufacturer's recommendations. 
2.1.6 Production of glycerol stocks 
Glycerol stocks of overnight cultures of bacteria were made by adding 0.5 ml 30 % 
glycerol to 0.5 ml bacterial culture, vortexing and rapidly freezing on dry ice. 
Glycerols were stored at -70°C. 
2.2 PCR 
Primers were made as in Section 2.3.1. New primers were tested alone and in pairs to 
test for non-specific background bands caused by amplification from one primer. In 
all PCRs, unless otherwise stated, Taq DNA polymerase was used (5 U/µ1, Gibco 
BRL) with 1x PCR buffer. 10 x PCR buffer (200 mM Tris-Cl pH 8.4,500 mM KCI), 
W1 detergent and 50 mM MgC12 were purchased with the Taq. dNTPS were 
purchased from Amersham. Paraffin oil was placed over each PCR to prevent 
evaporation. Each PCR is set out as follows: initial denaturation (optional), cycling 
of denaturation, annealing, extension, and final extension (optional). Unless 
otherwise stated, PCRs were analysed on agarose gels (see Section 2.1.2). 
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2.2.1 RT-PCR 
Reverse transcriptions (RTs) were carried out as follows: 0.5 µg total RNA was 
made up to 20.1 µl with ddH2O and heated to 75°C for 5 minutes. The following 
were then added: random hexamers (6-mer random oligos [pd(n)6], Pharmacia 
Biotech) to 3.3 µM, PCR buffer to 1 x, MgC12 to 3 mM, RNAse inhibitor 
(Amersham Pharmacia Biotech) to 1 U/µl. After incubation at 37°C for 5 minutes, 
400 U MMLV reverse transcriptase (200 U/µl, Gibco BRL) were added to each tube 
and incubated at 37°C for a further 60 minutes. 'No enzyme' and `no RNA' reactions 
acted as controls for the PCR. Samples were then heated to 95°C for 5 minutes and 1 
µl typically used in each PCR. 
PCRs were performed by mixing the following components: 1x PCR buffer, 1.5 mm 
MgCl2,200 p. M of each dNTP (dATP, dCTP, dGTP and dTTP), 0.05 %W1,0.25 
µM each primer, 1U (0.2 µl) Taq polymerase and water added to 19 µl. cDNA was 
added to this mixture. 
PCR conditions were as follows: 94°C -1 minute, 55°C -30 seconds, 72°C -30 
seconds for 1 cycle, followed by: 94°C -30 seconds, 55°C -1 minute, 72°C -1 minute 
for 25-30 cycles and finally 72°C for 5 minutes. 25 cycles were used for EFI cz 28 
cycles for Xpat, and 30 cycles for all other primer pairs. Linearity curves were run 
for every marker in every experiment by dilution of a cDNA sample. Three negative 
controls were also run for every marker: `no enzyme' (-RT), `no RNA' (-RNA) and 
a water control (-cDNA). 
Primers for each clone were as shown in Table 2.1 below. 
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Table 2.1: Primers used for RT-PCR analysis 
Where primers are taken from other sources, references are shown. 
Transcript Primers 
Xpat: 5' GCTGTGTCCGATGTAATG 3' 
5' GCTGCTCTGCTATGTGAT 3' 
ODC: 5' GGAGCTGCAAGTTGGAGA 3' 
5' TCAGTTGCCAGTGTGGTC 3' (Bassez et al., 1990) 
EFl ct 5' CAGATTGGTGCTGGATATGC 3' 
5' CACTGCCTTGATGACTCCTA 3' 
VegT: 5' CGAGGCTAACCAAGGCTTGA 3' 
5' TCCGGCACTGTAGCAATGTC3' 
Xcat-2: 5' TGACTCATGGAGCGACTACT 3' 
5' TCAGACGGTGAGACGTGTAT3' 
Xcat-3: 5' TTGGCTGACTAAGCACTTGA 3' 
5' CTTGCACAACGGTACTAGAA 3' 
Xdazl: 5' ATGGCGATTCAGCAGATTCC 3' 
5' ATTGGCTCCAGAAGCAGACA 3' 
XVLG-l: 5' GGATCGTCCACGTTCTTATG 3' 
5' AGGCGGAGGAATATAGGTCA3' 
fatvg: 5' TCACTTCAGTGGCCTTAACC 3' 
5' AGCCAGCTCTTCATCTGTTG 3' 
Vgl 5' GACCGCTAACGATGAGTG 3' 
5' AGGAATGTCTTCTGGCTC 3' 
, 
&catenin: 5' TTGGCTCACCAGTTGACTCT 3' 
5' AGCACACGGATAGCACCTTA 3' 
2.2.2 PCRs used to generate fragments for cloning into DNA constructs 
N. B. In all primers, nucleotides in lower case indicate sequence that is not present in 
the gene, that is restriction sites and anchors. 
2.2.2.1 Xpat ORF PCR for construct for oocyte expression 
This PCR was used to generate the ORF of Xpat with Hindu sites on the ends to 
enable cloning into the HindIII site of pSPJC2L for overexpression in oocytes. 
Primers were as follows: 
5'gactgaaagcttATGGCTTTGAAGGCAGAAGAC 3' 
5'ctgaggaagcttTCAAAATCTTAACAAAAACTTAAAC 3' 
PCR reactions were made as follows for each 25 µl reaction: 1 µl template (approx. 
0.5 ng), 0.2 µM of each primer, 2.5 U Pwo DNA polymerase (5 U/µl, Roche 
Molecular Biochemicals), 1x PCR buffer (10 x: 100 mM Tris-Cl, pH 8.85,250 mM 
KCI, 50 mM (NH4)2S04,20 mM MgSO4, Roche Molecular Biochemicals), 200 µM 
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of each dNTP. Cycling conditions were: 94°C -30 seconds, 50°C -30 seconds, 72°C - 
90 seconds, for 5 cycles, 94°C -30 seconds, 60°C -30 seconds, 72°C -90 seconds, for 
25 cycles and 72°C for 5 minutes. 
2.2.2.2 Xpat ORF PCR for construct for GST fusion protein expression 
This PCR was used to generate the ORF of Xpat with BgIII sites on the ends to 
enable cloning into the BamH 1 site of pGEX-2T for overexpression in bacteria. 
Primers were as follows: 
5' gccgagatctATGGCTTTGAAGGCAGAAG 3' 
5' gccgagatctCAGGCCAACATCCCACCAAG 3' 
PCR reaction and cycling conditions were as in Section 2.2.2.1 
2.2.2.3 Xpat UTRORF PCR for construct to determine translatability of Xpat in 
presence of a morpholino oligonucleotide in vitro 
The following PCR was used to generate the 5' UTR + ORF of Xpat to clone 
between the Bg1II and HindIII sites of pSPJC2L. 
Reaction and cycling conditions were as in Section 2.2.2.1 with the following 
primers: 
5' gccgagatctTGCAGCCTGTGTCTGAATG 3' 
5' ctgaggaagcttTCAAAATCTTAACAAAAACTTAAAC 3' 
2.2.2.4 GFP PCR for construct to generate XPAT-GFP fusion proteins 
Primers were designed to generate the ORF of GFP to insert between the Bg1II and 
EcoRl sites of pSPJC2L. 
Reaction and cycling conditions were as in Section 2.2.2.1 with the following 
primers: 
5' gccgagatctATGAGTAAAGGAGAAGAAC 3' 
5' gccggaattcTTATTTGTATAGTTCATCCAT 3' 
The resulting construct was called pSPJC2L-cGFP. 
2.2.2.5 XPAT-GFP fusion protein constructs 
This PCR was used to generate the ORF of Xpat (without the STOP codon) with 
Bg1II sites on the ends to enable cloning into the Bg1II site of pSPJC2L-cGFP for 
expression in oocytes. 
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Reaction and cycling conditions were as in Section 2.2.2.1 with the following 
primers: 
5' gccgagatctATGGCTTTGAAGGCAGAAG 3' (XPATGFP-1) 
5' gccgagatctCAGGCCAACATCCCACCAAG 3' (XPATGFP-8) 
2.2.2.6 Deletion constructs of Xpat-GFP 
These PCRs were to make Xpat-GFP constructs which, when translated, lack amino 
acids at the C-terminus or N-terminus of XPAT. Primers were designed to generate 
regions of the ORF of XPAT to insert into the BgIlI site of pSPJC2L-cGFP. 
A) To make NDEL-1-a deletion of the first 61 amino acids of XPAT 
Reaction and cycling conditions were as in Section 2.2.2.1, with the following 
primers: 
5'gccgagatctATGCAGCAGTGGCAGCTC 3' 
and XPATGFP-8. 
B) To make NDEL-2 -a deletion of the first 92 amino acids of XPAT 
Reaction and cycling conditions were as in Section 2.2.2.1, with the following 
primers: 
5'gccgagatctATGAACTCATTAAGTGGCAC 3' 
and XPAT GFP-8. 
C) To make NDEL-3 -a deletion of the first 159 amino acids of XPAT 
Reaction and cycling conditions were as in Section 2.2.2.1, with the following 
primers: 
5' gccgagatctATGCCTGCCACAAGCACTC 3' 
and XPATGFP-8. 
D) To make CDEL-1-a deletion of the last 128 amino acids of XPAT 
Reaction and cycling conditions were as in Section 2.2.2.1, with the following 
primers: 
5' gccgagatctAGTGCTTGTGGCAGGCATC 3' 
and XPATGFP-1. 
44 
2.2.2.7 Xpat and GFP ORF PCRs to make GFP-XPAT 
A) GFP ORF PCR. 
Primers were designed to generate the ORF of GFP (without the STOP codon) to 
insert between the Bg1II and Hind111 sites of pSPJC2L. 
PCR reaction and cycling conditions were as in Section 2.2.2.1 with the following 
primers: 
5' gccgagatctATGAGTAAAGGAGAAGAAC 3' 
5' gactgaaagcttTTTGTATAGTTCATCCATGC 3' 
The resulting construct was called pSPJC2L-NGFP. 
B) XPA T ORF PCR 
This PCR was used to generate the ORF of Xpat with Hindu sites on the ends to 
enable cloning into the HindIIl site of pSPJC2L-NGFP for expression in oocytes. 
Reaction and cycling conditions were as in Section 2.2.2.1 with the following 
primers: 
5' gactgaaagcttATGGCTTTGAAGGCAGAAGAC 3' 
5'ctgaggaagcttTCAAAATCTTAACAAAAACTTAAAC 3' 
2.2.2.8 Xpat ORF PCR for Myc-XPAT fusion protein expression 
This PCR was used to generate the ORF of Xpat to clone in-frame between the BgIII 
and XhoI sites of pCS3+MT. This vector contains 6 myc epitope tags. 
Reaction and cycling conditions were as in Section 2.2.2.1 with the following 
primers: 
5' gcgcagatctCGATGGCTTTGAAGGCAGAAGAC 3' 
5' gcgcctcgagTCAAAATCTTAACAAAAACTTAAAC 3' 
2.2.2.9 PCR to generate a template for transcription of dsXpat RNA 
This PCR was used to generate the ORF of Xpat with T7 promoter sequences on 
both ends. Thus, transcription of this PCR product with T7 RNA polymerase 
generated dsXpat RNA. 
Primers were as follows: 
5'taatacgactcactatagggagaccacGGCTTTGAAGGCAGAAGAC 3' 
5' taatcagactcactatagggagaccacTCAAAATCTTAACAAAAACTTAAACC 3' 
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PCR reactions were made as follows for each 25 µl reaction: 1 p1 template (approx. 
Ing), 1x PCR buffer, 1.5 mM MgC12,200 µM of each dNTP (dATP, dCTP, dGTP 
and dTTP), 0.05 %W1,0.25 µM each primer, 2.5 U (0.5 µl) Taq polymerase. 
Cycling conditions were: 94°C -20 seconds, 50°C -20 seconds, 72°C -20 seconds, for 
5 cycles, 94°C -20 seconds, 60°C -20 seconds, 72°C -20 seconds, for 25 cycles and 
72°C for 5 minutes. 
2.2.3 PCR to generate template for Xpat ORF in situ hybridisation probe 
This PCR was used to generate the ORF of Xpat with T7 promoter sequence on its 3' 
end. Transcription of this PCR product with T7 RNA polymerase generated antisense 
Xpat mRNA. Primers used were as follows: 
5' gccgagatctATGGCTTTGAAGGCAGAAG 3' (XPATGFP-1) 
5' taatcagactcactatagggagaccacTCAAAATCTTAACAAAAACTTAAACC 3' 
PCR reaction and cycling conditions were as in Section 2.2.2.9. 
2.2.4 SP6/internal primer PCRS on colonies 
Each 20 µl reaction comprised the following: 1x PCR buffer, 0.25 . tM of each 
primer, 1U Taq polymerase, 1.5 mM MgC12,0.05 % W1,200 tM of each dNTP and 
a scraping from a colony. 
Conditions were as follows: 94°C- 1 minute, 55°C- 30 seconds, 72°C- 30 seconds for 
one cycle, and then 94°C -30 seconds, 55°C- 1 minute, 72°C- 1 minute for 30 cycles 
and finally 72°C- 5 minutes for one cycle. 
Primers used to check for the presence of an insert following a ligation and 
transformation were: SP6 and the specific downstream primer used in the PCR step 
of the cloning strategy. Thus, the downstream primer varied depending on which 
construct had been made. 
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2.3 Sequencing 
2.3.1 Sequencing 
All constructs made were completely sequenced on both strands using Sequenase 
Version 2.0 (USB/Amersham Life Science), with 10 iCi [a-35S]-dATP per reaction. 
2-3 tg of dsDNA template was used for each reaction in 20 µl of water. To denature 
the DNA, 5 tl of 1M NaOH/1 mM EDTA was added and the reaction was incubated 
at room temperature for 5 minutes. DNA was precipitated by addition of 10 µl 5M 
ammonium acetate and 70 µl ethanol, left at -20°C for 20 minutes and recovered by 
centrifugation at 13K rpm for 15 minutes. Templates were then resuspended in 7 µl 
water. The reactions were then carried out exactly as specified by the manufacturers 
on microtitre plates. 1 pmol of all primers were used in the reactions. For many 
sequencing reactions SP6, T3 and T7 primers were used (depending on which vector 
the construct was in). All constructs were also sequenced using the PCR primers that 
they were constructed with (Section 2.2.2). The following primers were then used to 
complete sequencing: 
XPAT-SEQ1 5' GTGCATTACATCGGACACAG 3' 
SEQXPAT2A 5' CCTGCCCAGAAACCTAATGA 3' 
SEQXPAT2B 5'CCCAAAGGAGAAACGGAAGA 3' 
Primers were manufactured commercially by Gibco BRL. 
In some cases, regions of sequence were verified using automated cycle sequencing, 
using the ABI PRISMTM Dye Terminator Cycle Sequencing Ready Reaction Kit with 
AmpliTaq® DNA polymerase, FS (Perkin Emer) on the 373A DNA Sequencer 
(Applied Biosystems). In all cases, automated sequencing was performed by Lesley 
Ward. 
2.3.2 Sequencing gels 
0.4 mm gels were poured and used in a 40 cm gel apparatus. 6% Acrylamide gels 
were used, containing Acrylamide: NN-methylenebisacrylamide in the ratio 19: 1 
respectively, 1x TBE, 42% urea (w/v) and run in 1x TBE. 800 tl 10 % (w/v) APS 
and 140 µl TEMED were added per 100 mls of gel, just before pouring. Gels were 
run at 40 watts, fixed in 10 % (v/v) methanol, 10 % (v/v) acetic acid, vacuum dried at 
80°C and autoradiographed. 
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2.4 RNA manipulation 
2.4.1 Small scale preparation of RNA from 5-10 embryos or oocytes for use in 
RT-PCR (Section 2.2.1) 
All centrifugations were carried out at 13K rpm. 
Material was homogenised in 500 µl of XT buffer (0.3 M NaCl, 20 mM Tris-HCI 
pH 7.5,1 mM EDTA, 1% SDS). 180 µg Proteinase K (Boehringer Mannheim) was 
added to give a final concentration of 0.36 mg/ml, and incubated at 37°C for 15 
minutes. The homogenate was then extracted with an equal volume of phenol; 
separation was obtained by a 10 minute centrifugation. The upper phase was then 
phenol-chloroform (1: 1) extracted; this time separation was obtained with a5 minute 
spin. 
RNA (and DNA) was precipitated at -20°C for 30 minutes with 2 volumes of ethanol 
and 5 p. g of glycogen. Nucleic acids were recovered by centrifugation for 20 
minutes. Pellets were redissolved in 90 µl 1x DNase I buffer (10 x: 200 mM Tris-Cl 
pH 8.3,500 mM NaCl, 25 mM MgC12) diluted in ddH2O. 50 U Ribonuclease 
inhibitor (Amersham Pharmacia Biotech) and 20 U RNase-free DNAse I (Boehringer 
Mannheim) were added. Digestion was carried out for 30 minutes at 37°C, with 
vortexing every 10 minutes to ensure the pellet was resuspended. Samples were 
further proteinase digested at 37°C for 20 minutes, with addition of 360 µl XT buffer 
and 120 tg proteinase K. The samples were then extracted in one volume of phenol, 
followed by one volume of phenol: chloroform (1: 1). RNA was precipitated using 2 
volumes of ethanol at room temperature for 30 minutes and recovered with a 20 
minute spin. RNA pellets were then washed with 70 % ethanol and resuspended in 
20 µl of ddHZO (2-4 µl/oocyte). 
2.4.2 RNA labelling with digoxigenin-UTP by in vitro transcription with T7 and 
T3 RNA polymerases (for use in whole mounts- Section 2.5) 
Templates for digoxigenin-UTP (DIG) labelling transcriptions were prepared by 
linearising 1-4 . tg of the appropriate plasmid DNA with restriction enzymes for 2 
hours at 37°C. In cases where EcoRI and Xhol did not cut internally, they were used 
for antisense (T7 RNA polymerase) and sense (T3 RNA polymerase) transcript 
template production respectively. In other cases templates were linearised with 
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Cla1, (Xdazl, antisense) or HindIII (Xcat-2, antisense). The template for making Xpat 
ORF was generated by PCR as described in Section 2.2.3. A fraction of the digested 
sample was run on an agarose gel to check for complete digestion. The DNA was 
then purified using the Qiagen QlAquick Gel Extraction Kit, with the following 
modifications to the manufacturer's recommendations: 3 volumes of Buffer QG 
(Qiagen) and 1 volume of isopropanol was added to the digested DNA and the DNA 
was then applied to the QlAquick column as instructed in the manufacturer's 
recommendations, which were then followed as usual. The purified DNA was eluted 
into 30 µl EB (10 mM Tris-Cl, pH 8.5). DNA was checked again on an agarose gel. 
RNA was transcribed using the DIG RNA Labelling Mix (Boehringer Mannheim). 
Typically, when transcribing the antisense strand, T7 polymerase (Gibco BRL) was 
used and to transcribe the sense strand, T3 polymerase (Gibco BRL) was used. 
Each 20 µl RNA labelling reaction comprised: 0.5 µg linearised DNA template, 1x 
DIG RNA labelling mix (10 x: 10 mM ATP, 10 mM CTP, 10 mM GTP, 6.5 mM 
UTP, 3.5 mM DIG- I1-UTP, pH 7.5, Boehringer Mannheim), 1x T3/T7 transcription 
buffer (5 x: 200 mM Tris-Cl (pH 7.9), 30 mM MgC12,10 mM spermidine-(HC03, 
Gibco BRL), 50 U RNA polymerase (Gibco BRL), 50 U Ribonuclease Inhibitor 
(Amersham Pharmacia Biotech). This was incubated at 37°C for 2 hours, after which 
samples were DNAse treated by addition of 2U RNAse-free DNAse I (Boehringer 
Mannheim) for 15 minutes, and the RNA was precipitated with 1/10 volume 8M 
LiCI and 3 volumes ethanol, left at -20°C for 2 hours and recovered by centrifugation 
at 13K rpm for 15 minutes. RNA pellets were then washed with 70 % ethanol and 
resuspended in 100 µl hybridisation buffer (Section 2.5) and used as a 100 x stock. 
RNAs were checked on 0.8% agarose gels before and after DNAse treatment. 
2.4.3 In vitro transcription of mRNA 
To produce a template, the ORF (or ORF + UTR in certain cases) required was PCR 
amplified (Section 2.2.2) and cloned into the appropriate restriction site of pSPJC2L 
(Cook et al., 1993). Templates were linearised by restriction digestion and checked 
on agarose gels for completion of digestion. Templates were purified using gel 
extraction (Section 2.1.5). 
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In vitro transcription of RNA for microinjection, or for use in in vitro translation 
(Section 2.6.2), was performed with Ambion SP6 mMessage mMachineTM kit. The 
manufacturer's instructions were followed and the LiCI method for RNA 
precipitation was chosen for the subsequent ease of resuspension. RNAs were 
checked on 0.8 % agarose gels after resuspension and RNA yields were quantified by 
determination of the UV light absorbance at 260 nm, using an Ultraspec III 
spectrophotometer (Pharmacia) and associated software. 
2.5 Whole mount in situ hybridisation 
Oocytes and embryos were collected at various stages and vitelline membranes 
removed manually from embryos with forceps, or enzymatically (according to Islam 
and Moss, 1996). Embryos were fixed overnight at 4°C or for 1-2 hours at room 
temperature in MEMFA (100 mM MOPS pH 7.4,2 mM EGTA, 1 mM MgSO4,4 % 
formaldehyde). Embryos and oocytes were then dehydrated through an ethanol series 
for storage in 100 % ethanol at -20°C. This method is based on that of Harland 
(1991). 
Embryos and oocytes were rehydrated through an ethanol series to PBST (PBS [136 
mM NaCl, 2.6 mM KCI, 10 mM Na2HPO4,1.76 mM KH2PO4 pH 7.2] + 0.1 % (v/v) 
Tween-20). Embryos were then treated with 3 µg/ml proteinase K (Boehringer 
Mannheim) for 5-10 minutes, oocytes were treated with 50 µg/ml for 5-10 minutes. 
The embryos/oocytes were then washed in PBST twice for 5 minutes. A 20 minute 
fixation in 4% formaldehyde in PBST and then five 5 minute washes in PBST 
followed this. Embryos/oocytes were equilibrated in hybridisation buffer (50 % (v/v) 
formamide, 5x SSC, 1 mg/ml Type II Torula Yeast RNA (Sigma), 100 µg/ml 
Heparin (Sigma sodium salt grade 1A from porcine intestinal mucosa), 2% (w/v) 
BBR, 0.1 % (v/v) Tween-20,0.1 % (w/v) CHAPS), by placing in 50 % hybridisation 
buffer in PBST until oocytes/embryos sank, then in hybridisation buffer until they 
sank. Fresh hybridisation buffer was added and embryos and oocytes were pre- 
hybridised at 60°C for 5-6 hours. Hybridisation was carried out over-night at 52°C, 
by replacing the prehybridisation buffer with fresh hybridisation mix, containing 
1/100 of DIG labelled RNA probe denatured for 5 minutes at 70°C, giving a final 
concentration of approximately 1 µg/ml. 
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The following day embryos and oocytes were washed in: 2x SSC, 0.3 % CHAPS, at 
60°C for 3x 20 minutes. RNAse digestion was carried out for 30 minutes with 20 
µg/ml RNAse A in 2x SSC, 0.3 % CHAPS at 37°C. The following washes were 
subsequently carried out: [2 x SSC, 0.3 % CHAPS] at room temperature for 10 
minutes; [0.2 x SSC, 0.3 % CHAPS] at 60°C for 2x 30 minutes; [PBST, 0.3 % 
CHAPS] at 60°C for 2x 10 minutes; [PBST] at room temperature for 10 minutes; 
[PBST, 0.5 % BBR] at room temperature for 15 minutes. A 1/2000 anti-DIG 
antibody (DIG Nucleic Acid Detection Kit, Boehringer Mannheim) dilution in 
PBST, 0.5 % BBR was placed on the embryos/oocytes and they were incubated for 
16 hours at 4°C. 
Oocytes and embryos were then washed at room temperature for 5 hours, with hourly 
changes of PBST. This was followed by an overnight wash in PBST at room 
temperature. 
Two 5 minute washes were then carried out with NTMT (0.1M Tris pH 9.5,50mM 
MgC12,100 mM NaCl, 0.1 % (v/v) Tween-20,5 mM levamisole). Then, colour 
reaction reagents were added to fresh NTMT: 10 µl BCIP-NBT/ml (Boehringer 
Mannheim). Reactions were left to develop at 4°C in the dark. Reactions were 
stopped by a quick wash in TE buffer and samples were fixed in MEMFA for 1-2 
hours at room temperature or over-night at 4°C. 
After hybridisation, oocytes were washed in PBST and photographed on Kodak 
Ektachrome 160T film using a Stemi SVII (Zeiss) dissecting microscope. 
2.6 In vitro translation of proteins 
2.6.1 Coupled in vitro Transcription and Translation 
This was performed using the TNT® SP6 Coupled Reticulocyte Lysate System 
(Promega). Each 50 tl reaction comprised the following: 25 µl TNT® rabbit 
reticulocyte lysate, 2 µl TNT® Reaction Buffer, 1 µl TNT® SP6 RNA polymerase, 
20 µM Amino Acid Mixture Minus Methionine (Promega), 1 µg DNA template, 50 
U ribonuclease inhibitor (Amersham Pharmacia Biochem), 2 µl 35S-methionine 
(1,200 Ci/mmol at 10 mCi/ml). Reactions were incubated at 30°C for 90 minutes. 
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Typically 2.5 tl out of each 50 t1 reaction were loaded onto 12 % acrylamide gels to 
analyse the products of translation (Section 2.9.2). 
2.6.2 In vitro translation of mRNA 
This was performed using the Rabbit Reticulocyte Lysate System, Nuclease Treated 
(Promega). Each 50 µl reaction comprised the following: 35 µl rabbit reticulocyte 
lysate (Promega), 20 tM Amino Acid Mixture, Minus Methionine (Promega), 2 µl 
35S-methionine (1,200 Ci/mmol at 10 mCi/ml), 10-500 ng mRNA substrate in water 
(transcribed using mMessage mMachineTu, Ambion, as in Section 2.4.3) and 50 U 
Ribonuclease Inhibitor (100 U/µl, Amersham Pharmacia Biochem). Reactions were 
incubated at 30°C for 90 minutes. Typically 2.5 µl out of each 50 µ1 reaction were 
loaded onto 12 % acrylamide gels to analyse the products of translation (Section 
2.9.2). 
2.6.3 In vitro RNA homopolymer binding assays 
In vitro RNA homopolymer binding assays were performed exactly as described in 
Swanson and Dreyfuss (1988). Briefly, mRNAs were translated in reticulocyte lysate 
(Promega) in the presence of 35S-methionine (as described in Section 2.6.2) and 
added to Sepharose-conjugated RNA homopolymers (polyguanylic acid on 
Sepharose 4B, polyadenylic acid on Sepharose 4B, polycytidylic acid on 4% beaded 
agarose, polyuridylic acid on polyacrylhydrazido-agarose, all from Sigma) or dsDNA 
(on cellulose, also from Sigma) in binding buffer (100 mM-2 M NaCl, 0.5 % Triton 
X-100). Following binding and washing, the beads were resuspended in 50 µl SDS 
loading buffer, boiled for 3 minutes at 95°C and run on 12 % SDS-PAGE gels as 
described in Section 2.9.2. 
2.7 Production of XPAT-GST fusion proteins in bacteria 
Constructs for these experiments were made as described in Section 2.2.2.2. 
The ORF was cloned into pGEX-2T. pGEX-2T with no insert was used as a GST- 
only control throughout. Overnight cultures were diluted 1/10 in fresh LB and 
ampicillin and grown for 2 hours at 37°C. Cultures were then induced to express 
GST- XPAT (or GST) by addition of IPTG to a concentration of 0.1mM and grown 
at 37°C for a further 2 hours. Bacterial strains used were DH5a, BL21 and AD202 
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(genotypes given in Section 2.1.4.2), which all gave similar results for GST-XPAT. 
Samples were centrifuged at 3K rpm for 10 minutes and pellets resuspended in 1 ml 
PBS containing 0.1 mM PMSF. This was incubated on ice for 20 minutes and then 
the bacteria were lysed by sonication at 6µm wavelength for 4x 30 seconds. 100 µl 
was taken as a total protein sample and the remaining sample was centrifuged at 13K 
rpm for 15 minutes at 4°C. The supernatant was taken off (this is the soluble protein 
fraction) and the pellet was resuspended in 1 ml 0.5 % SDS. 
2.8 Immunisations and Preparation of Serum 
2.8.1 Production of MAP peptides 
20-30 . tg of MAP peptide was made, purchased and purified for immunisation by 
Alta Bioscience (School of Biochemistry, The University of Birmingham). Peptides 
were supplied lyophilised and were resuspended in PBS. 
2.8.2 Immunisations 
Rabbits and mice were immunised with the desired peptide in complete non- 
ulcerative Freunds adjuvant (Morris) (Guildhay Ltd). Complete Freunds adjuvant 
was prepared by adding 10 doses of intradermal BCG vaccine BP, resuspended in 0.4 
ml PBS, to 20 mis Freunds. Subsequently, boosts were carried out in incomplete 
non-ulcerative Freunds. For the primary injection and boosts 500 µg MAP peptide 
was injected into each rabbit, and 5 µg into each mouse. Rabbits and mice were 
injected every 4 weeks and test bleeds taken 10-14 days after each injection. 
2.8.3 Preparation of serum 
Blood was heated to 37°C for 15 minutes, clots that formed were detached by ringing 
with a Pasteur pipette and the blood left overnight at 4°C to contract further. Serum 
was taken and spun at 13K for 5 minutes, aliquoted and stored at -20°C. 
2.8.4 Enzyme Linked Immunosorbent Assay (ELISA) 
This assay was used to detect the binding of antibody to peptide, to determine if there 
was an immune response by the rabbit/mouse to the MAP peptide. MAP peptides 
were diluted to final concentration of 1µg/ml in coating solution (50 mM sodium 
carbonate pH 9.6). 150 µl of the peptide solution was put into the wells of a 
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polystyrene 96-well microtitre plate (Nunc). A complete column of wells was coated 
for each peptide. The wells of column 1, the blank, were all coated with coating 
buffer only. The plate was incubated overnight at 4°C to coat. 
The coating buffer was removed from the wells and the wells were filled to capacity 
(320 µl) with blocking solution (0.5 % (w/v) gelatin in 1x PBS [10 x PBS, 150 mM 
pH 7.2: 80 g NaCl, 2g KCI, 11.5 g Na2HPO4,2 g KH2PO4 per litre]). The plate was 
then incubated at 37°C for 30 minutes. The blocking solution was removed and the 
wells were washed 3 times with 0.1 % v/v Tween-20 in PBS. Rabbit or mouse serum 
was diluted in the range 1/1000-1/4000, and normal rabbit or mouse serum was used 
at 1/1000. Each well used was then filled with 150 µl of antibody solution. The top 
row was reserved for normal serum so that a measure against each peptide could be 
obtained. The plate was incubated at 37°C for 30 minutes. 
The antibody solutions were removed and the wells washed 5 times with 0.1 % (v/v) 
Tween-20 in PBS. Each well used was then filled with 150 µl of horseradish 
peroxidase-conjugated goat anti-rabbit IgG (Bio-RAD laboratories) or horseradish 
peroxidase-conjugated rabbit anti-mouse IgG (Sigma), diluted 1/3000 with PBS. The 
plate was incubated at 37°C for 30 minutes. The secondary antibody solution was 
removed and the wells were washed 5 times with 0.1 % v/v Tween-20 in PBS. 
Colour was then developed by addition of 150 µl/well of substrate (per 25 ml: 5 mg 
o-Phenylenediamine (OPD) tablets (5 mg/tablet, Sigma), 0.74 % (w/v) Na2HPO4, 
0.225 (w/v) citric acid and 10 µl 30% H202). Colour was allowed to develop for 30 
minutes in the dark and was terminated by the addition of 100 µl 2M H2SO4. The 
absorbance at 490 nm was recorded. 
2.9 Protein Analysis 
2.9.1 Protein extraction 
All samples were diluted in 2x loading dye (to give final concentration 1x dye: 50 
mM Tris-CI pH 6.8,1 % 2-mercaptoethanol, 2% SDS, 0.1 % bromophenol blue, 10 
% glycerol). Samples were heated at 95°C for 5 minutes before loading. 
" Oocytes and embryos; samples were homogenised in 10-20 µl per oocyte (or 
embryo) of Barth's saline containing 1 mM PMSF, and insoluble proteins removed 
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by centrifugation at 13K rpm for 5 minutes. Various volumes were loaded, typically 
the equivalent of 1/3 oocyte per lane of mini gel. 
" Bacteria: pellets were resuspended in 1x loading dye and various amounts were 
loaded, typically around 0.05-0.2 ml of induced culture. 
2.9.2 Protein gels 
Gels were made with a 12 % acrylamide (37.5: 1 acrylamide: NN- 
methylenebisacrylamide respectively) resolving gel (0.375 M Tris-Cl pH 8.8,0.1% 
SDS, 0.1 % APS, 4 µl TEMED/10 mls gel) and 5% (37.5: 1) acrylamide stacking gel 
(126 mM Tris-HC1 pH 6.8,0.1 % SDS, 0.1 % APS, 5 µl TEMED/5 ml gel) and run 
in Tris-glycine buffer (40 mM Tris, 253 mM glycine, 0.1 % SDS). The gels were run 
at 100 volts. Pre-stained size markers were loaded onto each gel: See B1ueTMPlus2 
Pre-Stained Standards (NOVEXTM Novel experimental technology). 
Gels were stained with 0.2 % Coomassie blue in 10 % acetic acid and 40 % 
methanol, and destained in 10 % glacial acetic acid and 40 % methanol. 
Gels were dried under vacuum at 80°C. 
2.9.3 Western Blotting 
Gels were run as in Section 2.9.2. All materials used in the blot were soaked in 1x 
western transfer buffer (40 mM Tris, 194 mM glycine, 20 % Analar grade methanol) 
prior to use. Blots were set up as follows: cathode side- 3 sheets of Whatman paper, 
gel, nitrocellulose membrane (HybondTM-C, Amersham), 3 sheets Whatman paper, in 
a Mini Trans-blot® Electrophoretic Transfer Cell (Bio-rad) apparatus. Blots were 
run for 1 hour at 100 volts on a magnetic stirrer to recircularise buffer. 
Membranes were rinsed in TBS (10 mM Tris pH 8.0,150 mM NaCI) and blocked in 
5% Marvel milk powder in TBST (10 mM Tris-Cl, pH 8.0,150 mM NaCI, 0.1 % 
(v/v) Tween-20) for 1-2 hours. Primary antibodies (serum) were placed on blots in 
TBST/5 % Marvel and left overnight, shaking at 4°C. 
4x5 minute washes in TBST were performed at room temperature. Secondary 
antibody (Goat Anti-Rabbit IgG (H + L) Horseradish Peroxidase Conjugate, Bio-Rad 
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Laboratories; or Rabbit Anti-Mouse IgG (whole Molecule) Peroxidase Conjugate, 
Sigma) was diluted 1/3000 in 5% Marvel milk powder in TBST and incubated at 
room temperature for >2 hours. Membranes were then washed for 2x5 minutes with 
TBST and 2x5 minutes in TBS. Finally filters were rinsed in 100 mM Tris-Cl pH 
7.5 and then the substrate added for the horseradish peroxidase enzyme [3,3' 
diaminobenzidine (DAB) tetrahydrochloride tablets (Sigma) at 0.5 mg/ml] in 100 
mM Tris-Cl pH 7.5 and 12 µl 30 % hydrogen peroxide added for every 10 mg of 
DAB used. Reactions were left to develop colour for up to 5 minutes and the reaction 
stopped by washing extensively in TBST. 
2.9.4 Immunoprecipitations 
For radioactive immunoprecipitations, oocytes were prepared as described in Section 
2.10.6. Oocytes were homogenised in 200 µl of ice cold EBC lysis buffer (150 mM 
NaCl, 1% NP-40,50 mM Tris pH 8.0,2 mM EDTA, 1 mM PMSF, 1 mM DTT), 
and the volume made up to 500 µl (per 10 oocytes) with EBC. Debris was removed 
by a5 minute centrifugation at 13K rpm. The lysate was removed. 10 µl were 
removed for analysis on an SDS PAGE gel to test for 'incorporation of 35S- 
methionine and overexpression of proteins in oocytes. To the lysate, various dilutions 
of serum were added, usually between 1/100 and 1/500: Monoclonal Anti-c-myc 
clone 9E10 (Sigma) was used at 1/100 dilution. Samples were then incubated on ice 
for 1 hour. 40 µl of protein-A Sepharose beads (50% slurry in PBS) were added per 
500 µl lysate and the samples were incubated at 4°C with rotation for 1 hour. The 
Sepharose was allowed to settle under gravity and the supernatant was removed. The 
beads were then washed 3 times in NETNO. 1 buffer (20 mM Tris-Cl pH 8.0,100 
mM NaCl, 1 mM EDTA, 0.5 % NP-40). The final wash was removed to leave -50 µl 
total volume (of beads + buffer). An equal volume of 2x SDS loading dye was 
added and the samples heated at 95°C for 3 minutes prior to gel analysis. 
2.9.5 Whole mount immunocytochemistry 
This was performed as described in Sive et al. (2000) with the following 
modifications: the primary antibody, GFP (FL) rabbit polyclonal antibody (200 
µg/ml, Santa Cruz Biotechnology), was used at a 1/100 dilution. Secondary antibody: 
Goat Anti-Rabbit IgG (H + L) Horseradish Peroxidase Conjugate (Bio-Rad 
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Laboratories) was diluted 1/200 in PBT; or Goat Anti-Rabbit IgG (whole molecule) 
FITC conjugate (Sigma) was diluted 1/50 in PBT. At the end of the protocol, oocytes 
were fixed in Bouin's (9.25 % formaldehyde (v/v), 5% (v/v) glacial acetic acid) 
overnight at room temperature, washed for 5x 20 minutes in 70 % ethanol buffered 
with PBST and then bleached. Bleaching was performed in bleaching solution (1 % 
(v/v) H202,5% formamide (v/v), 0.5 x SSC) exactly as described in Sive et al. 
(2000). 
2.10 Embryo and Oocvte Culture and Manipulation 
Embryos were staged according to Nieuwkoop and Faber (1967). 
2.10.1 Embryo culture and dissection 
Female frogs were injected with 50-100 U follicle stimulating hormone (FSH) 48- 
144 hours prior to laying and 600 U human chorionic gonadotrophin (HCG) 16 hours 
prior to laying. Frogs were placed in Barth's saline (88 mM NaCl, 1.0 mM KCI, 2.5 
mM NaHCO3,15 mM Tris-Cl pH 7.6,0.3 mM Ca(NO)2,0.41 mM CaC12,0.82 mM 
MgSO4) for laying and eggs removed into small dishes of Barth's saline. Testes were 
manually dissected and placed into Barth's saline. Eggs were flooded in water after 
wiping with split testis and allowed to fertilise for 30 minutes. Jelly was removed by 
a 10 minute treatment in 2% (w/v) cysteine pH 8.0 and then washed three times in 
0.1 x Barth's saline. For culturing gentomycin was added to 10 pg/ml. 
Embryos were dissected in Barth's saline, after manual removal of vitelline 
membranes. 
2.10.2 Embryo injection 
Embryos were injected, usually bilaterally at the two cell stage, with various amounts 
of mRNA (Section 2.4.3) in 6% Ficoll (w/v in 0.1 x Barth's saline) using a 
micromanipulator and fine drawn out capillary tube. Injected embryos were then 
transferred to 0.1 x Barth's saline for culturing. 
57 
2.10.3 Oocyte injection 
Stage VI oocytes were dissected from ovaries, injected with various amounts of 
mRNA or 10-15 ng of antisense oligonucleotide and cultured in Barth's saline at 
18°C. 
Table 2.2 Oligonucleotides used for antisense experiments 
Where oliaos are taken from other sources, references are shown. 
Primer Name Primer sequence 
asX at-1 5' TTGACCATCTGAAGACCG 3' 
asXp at-2 5' GAACATCACTACAGGTGC 3' 
asXp at-3 5' CACAAGCACTCCACGGAA 3' 
asX at-4 5' AGTGGCAGCTCTTAGAAG 3' 
asXp at-5 5' GTTGAGGACACGTCAGGA 3' 
asXp at-6 5' GCTGAGAACACTACCGTT 3' 
asXp at-7 5' TGAAGACCGATGTAGCAG 3' 
asXp at-8 5' CCAGTTGATCCAGAGCTT 3' 
asXp at-9 5' CCTCGCTACAGATGGCTA 3' 
asX at-10 5' CACGTCAGGATAGAGCTT 3' 
asX at-11 5' TCCAACTACGAGCCACAT 3' 
asXp at-12 5' TTCTGCCTTCAAAGCCATAGA 3' 
asVe T 5' CAGCAGCATGTACTTGGC 3' (Zhang et al., 1998) 
Antisense oligonucleotides were used to deplete Xpat mRNA or VegT mRNA at 
injection doses of 10-15 ng per oocyte. These oligonucleotides were synthesised in a 
more stable modified form in which the 5' and 3' terminal four bases were linked by 
phosphorothioate linkages instead of the conventional phosphodiester bonds 
(asXpatl -11 and asVegT, INTERACTIVA biotechnologie GmbH; asXpatl2, Gibco 
BRL). The sequences of the antisense oligonucleotides used are shown in Table 2.2. 
Morpholino antisense oligodeoxynucleotides were also used to prevent the 
translation of specific proteins. Morpholino oligos have substitutions of the riboside 
moieties with nitrogen-containing morpholine moieties and are phosphorodiamidate 
linked (Summerton & Weller, 1997). All morpholinos used were 25-mers and had 
the following sequences: 
Xpat morpholino: 5' ATTCTCATTCTCAGCAGCAAAAGGA 3', 
Xsox1713 morpholino: 5' TGATTCGGAGTGCTGTGGTGATTAG 3', 
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Standard control morpholino: 5' CCTCTTACCTCAGTTACAATTTATA 3' (Gene 
Tools LLC). Morpholino oligos were resuspended in sterile filtered water and 
injected in doses of 10-50 ng per oocyte. 
2.10.4 Culturing of oocytes in growth conditions and drug treatments 
Oocytes of the stages required were dissected and injected. Oocytes were cultured in 
OCM (oocyte culture medium), as previously described in Yisraeli and Melton, 
(1988): 0.5 x Leibowitz L-15 medium (Gibco BRL), 1 mM L-glutamine, 1 µg/ml 
insulin, 15 mM Hepes pH 7.8,50 U/ml nystatin, 100 pg/ml gentamycin, 100 U/ml 
penicillin-streptomycin, 10 % (v/v) vitellogenin-containing frog serum (prepared as 
in Yisraeli and Melton, 1988). Occasionally, instead of 10 % (v/v) vitellogenin- 
containing frog serum, purified vitellogenin to a final concentration of 5 mg/ml was 
used (purified as described in Kloc & Etkin, 1999). 
Cytoskeletal inhibitors were added to the media when oocytes were injected and 
were replaced daily. The inhibitors were dissolved in DMSO (except 
demecolcemine, which was dissolved in ethanol) at the following stock 
concentrations: cytochalasin D (Sigma) 2 mM, paclitaxel (Sigma) 5 mg/ml, 
demecolcemine (Sigma) 10 mM, nocodazole (Sigma) 1 mg/ml. Cytochalasin D and 
nocodazole were stored at -20°C, whilst paclitaxel and demecolcemine were stored at 
+4°C. The cytoskeletal inhibitors were used at the following working concentrations: 
cytochalasin D2 µM, paclitaxel 5 µg/ml, demecolcemine 10 µM, nocodazole 1 
µg/ml. 
2.10.5 Oocyte dissection 
Oocytes were dissected in Barth's saline. A manual dissection procedure was used to 
remove nuclei (as described in Woodland and Adamson, 1977). For oocyte bisection, 
oocytes were first fixed by heating to 75-85 °C in Barth's saline for 30 seconds. They 
were then cut open using a scalpel. 
2.10.6 Photography 
Oocytes expressing GFP constructs were photographed using a Leica (MZFLIII) 
DC100 dissecting microscope and digital camera. Pictures of oocytes at a higher 
59 
magnification (x 100 to x 400) were taken using a Nikon (UFX-II) Optiphot 
microscope and the Leica digital camera. 
2.10.7 Production of protein in oocytes and protein analysis 
This method was used to test in vitro transcribed mRNAs (Section 2.4.3) and for 
immunological procedures (Section 2.9.4). Oocytes were injected and cultured ± 35S- 
methionine label to assess the translatability of the message prior to overexpression 
studies and to make radioactively labelled proteins. 
Stage VI oocytes were dissected from ovaries, injected with mRNA and cultured 
overnight in Barth's saline with 10-15 tCi 35S-methionine (10 pCi/µl, 1000 
Ci/mmol) per 8 oocytes. For protein analysis of transcribed messages oocytes were 
typically homogenised in 20 µl/oocyte of: Barth's saline, 1 mM PMSF, 0.5 µg/ml 
leupeptin. Insoluble material was removed by centrifugation at 13K rpm for 5 
minutes. The extract of approximately 1/3 of an oocyte was loaded onto each lane of 
a protein gel (Section 2.9.2), gels were dried and autoradiographed to visualise 
production of protein. 
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Chapter 3: Investigation of the dynamics of XPAT localisation using XPAT 
tagged with green fluorescent protein (GFP) 
3.1 An introduction to GFP and the use of GFP fusion constructs in expression 
studies 
The introduction of green fluorescent protein (GFP) from the jellyfish Aequorea 
victoria as an endogenous fluorescent tag promises to provide both an innocuous 
means of rendering target proteins visible and of providing information about 
cytoskeletal function in living cells. Initial studies have been encouraging in showing 
that GFP and fusion constructs of GFP with a variety of cellular proteins remain 
fluorescent in a variety of cell types and species. The fusion proteins also behaved in a 
manner similar to the native proteins. 
GFP (reviewed by Tsien, 1998) was discovered by Shimomura et al. (1962), but the 
gene was not cloned until 30 years later (Prash r et al., 1992). The crystal structure of 
GFP was recently determined at 1.9 angstrom resolution (Ormo et al., 1996; Yang et 
V 
al., 1996) and this revealed that the protein consists of an 11-stranded (3-barrel 
structure (the ß-can) that surrounds a single central cc-helix. The chromophore is 
formed by the spontaneous cyclisation of residues Ser-65, Tyr-66 and Gly-67, 
followed by oxidation of the a-(3 bond of Tyr-66 (Heim et al., 1994; Inouye and Tsuji, 
1994). This autocatalytic post-translational reaction occurs in -4 hours in native GFP 
(Heim et al., 1994; Inouye and Tsuji, 1994). The chromophore forms from the central 
cc-helix and is contained at almost the exact centre of the 13-can (Ormo et al., 1996; 
Yang et al., 1996; Brejc et al., 1997). Many of the physical properties of GFP (such as 
resistance to heat, urea, detergents and formaldehyde fixation) result from the 
insulation of the chromophore inside the ß-barrel. 
The isolated chromophore and intact GFP both absorb light maximally at -390 nm 
with a smaller peak of absorption at 480nm (Morise et al., 1974; Cody et al., 1993). 
However, only intact GFP emits green light, the emission sprectrum peaking at 508nm 
(Morise et al., 1974). The GFP gene contains all the information required for the 
formation of the chromophore. Thus, no Cnidaria-specific biosynthetic pathways or 
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agents such as antibodies, cofactors or substrates are necessary for its activity (Chalfie 
et al., 1994). 
Ludin et al. (1996) modified previously developed epitope tag vectors to incorporate 
GFP in two different forms suitable for its addition to target proteins at either N- or C- 
terminus. They showed that when MAP2 protein was tagged using such a vector it 
retained its phenotypic effects on transfected cells, which could be visualised in the 
living state. 
The main purpose of using GFP-tagged proteins is to study dynamic events and their 
regulation in vivo using non-intrusive techniques. As a reporter, GFP has considerable 
advantages compared with the other conventional ones in that substrates and pre- 
treatment are not required for observation of the fluorescence in intact organs or 
tissue. Also, the analysis can be carried out on a real-time basis without killing 
animals or cells. 
When injected into Xenopus oocytes, GFP-tagged proteins can be visualised in the 
living cells using standard fluorescent microscopy techniques. To investigate where 
XPAT protein is localised within the Xenopus oocyte, it was decided to make XPAT: 
GFP chimeras to visualise XPAT distribution. Two constructs were made 
incorporating GFP as a fluorescent tag at the N- terminus (in GFP-XPAT) or C- 
terminus (in XPAT-GFP) of the encoded fusion protein. 
3.2 The production of Xpat:: GFP chimeras 
3.2.1 Resequencing of Xpat cDNA 
During construction of Xpat-GFP, it became apparent that there must be some errors 
in the original Xpat cDNA sequence (Hudson and Woodland, 1998), since all attempts 
to make Xpat-GFP generated an XPAT-sized protein product (35kDa) in an in vitro 
transcription and translation reaction (Figure 3.2. E) and not a product of the expected 
size for XPAT-GFP (65kDa). However, the GFP in the vector alone (prior to the 
additional ligation of Xpat) translated well and at the correct size (30kDa), as shown 
in Figure 3.2. E. It seemed likely therefore that there was an error in the sequence at 
the 3' end of the Xpat ORF near to the predicted STOP codon, and so the Xpat ORF 
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was resequenced. This was done using both manual and automatic sequencing 
reactions on both strands of the cDNA using primers spanning the length of the ORF. 
The correct cDNA and protein sequences of Xpat are shown in Figure 3.1, with 
alterations from the published Xpat sequence (Hudson and Woodland, 1998) 
highlighted in red. As predicted, there was an error in the sequence at the 3' region of 
Xpat's ORF and in fact the actual XPAT protein is a 293 amino acid polypeptide, 10 
amino acids shorter than the 303 amino acid-polypeptide originally predicted. 
Figure 3.1: Corrected cDNA and predicted protein sequence of Xpat 
TGCAGCCTGTGTCTGAATGAATCCTCCTTTTGCTGCTGAGAATGAGAATTTTAGATGTGT 
1 ---------+---------+---------+---------+---------+---------+ 60 
ACGTCGGACACAGACTTACTTAGGAGGAAAACGACGACTCTTACTCTTAAAATCTACACA 
TCAAATTTAAAGGCTTTCAGGATAGCCCAGACTAGAGAATCTCTATGGCTTTGAAGGCAG 
61 ---------+---------+---------+---------+---------+---------+ 120 
AGTTTAAATTTCCGAAAGTCCTATCGGGTCTGATCTCTTAGAGATACCGAAACTTCCGTC 
MALKA E- 
AAGACTCTTTTGATATTTACTCCCAGTTGATCCAGAGCTTCTGCAGATATGCTGAGAACA 
121 ---------+---------+---------+---------+---------+---------+ 180 
TTCTGAGAAAACTATAAATGAGGGTCAACTAGGTCTCGAAGACGTCTATACGACTCTTGT 
DSFDIYSQLIQSFCRYAEN T- 
CTACCGTTTCAGAAAGCCAATCCCCAGCTTTCAATGCACAAAAGGAATTCCAAACTTGTC 
181 ---------+---------+---------+---------+---------+---------+ 240 
GATGGCAAAGTCTTTCGGTTAGGGGTCGAAAGTTACGTGTTTTCCTTAAGGTTTGAACAG 
TVSESQSPAFNAQKEFQTC Q- 
AAGACCATGCATGCTGTACACACTCTGAAGCCCATACGCACATTTTGATGCAGCAGTGGC 
241 ---------+---------+---------+---------+---------+---------+ 300 
TTCTGGTACGTACGACATGTGTGAGACTTCGGGTATGCGTGTAAAACTACGTCGTCACCG 
DHACCTHSEAHTHILMQQW Q- 
AGCTCTTAGAAGAACAGTGGGAGTACATTGACCATCTGAAGACCGATGTAGCAGCCCTGA 
301 ---------+---------+---------+---------+---------+---------+ 360 
TCGAGAATCTTCTTGTCACCCTCATGTAACTGGTAGACTTCTGGCTACATCGTCGGGACT 
LLEEQWEYIDHLKTDVAAL K- 
AACAGTTGCTGCATGGTTTCATGAACTCATTAAGTGGCACTGACAGTGGCATGGAGGGTA 
361 ---------+---------+---------+---------+---------+---------+ 420 
TTGTCAACGACGTACCAAAGTACTTGAGTAATTCACCGTGACTGTCACCGTACCTCCCAT 
QLLHGFMNSLSGTDSGMEG T- 
CAAATCATTTTCTTCCTCCCCACCAAAACCCAACTTTGCTTAAAGATGAGGAAATTGTTG 
421 ---------+---------+---------+---------+---------+---------+ 480 
GTTTAGTAAAAGAAGGAGGGGTGGTTTTGGGTTGAAACGAATTTCTACTCCTTTAACAAC 
NHFLPPHQNPTLLKDEEIV A- 
CAAGTGCTCTAAACAGGCCAAGCGTTGATATCAATGGATTTGAAGAGAACATCACTACAG 
481 ---------+---------+---------+---------+---------+---------+ 540 
GTTCACGAGATTTGTCCGGTTCGCAACTATAGTTACCTAAACTTCTCTTGTAGTGATGTC 
SALNRPSVDINGFEENITT G- 
GTGCCCAAATCCATGCAGCATTTACCAAAAGCCCCAAAAAGATGCCTGCCACAAGCACTC 
541 ---------+---------+---------+---------+---------+---------+ 600 
CACGGGTTTAGGTACGTCGTAAATGGTTTTCGGGGTTTTTCTACGGACGGTGTTCGTGAG 
AQIHAAFTKSPKKMPATST P- 
CACGGAAATCTGAAGTTCTGTGGAGCTGCAGTCCGACCCTCGCTACAGATGGCTATTTTA 
601 ---------+---------+---------+---------+---------+---------+ 660 
GTGCCTTTAGACTTCAAGACACCTCGACGTCAGGCTGGGAGCGATGTCTACCGATAAAAT 
RKSEVLWSCSPTLATDGYF M- 
TGCTTCCTGACATTATCCTAAATCCCCTGGATGGAAAGAAGCTAGTTTCCATGCTGCGCA 
661 ---------+---------+---------+---------+---------+---------+ 720 
ACGAAGGACTGTAATAGGATTTAGGGGACCTACCTTTCTTCGATCAAAGGTACGACGCGT 
LPDIILNPLDGKKLVSMLR S- 
64 
GCTCCAACTACGAGCCACATCGTTTTGCAGAGCTTCTGTTTCAACATCACGTTCCCCATT 
721 ---------+---------+---------+---------+---------+---------+ 780 
CGAGGTTGATGCTCGGTGTAGCAAAACGTCTCGAAGACAAAGTTGTAGTGCAAGGGGTAA 
SNYEPHRFAELLFQHHVPH S- 
CCCTCTTCCAACTGTGGGCTAACAAAGTGAACTTTGATGGTTCCAGAGGGAAACTTGGCC 
781 ---------+---------+---------+---------+---------+---------+ 840 
GGGAGAAGGTTGACACCCGATTGTTTCACTTGAAACTACCAAGGTCTCCCTTTGAACCGG 
LFQLWANK 'V NFDGSRGKLG L- 
TGCCCAGAAACCTAATGATAGACATCTTGCACCAAACATCCAAAAGGTTTGTCTTGGGCC 
841 ---------+---------+---------+----=----+---------+---------+ 900 
ACGGGTCTTTGGATTACTATCTGTAGAACGTGGTTTGTAGGTTTTCCAAACAGAACCCGG 
PRNLMIDILHQTSKRFVLG P- 
CAAAGGAGAAACGGAAGATTAAGACAAGGTTGAATTTGTTGTTGAGGACACGTCAGGATA 
901 ---------+---------+---------+---------+---------+---------+ 960 
GTTTCCTCTTTGCCTTCTAATTCTGTTCCAACTTAAACAACAACTCCTGTGCAGTCCTAT 
KEKRKIKTRLNLLLRTRQD R- 
GAGCTTGGTGGGATGTTGGCCTGTAGGCAAAGGTTTAAGTTTTTGTTAAGATTT 
961 ---------+---------+---------+---------+---------+---- 1014 
CTCGAACCACCCTACAACCGGACATCCGTTTCCAAATTCAAAAACAATTCTAAA 
AWWDVGL. 
3.2.2 The production of XPAT-GFP and GFP-XPAT 
In order to incorporate GFP as a fluorescent tag at the N- or C- terminus of XPAT, the 
pSPJC2L vector (Cook et al., 1993) was modified to accept cloned cDNA fragments 
to be expressed in frame with GFP. 
In order to construct GFP-Xpat, the coding region for GFP was amplified by PCR 
using primers that created 5' BglII and 3' Hindu sites. The resulting PCR fragment 
was cloned into the BgIII and HindIII sites of pSPJC2L, creating pSPJC2L-NGFP. 
The region encoding the Xpat ORF was amplified from a cDNA library clone with 
primers creating 5' and 3' HindIIl sites. The resulting fragment was cloned into the 
HindIII site of pSPJC2L-NGFP, generating GFP-Xpat, Xpat tagged with GFP at its N- 
terminus. This clone is illustrated in Figure 3.2A. 
To construct Xpat-GFP, the GFP coding sequence was amplified using primers 
designed to create a 5' BgIII and a 3' EcoRl site. Finally, the resulting fragment was 
cloned into the Bg1II and EcoRI sites of pSPJC2L to generate pSPJC2L-cGFP. This 
vector thus contained restriction sites that could be used to create mRNA encoding 
proteins tagged with GFP at the C-terminus. Fluorescently tagged Xpat was prepared 
using this vector containing GFP. The region containing Xpat's ORF was amplified 
from a cDNA library clone with primers creating 5' and 3' Bg1II sites. The resulting 
fragment was cloned into the BgIII site of pSPJC2L-cGFP generating Xpat-GFP. This 
clone is shown in Figure 3.2. B. 
Once constructs were made, restriction digestion was used to confirm that the inserts 
were present and that the orientation of Xpat was correct. This was necessary because 
Xpat was generated with HindIII on both ends of the PCR product (in GFP-Xpat) and 
with Bg1III on both ends of its PCR product (in Xpat-GFP) thus it could be ligated 
into the construct in either of two possible orientations. Figure 3.2. C and 3.2D show 
restriction digests on GFP-Xpat and Xpat-GFP, respectively; the digests are consistent 
with Xpat having inserted in the correct orientation, in-frame with GFP, in both 
constructs. 
Following restriction digestion, in vitro-coupled transcription and translation reactions 
were performed using Xpat-GFP or GFP-Xpat DNA as a template. A fraction of each 
reaction was resolved by SDS-PAGE, alongside translations of both Xpat and GFP. 
An autoradiograph of this gel is shown in Figure 3.2. F, and indicates that both XPAT- 
GFP and GFP-XPAT have an apparent molecular weight of approximately 65kDa, the 
expected size for these chimeras. In 3.2. F, it is not obvious that XPAT-GFP and GFP- 
XPAT are exactly the same size, since they are not in adjacent lanes of the gel. A 
further protein gel was run to clarify the sizes of both proteins, an autoradiograph of 
this gel is shown in 3.2. G. As this figure shows, XPAT-GFP and GFP-XPAT are 
identical in size, as expected. 
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Figure 3.2: Cloning of Xpat-GFP and GFP-Xnat. 
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(A) Vector map of GFP-Xpat in pSPJC2L, with positions of restriction enzyme sites marked. (B) The vector map of Xpat-GFP 
in pSPJC2L with restriction enzyme sites marked. The 3' and 5'UTRs present in pSPJC2L vector are globin UTRs. (C) I% 
agarose gel of restriction enzyme digests on GFP-Xpat DNA; BgIII and Hind1Il double digest was used to confirm the presence 
of GFP and Xpat inserts in the clone, and EcoR 1 was used to confirm the orientation of Xpat in the clone (see map in A for 
details). (D) 1% agarose gel of restriction enzyme digests on Xpat-GFP DNA; BglIl and EcoRI double digest was used to 
confirm the presence of GFP and Xpat inserts in the clone, and the orientation of Xpat in the clone was confirmed by EcoR 1 
digestion (see map in B for details). (E) Autoradiograph of 12% acrylamide gel of in vitro transcription and translation 
reactions (performed using rabbit reticulocyte lysate) using Xpat, GFP and 2 original attempts to generate Xpat-GFP cDNA as 
a template. (F) and (G) show autoradiographs of 12% SDS-PAGE gels of (rabbit reticulocyte lysate) in vitro transcription and 
translation reactions using Xpat, GFP, GFP-Xpat and Xpat-GFP DNA as templates. 
Thus, the pSPJC2L vector was modified to accept cloned cDNA fragments to be 
expressed in frame with GFP. These vectors provide a fast and convenient way of 
generating fusion constructs that include the sequence of a protein or protein fragment 
to be studied, tagged with GFP. In Xenopus oocytes, GFP-tagged proteins are 
fluorescent and can be easily localized by fluorescence microscopy using standard 
GFP filter sets. 
3.3 The localisation of XPAT-GFP and GFP-XPAT in oocytes 
To analyse the subcellular localisation of the Xpat gene product, XPAT protein was 
tagged with GFP at either the carboxyl or the amino terminus, as described in 3.2. The 
resultant chimeric mRNAs (Xpat-GFP and GFP-Xpat) were injected into the 
equatorial region of Xenopus oocytes, at a dose of 2ng per oocyte, and localisation of 
the translated product was examined by fluorescent microscopy. 
69.6% of stage III, N and V Xenopus oocytes appeared ubiquitously fluorescent when 
injected with GFP (see Figure 3.3A), 100% were negative when injected with GFP- 
Xpat, and a small number (37.5%) were generally fluorescent when injected with 
Xpat-GFP mRNA, but the rest were negative (Figure 3.3B). Neither GFP-XPAT nor 
XPAT-GFP proteins appeared to localise in stage III, IV or V oocytes. 
However, in stage VI oocytes a different phenomenon was observed. Oocytes were 
injected with -2 ng GFP mRNA and cultured in vitro at 18°C in OCM. As can be 
seen in Figures 3.3C and D, control GFP mRNA injection into Xenopus oocytes 
resulted in an even and non-localised distribution of GFP fluorescence within the 
oocyte, and homogeneous signals in the cytoplasm. This demonstrates that GFP alone 
does not mediate any specific intracellular targeting events. In contrast, the majority 
of stage VI oocytes injected with the chimeric GFP-Xpat mRNA appeared negative, 
showing no external fluorescence. However, although no fluorescence was seen 
localising externally, dissected nuclei were fluorescent - highlighting that GFP-tagged 
XPAT is localised to the nucleus of Xenopus oocytes (Figure 3.3J and Section 3.3.3). 
Localisation of XPAT-GFP protein was also observed in stage VI Xenopus oocytes. 
On day 1 (18 hours after injection), the fusion protein was expressed principally in an 
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equatorial domain around the point of injection. There was diffuse fluorescence in 
some oocytes (Figure 3.3E shows four such oocytes, expressing XPAT-GFP in 
equatorial region), but also small granules, -1-2 µm in diameter which could easily be 
seen in a dissecting stereomicroscope (as seen in the oocyte shown in Figure 3.3F). 
By 42 hours after injection in many oocytes most of the fluorescence was found at, or 
just lateral to, the vegetal pole. At this stage the fluorescence was predominantly 
punctate, but at the pole the granules were larger (see Figures 3.3G, H and I). Figure 
3.3G is a photograph of the same oocyte shown in 3.3F taken 24 hours later and 
clearly shows that the particles of XPAT-GFP protein expression have grown larger 
during this period. Figure 3.3H shows an oocyte expressing XPAT-GFP in small 
granules at the vegetal pole 42 hours after injection of Xpat-GFP mRNA. Figure 3.31 
shows an enlarged view of an oocyte expressing XPAT-GFP in granules, this 
photograph clearly shows how the small particles appear to be aggregating into larger 
granules towards the vegetal pole of the oocyte. By day 3 (66-72 hours after injection) 
the granules had, in many cases, aggregated into large structures (of between 10-50 
pm across) exactly like the granules seen by in situ hybridisation to germ plasm 
RNAs, and also with some monoclonal antibodies raised against unknown germ plasm 
constituents (Denegre et al, 1997). These granules were seen at or just lateral to the 
vegetal pole (Figures 3.4 A, B, C, D and E). Figure 3.4A shows three oocytes 
expressing XPAT-GFP in granules at the vegetal pole. Figure 3.4B is a photograph of 
an oocyte expressing fluorescent granules of XPAT-GFP protein. However, 3.4C is a 
good example of an oocyte expressing even larger aggregates of fusion protein 
granules at its vegetal pole. A direct view of the vegetal pole of this oocyte is shown 
in Figure 3.4D. A different oocyte that is expressing large granules of XPAT-GFP 
protein, again at its vegetal pole, is shown in Figure 3.4E. 
In order to get a better perception of exactly what was happening to the particles and 
granules of XPAT-GFP protein in oocytes, a higher magnification microscope was 
used (Figures 3.4 F and G). Figure 3.4F shows a higher magnification view (x200) of 
the vegetal region localisation of XPAT-GFP protein after 18hours in culture, small 
granules of XPAT-GFP are clearly visible. Figure 3.4G is a high power photograph 
(200x magnification) of large granules of XPAT-GFP protein formed 42 hours after 
injection. These photographs confirm that the small punctate particles of XPAT-GFP 
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(Opposite) Figure 3.3: Expression of XPAT-GFP, GFP and GFP-XPAT in 
Xenopus oocytes 
Oocytes were injected with 2 ng of Xpat-GFP, GFP or GFP-Xpat mRNA and 
cultured in vitro in OCM at 18°C. Localisation of protein was examined by 
fluorescent microscopy after various times in culture. (A) Stage III and IV oocytes 
injected with GFP mRNA. (B) Stage IV oocytes injected with Xpat-GFP mRNA. (C) 
Stage VI oocytes shown 18 hours post-injection with GFP mRNA. (D) Oocytes 
expressing GFP, 42 hours after injection. (E)+(F) Stage VI oocytes 18 hours after 
injection with Xpat-GFP mRNA. (G) Shows the oocyte in (F) 42 hours after Xpat- 
GFP injection. (H) Another oocyte expressing small granules of XPAT-GFP protein, 
at its vegetal pole 42 hours after mRNA injection. (I) A vegetal view of granules of 
XPAT-GFP forming in a stage VI Xenopus oocyte, 42 hours after injection with 
mRNA. (J) Two stage VI oocytes injected with GFP-Xpat mRNA, showing no 
external fluorescence after 42hours in culture. In (A) and (B) the scale bars represent 
200µm. In (C) -(J) each oocyte is -1.2mm in diameter. 
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protein are aggregating into larger structures (shown particularly well in Figure 3.4G). 
Thus, after 3 days, XPAT-GFP appears to be distributed in a similar way to germ 
plasm itself. 
The striking localisation of fluorescence from XPAT-GFP in particulate structures in 
the vegetal hemisphere of oocytes, compared to the lack of localisation of unfused 
GFP, demonstrates that the XPAT domain of the fusion protein is in fact responsible 
for the targeting and localisation of this fluorescence. 
Two separate experiments were then performed using stage VI Xenopus oocytes. 
GFP-Xpat, Xpat-GFP or GFP alone were injected into either the animal region or the 
vegetal region of an oocyte and oocytes were then cultured in vitro for up to three 
days. The oocytes were then scored for localisation of fluorescence. Table 3.1 shows 
the numbers of oocytes that showed vegetal localisation. The experiments summarised 
in this table were done concomitantly under identical conditions. 
Table 3.1 The localisation of XPAT-GFP versus GFP-XPAT in stage VI Xenopus 
oocvtes 
Time post- GFP FP-Xpat Xpat-GFP GFP GFP-Xpat Xpat-GFP 
injection injected nfected injected injected injected injected 
Ve etall e etall 
[ 
vegetally animally animally animally 
Day 1 G: 93.5% : 19.3% N V: 39.7% G: 86.0% V: 3.9% V: 10.9% 
18 hours -: 6.5% 14.0% E: E: 29.3% -: 14.0% EtA: 17.7% E/A: 47.8% 
-: 66.7% -: 31.0% -: 78.4% -: 41.3% 
N=77 N=57 N=58 N=57 N=51 N=46 
Day 2 G: 86.2% V: 9.6% V: 41.8% G: 85.2% V: 4.2% V: 23.8% 
42 hours -: 13.8% E: 1.9% E: 27.3% -: 14.8% EJA: 4.2% E/A: 23.8% 
-: 88.5% -: 30.9% -: 91.6% -: 52.4% 
N=58 N=52 N=55 N=54 N=48 N=42 
Day 3 G: 74.5% V: 8.7% V: 25% - G: 57.1% V: 7.4% V 22.7% 66 hours -: 25.5% E: 0% E: 35.7% -: 42.9% E: 0% E/A: 27.3% 
-: 91.3% -: 39.3% : 92.6% -: 50.0% 
N=47 N=23 N=28 N=28 N=27 N=22 
G= general fluorescence, -= no fluorescence, V= vegetal fluorescence, E= equatorial 
fluorescence, A= animal fluorescence, N= number of oocytes scored. Oocytes that died were 
removed from culture and discarded, thus affecting scores. 
As Table 3.1 shows, 18 hours after vegetal injection of Xpat-GFP, -40% of oocytes 
show vegetal fluorescence, by day 3 this decreases to 25%. However, 18 hours post 
vegetal injection of GFP-Xpat, 19% of oocytes show vegetal fluorescence, this 
number decreasing to 9% by day 3.18 hours after a vegetal injection of GFP, used as 
a control, 94% of oocytes showed a general fluorescence throughout the oocyte. On 
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(Opposite) Figure 3.4: Expression of XPAT-GFP in Xenopus oocytes 
Stage VI Xenopus oocytes were injected with 2 ng of Xpat-GFP mRNA and cultured 
in vitro in OCM at 18°C. After 66 hours (unless otherwise stated) the localisation of 
XPAT-GFP was examined by fluorescent microscopy. (A) Three oocytes expressing 
granules of XPAT-GFP at their vegetal poles. (B) An oocyte expressing granules of 
XPAT-GFP protein. (C) An oocyte showing aggregation of granules of XPAT-GFP 
protein. (D) A vegetal view of the oocyte in (C) showing aggregating granules. (E) 
Another stage VI oocyte expressing granules of XPAT-GFP protein at its vegetal 
pole. (F) A high magnification photograph (x200) of an oocyte 18 hours after 
injection with Xpat-GFP mRNA, showing small fluorescent granules visible at the 
vegetal pole. (G) A high magnification photograph (x200) of large granules of XPAT- 
GFP protein formed at the vegetal pole of an oocyte 42 hours after injection with 
mRNA. In (A) -(E) each oocyte is -1.2mm in diameter. The scale bar in (F) and (G) 
represents 50 µm. 
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day 3, this figure reduces to 75%. This reduction is probably related to the health of 
the oocytes, since the remaining 25% are apparently negative. 
It was also decided to determine the effect of injecting RNA into the animal pole of 
the oocyte. 86% of these oocytes show general fluorescence 18 hours post GFP 
injection. By day 3, however, this reduces to 57% (again likely due to the health of the 
oocytes). In comparison, 18 hours after animal injection of GFP-Xpat, 78% of oocytes 
are negative, 18% show equatorial or animal fluorescence and 4% are vegetal. By day 
3,7% show vegetal expression and 93% appear negative. 
18 hours after an animal injection of Xpat-GFP, 41% of oocytes are negative, 48% 
show equatorial/animal injection and 11% show vegetal localisation of XPAT-GFP. 
By day 3,50% of oocytes are negative, 23% show equatorial or animal expression 
whereas 27% now have vegetal localisation, and, as previously described, this is 
granular. Thus, the localisation of XPAT-GFP appears to be dynamic, capable of 
moving from animal to vegetal pole. Indeed, a very similar proportion of oocytes 
injected (in the animal pole) with Xpat-GFP achieve localisation to the vegetal pole 
by day 3 compared with oocytes injected vegetally with Xpat-GFP (23% compared 
with 25%). 
It is worth noting that following an animal injection (compared with a vegetal 
injection), a greater proportion of oocytes are negative. This is true of GFP, GFP- 
Xpat or Xpat-GFP injection. By day 3,43% of oocytes injected animally with GFP 
were negative whereas only 26% of those oocytes injected vegetally with GFP were 
negative. This is because there is a risk of injecting the RNA into oocyte nucleus 
rather than into the cytoplasm, which could stop translation (Braddock et al., 1989). 
Thus, the results for XPAT-GFP seemed most encouraging. In other literature, C- 
terminal GFP tags are used (rather than N-terminal ones) in the majority of 
experiments in order to see the expected localisation; for example, Xenf (Nakatani et 
al., 2000) and APC (Mimori-Kiyosue et al., 2000) in Xenopus A6 epithelial cells, 
XFD (Pownall et al., 1998) and GABAA (Chappel et al., 1998) in Xenopus oocytes, 
and Dishevelled (Miller et al., 1999) in oocytes and fertilised eggs. On the other hand, 
Sayers et al. (1997) used GFP-insositol 1,4,5-trophosphate which localises to the 
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animal pole and perinuclear region of Xenopus laevis oocytes. However, the C- 
terminal region of this protein is functional as a channel (ES) domain. Mishima and 
Nishida (1999) used both C- and N-terminal GFP tagged versions of X coronin. Both 
constructs gave consistent localisation to same place as seen previously in fixed 
immuno-fluorescent staining. Likewise, Ludin et al. (1996) used both orientations and 
saw that both were visible for MAD2C. For every example stated, no authors 
indicated failure of any fusion protein to localise in the expected manner. 
3.3.1 The effect of injection site on localisation of XPAT-GFP in Xenopus oocytes 
Since it seems from the results in Table 3.1, discussed in Section 3.2, that the location 
of the site of injection (animal versus vegetal) has an effect on both vegetal 
localisation and on number (and percentage) of oocytes that appear negative. It was 
decided to examine this further, using greater numbers of oocytes for XPAT-GFP. 
XPAT-GFP was further pursued, whereas GFP-XPAT was not because the 
localisation of XPAT-GFP seemed more promising. 
Larger numbers of oocytes in several different experiments were injected in either the 
vegetal half (towards the vegetal pole but not directly at the vegetal pole since this 
could directly disrupt the germ plasm), the animal half (Section 3.2) or at the 
equatorial region of the oocyte. These oocytes were then cultured in vitro for up to 3 
days and then scored for the localisation of the fluorescence. The results from these 
experiments were pooled and are recorded in Table 3.2. 
Table 3.2 The location of the iniection site affects the localisation of XPAT-GFP 
Time Xpat-GFP injected Xpat-GFP injected Xpat-GFP injected 
post injection animally equatorially ve etall 
Day 1 V: 10.9% V: 13.2% V: 53.15% 
18 hours E/A: 47.8% E: 61.6% E: 22.8% 
-: 41.3% -: 25.2% -: 24.05% 
N=46 N=357 N=79 
Day 2 V: 23.8% V: 23.5% V: 41.8% 
42 hours E/A: 23.8% E: 51.2% E: 27.3% 
-: 52.4% -: 25.3% -: 30.9% 
N=42 N=293 N=55 
Day 3 V: 22.7% V: 3 1.0% V: 42.4% 
66 hours E/A: 27.3% E: 44.4% E: 4.8% 
-: 50% -: 24.6% -: 52.9% 
N=22 N=329 N=210 
V= vegetally fluorescent. E= equatorially fluorescent, A= animally fluorescent, -= no fluorescence, 
N= number of oocytes scored. 
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For the experiments described next, which are summarised in Table 3.2, greater 
numbers of oocytes were scored on day 3 than on days 1 and 2 because some oocytes 
were not analysed for 3 days before assessing the localisation. 
As previously described in 3.2, oocytes injected with Xpat-GFP animally showed 
-11% vegetal localisation on day 1. This figure rises to 24% on day 2 and 23% on day 
3. Numbers of negative oocytes were 41% on day 1,52% on day 2 and 50% on day 3. 
Xpat-GFP appears to be translated at the site of injection, so fluorescence is seen here 
and then the XPAT-GFP appears to translocate towards the vegetal pole. 
With an injection into the equatorial region (Table 3.2), day 1 sees 13% vegetal 
localisation, on day 2 this rises to 24% and by day 3 it increases to 31%. Thus, each 
day sees increasing numbers of oocytes showing vegetal localisation. This is possibly 
because the XPAT-GFP protein is moving to its "correct" location in the oocyte, 
which takes time, but there is less distance to travel from the equatorial region than 
from the animal pole. It is also interesting to note that the number of negative oocytes 
is less in the sample injected equatorially; by day 3 only 25% are negative (compared 
with 50% in animally injected oocytes). 
In those oocytes injected in the vegetal pole, day 1 sees 53% of oocytes showing 
vegetal expression, a high percentage as would be expected at the site of injection. 
Oocytes injected in the equatorial region and in the animal pole also show 
fluorescence in the region of injection - 62% of oocytes injected in the equator still 
show fluorescence here 18 hours later; and 48% of those oocytes injected at the 
animal pole still show animal or equatorial fluorescence 18 hours after injection. 
Thus, as previously suggested, Xpat-GFP appears to be translated at the site of 
injection, so fluorescence is firstly seen here and then the XPAT-GFP appears to 
translocate towards the vegetal pole. 
On day 2,42% of oocytes that had been injected in the equator show vegetal 
localisation and on day 3 this percentage stays about the same. However, the number 
of negative oocytes increases with the length of time the oocytes are in culture; on day 
1 24% are negative, by day 2 this is 31% and on day 3 53% are negative. This is 
probably related to the health of the oocytes as prolonged times in culture seem to 
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lead to some deterioration. Also, if oocytes do not show XPAT-GFP localisation in 
the vegetal region they tend, by day 3, to be negative. 
Thus, it seems that vegetal injection gives a higher percentage of vegetally localised 
XPAT-GFP throughout the experiments at any given time but, for example, on day 3 
43% of oocytes show vegetal fluorescence after a vegetal pole injection, compared 
with 31% vegetal after an equatorial injection and 23% vegetal after an injection in 
the animal pole. This is to be expected since Xpat-GFP is translated at the injection 
site; if oocytes are injected at the vegetal pole (where XPAT seems to localise) then 
the fluorescence will remain in the vegetal region, whereas animal or equatorial 
injected Xpat-GFP is translated and then the protein has to translocate to the vegetal 
pole. However, there are fewer negative oocytes on day 2 and day 3 after an 
equatorial injection compared to a vegetal injection. It seems that equatorial injection 
causes Xpat-GFP to be translated at the injection site and then the protein translocates 
vegetally over time. 
3.3.2 The effect of culture medium on localisation of XPAT-GFP in oocytes 
It was decided to determine whether or not the culture medium used had any effect on 
XPAT-GFP localisation in oocytes. This was done because stage III and IV oocytes 
need serum in their medium in order for mRNA to be localised (Yisraeli and Melton, 
1988). It was thus interesting to determine whether the localisation of XPAT-GFP 
protein also needs serum. The results shown are a compendium of data from a number 
of experiments. Each experiment showed the same trend although the proportions in 
each category varied. The oocytes were injected equatorially and cultured in either 
oocyte culture medium (OCM) (made up of 50% Leibowitz medium containing. 10% 
vitellogenin containing-frog serum), or simply 50% Leibowitz medium. Oocytes were 
scored daily for the localisation of fluorescence, the results of these experiments are 
summarised in Table 3.3. 
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Table 3.3: The effect addition of serum to the culture medium had on the 
localisation of XPAT"GFP and GFP in Xennnus nocvte. r. 
Time GFP GFP Xpat-GFP Xpat-GFP 
Post- injected injected injected injected 
injection - serum + serum - serum + serum 
Day 1 G: 89.1% G: 88.3% V: 35.3% V: 18.9% 
18 hours -: 10.9% -: 11.7% E: 15.7% E: 58.5% 
-: 49.0% -: 22.6% 
N=55 N=60 N=51 N=53 
Day 2 G: 77.8% G: 93.1% V: 22.2% V: 44.2% 
42 hours -: 22.2% -: 6.9% E: 22.2% E: 28.9% 
-: 55.6% -: 26.9% 
N=54 N=58 N=45 N=52 
Day 3 G: 55.6% G: 71.4% V: 36.5% V: 35.5% 
66 hours -: 44.4% -: 28.6% E: 2.8% E: 12.2% 
-: 60.7% -: 52.3% 
N=27 N=28 N=107 N=107 
G= general fluorescence, -= no external fluorescence, V= vegetal fluorescence, E= 
equatorial fluorescence, N= number of oocytes scored. mRNA was injected 
equatorially into stage VI oocytes. 
Unfused GFP was injected into oocytes as a control. As a general trend, the 
percentage of these injected oocytes showing fluorescence decreases with time. This 
is true whether these oocytes are cultured with or without serum in the medium. 
Likewise, the number of negative oocytes (those showing no external fluorescence) 
increases with time in culture, from 11% on day 1 to 44% on day 3 (with no serum) 
and from 12% on day 1 to 29% on day 3 (with serum in the medium). However, fewer 
oocytes are negative after 2 or 3 days in culture when serum is in the medium than 
when it is not (Table 3.3). 
Similar trends are seen in Xpat-GFP injected oocytes. The number of negative 
oocytes increases with time in culture both with and without serum. However, fewer 
negative oocytes are seen in the sample cultured with serum than in the sample 
cultured without it (Table 3.3). For example, 49% of oocytes were negative without 
serum compared with 23% negative with serum; by day 3,61% are negative with no 
serum compared with 52% with it. The presence of serum in the medium also has an 
obvious effect on vegetal localisation of XPAT-GFP. In the presence of serum 19% of 
oocytes show vegetal localisation on day 1, this increases to 44% on day 2 and by day 
3 this figure is 36%. However, without serum, 35% of oocytes show vegetal 
localisation on day 1, dipping to 22% on day 2 and finally rising to 37% on day 3. 
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Thus, on day 2,22% of oocytes show vegetal expression (without serum) and 44% 
show vegetal expression (with serum). But, by day 3 the numbers of oocytes showing 
vegetal localisation of XPAT-GFP are very similar whether serum is in the medium or 
not. Thus, the main effect of serum in OCM is to reduce the number of oocytes 
showing no external fluorescence (for GFP or Xpat-GFP injected oocytes). 
It was decided, on the basis of these results, that to obtain the greatest numbers of 
oocytes with vegetal fluorescence, vegetal injection followed by culture in serum- 
containing medium is necessary. However, to obtain greater numbers of oocytes 
expressing XPAT-GFP in any region, equatorial injection and then culture in serum- 
containing medium is necessary. Thus, serum was used in OCM for all subsequent 
experiments and either vegetal or equatorial injection was used depending on the aim 
of each experiment. 
3.3.3 The nuclear localisation of XPAT-GFP and GFP-XPAT 
Since a great proportion of the oocytes injected with GFP-Xpat, Xpat-GFP and even 
GFP appeared to show no fluorescence after 3 days in culture (that is, were scored as 
negative), it was decided to determine whether the GFP fusion proteins were still 
present or were no longer being translated. One possible explanation for the large 
numbers of apparently negative oocytes was that the fluorescence was actually present 
in the nucleus. To determine whether this was true, nuclei were removed from several 
oocytes, which had been injected with Xpat-GFP or GFP-Xpat and yet appeared 
negative. All nuclei removed from externally fluorescent oocytes were positive for 
fluorescence, whether cultured with or without serum. Those nuclei removed from 
apparently negative GFP-Xpat injected oocytes and Xpat-GFP injected oocytes were 
all fluorescent too. Figure 3.5 (B and C) shows a nucleus removed from a GFP-Xpat 
injected oocyte and Figure 3.5D shows a nucleus removed from an Xpat-GFP-injected 
oocyte. Both of these nuclei are fluorescent and thus contain GFP fusion protein. 
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In total, 11/11 nuclei from superficially negative Xpat-GFP injected oocytes, 2/2 
nuclei from positive Xpat-GFP oocytes, 11/11 nuclei from superficially negative 
GFP-Xpat and 3/3 nuclei from GFP injected oocytes were fluorescent. Interestingly, 
stage N and V oocytes injected with Xpat-GFP, which appeared negative and showed 
no localisation, also had positive nuclei (2/2 nuclei were positive); Figure 3.5A shows 
the nucleus from one such oocyte. 
It was also decided that it would be interesting to look inside Xpat-GFP and GFP 
injected oocytes to determine if granules and particles were purely superficial or not. 
To do this, oocytes were fixed by heating to 75-85°C in Barth's saline for 30 seconds 
and then cut open using a scalpel. Figure 3.5 shows oocytes dissected in this way. 
Figure 3.5E shows an oocyte that expressed GFP and was bisected; the nucleus of this 
oocyte was fluorescent as was the rest of the oocyte. Figure 3.5F shows an oocyte that 
expressed XPAT-GFP protein in particles (rather than granules) at the vegetal pole 
and was cut in two. It could be seen that these particles were mainly, but not totally, 
superficial and were also visible under the surface of the oocyte, as if moving towards 
the pole. An oocyte expressing particles of XPAT-GFP protein at its equator was cut 
in half (Figure 3.5G). It was obvious that these particles were present inside the 
oocyte in the cytoplasm of the vegetal region, thus they were not purely superficial. 
Figure 3.5H shows an oocyte expressing small granules of XPAT-GFP protein at its 
equator. When this oocyte was bisected (Figure 3.51) it could be seen that these 
granules were quite superficial and seemed to be present just at the oocyte's surface. 
In contrast, when the oocyte shown in Figure 3.5J, expressing particles of XPAT-GFP 
just lateral to the vegetal pole, was bisected (Figure 3.5K) it could be seen that these 
particles were not all superficial. There were small particles of XPAT-GFP protein 
present inside the oocyte under the surface in the vegetal region. Again, the nucleus 
was fluorescent and thus contained XPAT-GFP protein. Thus, small particles of 
XPAT-GFP are present fairly widely in a gradient from the surface of the oocyte, 
whereas larger granules are predominantly superficial with a few more-internal, but in 
the same region of the cell. 
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Figure 3.5: To determine where XPAT-(; FP, GFP and (WP-XPAT proteins localise inside 
Xenupus oucytes following mkroinjeetiun of mRNA. 
(A) Stage IV nocyte injected with Xpai-GFP which has had its nucleus removed. (B) Stage VI 
oocyte injected with (JFP-Xput which has had its nucleus removed. (C) Same oocyte as in as (B) but 
photographed under UV light. (I)) Stage VI oocyte injected with Xpat-CFI' with its nucleus 
removed. (F. ) Stage VI oocyte injected with (WI', cut in half. (F) Bisected stage VI oocyte 
expressing XI'AT-GFP protein in particles at the vegetal pole. (G) Bisected stage VI oocyte 
expressing Xpat-GFY protein in granules lateral to vegetal pole. the granules are not totally 
superficial. (H)Stage VI oocyte expressing XPAT-(WP protein in small granules at equator. (1) 
Uucyte seen in (H) bisected , particles are quite superficial in this oocyte. (J) Stage VI oocyte 
expressing XI'AT-(; FP protein in small granules lateral to the vegetal pole. (K) Docyte shown in (J) 
cut in hall', illustrating that not all XPAT-GFP particles are superficial. In (A) the scale bar 
represents 2(X) µm. In (B)-(K) the diameter of each oocyte is -1.2 mm. 
3.4 To confirm the subcellular localisation of GFP-XPAT and XPAT-GFP by in 
vivo radiolabelling 
Visual examination emphasises the particulate forms of XPAT; thus, it was decided to 
use a second approach to investigate the localisation of XPAT-GFP, GFP-XPAT and 
indeed XPAT itself within the Xenopus oocyte. To this end, stage VI Xenopus oocytes 
were injected with 20 ng of mRNA for Xpat, GFP, GFP-Xpat or Xpat-GFP. The 
oocytes were then cultured overnight at 18 °C in the presence of 35S-methionine. This 
is taken up by oocytes and radiolabels all newly translated proteins. The following 
day, nuclei were removed from some of these oocytes and homogenised (N fraction) 
and the remaining cytoplasm and membranes were homogenised and centrifuged to 
give a cytosol (soluble, Cs) fraction and a cytoplasm insoluble (pellet- Ci) fraction. 
Some oocytes were homogenised whole to give an oocyte total protein (T) fraction. 
These fractions were then resolved on an acrylamide gel, alongside control 
(uninjected) oocyte fractions that were prepared in the same way. The gels were then 
subjected to autoradiography. An additional band of the expected size was seen in 
fractions from each of the injected oocyte samples when compared with control 
oocyte fractions. Figure 3.6 shows autoradiographs of these protein gels. 
Nuclei were removed from oocytes using a manual dissection procedure (as described 
by Woodland and Adamson, 1977). Several studies have indicated that this manual 
enucleation method yields nuclei with virtually undetectable levels of cytoplasmic 
contamination (including Bonner, 1975; Woodland and Adamson, 1977; Braddock et 
al., 1994). For example, it was determined that manual enucleation yields expected 
nucleus: cytoplasm concentration ratios for injected proteins: BSA was enriched in the 
cytoplasmic fraction, whereas histones were concentrated in the nuclear fraction 
(Bonner, 1975; Woodland and Adamson, 1977). Similarly, Braddock et al. (1994) 
manually dissected nuclei out of Xenopus oocytes and ran the resulting fractions on a 
gel. They then used western blot analysis and probed with antibodies to 
nucleoplasmin (a nucleus specific protein) and CAT (a cytoplasmic protein whose 
RNA had been injected into the cytoplasm). They demonstrated that the fractions 
were not contaminated, as nucleoplasmin was located specifically in the nucleus, 
whereas CAT could be detected in the cytoplasmic but not in the nuclear fraction 
(Braddock et al., 1994). 
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Figure 3.6: To determine the subcellular localisation of GFP-XPAT and XPAT-GFP by in vivo 
radiolabelling. 
Stage VI Xenopus oocytes were injected with 20ng of GFP, Xpat, GFP-Xpat or Xpat-GFP mRNA 
or left uninjected. They were cultured over-night in the presence of 35S-methionine. The following 
day, oocytes were homogenised to give a Total protein sample (T), nuclei were removed from 
oocytes to give a nuclei (N) fraction. The remaining membranes and cytoplasm were homogenised 
and centrifuged to give a cytosol soluble fraction (Cs) and a pellet of insoluble cytoplasm (Ci). 
These fractions were resolved by SDS-PAGE, ensuring equal amounts of each protein sample were 
loaded (equivalent to 1/3 of an oocyte per lane). On each gel all 4 control (uninjected) oocyte 
fractions were run along side 4 fractions from one of the injected oocytes. Gels were then 
autoradiographed, and these autoradiographs are shown: (A) GFP, (B) XPAT, (C) GFP-XPAT, (D) 
XPAT-GFP. 
CO ROL X AT 
N Cs CYTN Cs Ci 
CONTROL 
TN Cs Ci 
As Figure 3.6 shows, XPAT (35 kDa) is present in all fractions: nuclear, cytosolic 
soluble and cytoplasm insoluble fractions, but is stronger in the two cytoplasm 
fractions. GFP runs as a band of 30 kDa. GFP is found in the nuclear and cytosolic 
soluble fractions of the oocyte (and as a faint band in the insoluble cytoplasm 
fraction). However, the GFP band is strongest in the soluble cytosolic fraction and a 
greater proportion of GFP is seen in the nucleus than XPAT. GFP-XPAT (65 kDa) is 
found in all 4 fractions and seems to be in the nucleus, cytosol and cytoplasm 
insoluble fractions to roughly equal levels. XPAT-GFP (65 kDa) is also seen in all 
fractions, but it is a very faint band in the nucleus and the soluble fraction of the 
cytosol, whereas the majority of the protein is seen in the cytoplasm insoluble 
fraction. Thus, the localisation of GFP-XPAT mainly resembles GFP but is also seen 
in the insoluble fraction, like XPAT. XPAT-GFP is markedly different from GFP - it 
is seen mainly in the cytoplasm insoluble fraction, whereas the GFP band is very faint 
in this fraction. However, XPAT looks different from XPAT-GFP, being more 
soluble. XPAT is present in both the insoluble and the soluble cytoplasmic fractions, 
whereas XPAT-GFP appears to be largely insoluble by this method. This suggests that 
XPAT-GFP is mainly distributed as insoluble particles or granules. Whilst XPAT can 
likewise form insoluble particles, it is largely expressed as soluble protein in stage VI 
oocytes, at least when overexpressed. 
The oocyte nucleus occupies about 4% of the aqueous volume of the cell (Bonner, 
1975), so an evenly distributed protein should show this distribution. XPAT shows 
close to a 50: 50 nucleus: cytoplasm distribution, which is what histone nuclear 
proteins show using this method (Woodland and Adamson, 1977). However, the 
distribution of XPAT-GFP is clearly seen as a partitioning between nucleus and 
cytoplasm in sectioned oocytes. Unlike GFP, the perinuclear region is fluorescence- 
free, unless the XPAT-GFP remains nuclear and close to the nucleus on one side. It 
seems clear that the XPAT-GFP is either nuclear and non-particulate or particulate 
and in a limited, mainly peripheral, part of the cytoplasm. Presumably, it is limited by 
binding to cytoplasmic components, likely the cytoskeleton, and this prevents 
translocation to the nucleus. The particulate material in the cytoplasm would be 
pelleted and hence present in the cytoplasmic insoluble fraction. GFP and GFP-XPAT 
do not form particles, so are not concentrated in the insoluble fraction; they are 
diffusely in all cytoplasm (as long as it persists on the case of GFP-XPAT) and so are 
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not anchored and are free to enter the nucleus. It is notable that XPAT contains a 
putative bipartite nuclear localisation signal (see Chapter 5). 
3.5 In situ hybridisations to GFP in oocytes expressing XPAT-GFP and GFP 
XPAT-GFP protein localises near the point of mRNA injection in stage VI Xenopus 
oocytes (Section 3.2.1). Xpat-GFP mRNA has globin UTRs and globin mRNA moves 
very slowly in Xenopus oocytes; Drummond et al. (1985) observed little movement of 
RNA from the animal half to the vegetal half even 48 hours after injection. In 
contrast, similar amounts of mRNA were present in both halves 48 hours after vegetal 
pole injection (Drummond et al., 1985). In order to determine what actually happens 
to the Xpat-GFP mRNA following its injection into oocytes, in situ hybridisation 
analysis was performed. Stage VI Xenopus oocytes were injected equatorially with 
2ng Xpat-GFP or GFP mRNA, cultured in OCM at 18°C and fixed at intervals. In situ 
hybridisation was then performed to determine a time course of the localisation of 
injected mRNA. As a control for this experiment, oocytes that had been injected with 
GFP mRNA were also concomitantly hybridised in situ. For this experiment, a GFP 
riboprobe was used, as this was specific for the injected mRNA. 
Figure 3.7 shows photographs of the in situ hybridisation analysis of oocytes injected 
with Xpat-GFP or GFP. Two hours after injection, the GFP mRNA could be seen as a 
purple patch around the site of injection; Xpat-GFP mRNA was always seen as a 
small 50µm diameter spot, whereas GFP mRNA was often seen in a broader patch at 
this stage, up to -250µm across. 18hours after injection (Figure 3.7), both GFP and 
Xpat-GFP mRNA domains broaden, GFP injected oocytes showed patches of GFP 
mRNA up to 550µm across, whereas Xpat-GFP remains a bit tighter in localisation- 
only a maximum of 350µm in diameter. Thus, it is already obvious that Xpat-GFP 
mRNA is localising differently to GFP mRNA. 
By day 2,42 hours post-injection, the two mRNAs were quite different in localisation, 
as Figure 3.7 shows. GFP was still localised in a wider domain, in patches of up to 
-650µm. Whereas Xpat-GFP seemed to be in much smaller areas, of which there 
were many in any one oocyte. These patches were generally -75µm across and spread 
from the equatorial to the vegetal region in the same way that the XPAT-GFP protein 
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Figure 3.7: In situ hybridisation analysis of injected mRNA in Xenopus nocytes. 
Stage VI oocytes were injected equatorially with 2 ng of either GFP or Xput-GFP mRNA, and 
then cultured in vitro in OCM at I8°C. Oocytes were then fixed after various times in culture 
and in situ hybridisation analysis, using a GFP riboprobe, was performed to provide a time 
course fur exogenous rRNA localisation. Oocytes were not bleached, however those 
hybridised in situ after 72 hours were all placed into Murray's clearing agent and then 
methanol before being photographed, thus they appear different in colour to the other oocytes. 
Exogenous GFP mRNA is localised in a much wider domain than Xput-GFP mRNA. The 
diameter of each stage VI oocyte is -1.2 mini. 
GFP-injected oocytes 
is localising. Similarly, on day 3 (66 hours post-injection) GFP was still seen in large 
patches (of approximately the same size as those seen on day 2), whereas Xpat-GFP 
localisation varies between oocytes. For example, in Figure 3.7, two different oocytes 
are shown- one shows a patch of Xpat-GFP mRNA localisation on the equator of the 
oocyte (-4001im) and a second shows many small areas of staining in the vegetal 
pole- resembling the particles of XPAT-GFP protein localisation. 
At present, it is unclear where XPAT-GFP protein is located in relation to its mRNA 
as it was necessary to bleach oocytes after in situ hybridisation to detect the signal 
efficiently. Bleaching affects fluorescence of the GFP, so it can no longer be seen 
under the microscope. In situ hybridisation with antisense GFP riboprobe then 
subsequent whole-mount immunostaining for GFP was attempted on oocytes 
overexpressing XPAT-GJ'P. Unfortunately, due to time constraints, this procedure 
was only performed twice, When an HRP-conjugated secondary antibody was used to 
detect GFP, this resulted in over-staining, which meant the in situ hybridisation signal 
was masked. Using an FITC-conjugated secondary antibody for immunostaining 
meant the oocytes could not be bleached (as this would quench fluorescence) and, as 
the in situ hybridisation signal was weak, no conclusions could be drawn from this 
experiment. Thus, this procedure needs to be optimised to determine whether Xpat 
GFP mRNA and protein colocalise in oocytes. One hypothesis would be that Xpat- 
GFP mRNA is in the same location as the protein it encodes. 
Interestingly, Xpat-GFP and GFP mRNAs localise in completely different ways. The 
only difference in the mRNAs themselves is the addition of sequence encoding Xpat's 
ORF, as the GFP mRNA is transcribed from exactly the same vector as Xpat-GFP. 
Thus the Xpat ORF (as this is the only Xpat sequence in this construct) has an effect 
on localisation of the mRNA. This is different from results gained previously in stage 
III and N oocytes when it was determined that the 3'UTR of Xpat directs mRNA 
localisation (Hudson and Woodland, 1998). 
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3.6 The effect of XPAT-GFP on the endogenous germ plasm in oocytes 
Stage VI Xenopus oocytes were injected with 2ng of Xpat-GFP or GFP mRNA, 
cultured in OCM at 18°C and after 18 hours and 72 hours in culture, oocytes were 
removed and fixed. Then in situ hybridisation analysis was performed using Xcat-2 as 
a riboprobe. This was done in order to determine whether the injection and expression 
of XPAT-GFP affects the endogenous germ plasm in oocytes and also to check 
whether increasing time in culture affects the germ plasm. Xcat-2 was used as a 
marker of germ plasm in this experiment. The results of these in situ hybridisations 
are shown in Figure 3.8. 
After 18hours in culture, both Xpat-GFP and GFP-injected oocytes show Xcat-2 is 
expressed in particles in a disc shape on the vegetal pole. Thus, XPAT-GFP has not 
affected endogenous germ plasm after 18 hours. Similarly, after 72 hours in culture, 
both Xpat-GFP and GFP-injected oocytes still show Xcat-2 expression, in the same 
pattern and location and as strongly as before. Thus, XPAT-GFP has not affected the 
germ plasm in stage VI oocytes. However, the diameter of the Xcat-2 expression 
domain in Xpat-GFP-injected oocytes appears smaller than that in GFP-injected 
oocytes after 72 hours in culture. 
In order to ascertain whether or not there was a statistically significant difference 
between the size of Xcat-2 expression domain in Xpat-GFP and GFP-injected 
oocytes, the Student's T test was performed. An eye-piece graticule (calibrated using 
a micrometer slide) in a dissecting microscope was used to measure the diameter of 
the Xcat-2 expression domain in oocyte. Oocytes were injected with 2ng of GFP or 
Xpat-GFP mRNA, cultured in vitro for 72 hours, then fixed, in situ hybridised with 
Xcat-2 probe and the diameter of the expression domain measured. Table 3.4 shows 
the mean diameter of expression domain of Xcat-2 in GFP-injected oocytes, in 
oocytes expressing XPAT-GFP in the equatorial region and oocytes expressing 
XPAT-GFP in granules at the vegetal pole. (For raw data see Appendix 1). 
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Figure 3.8: In situ hybridisation to Xcat-2 or Xpat in oocytes that had been injected with 
GFP or Xpat-GFP mRNA. 
Stage VI Xenopus oocytes were injected equatorially with 2 ng of Xpat-GFP or GFP InRNA 
and cultured in vitro in 50 'I Leibowitz medium at I8°C for up to 72 hours. Oocytes were then 
fixed and in situ hybridisation analysis performed. Xcut-2 was used as a marker of the germ 
plasm. A riboprobe specific for Xpat's 3'UTR was used to detect purely endogenous Xput 
mRNA: as the injected Xput-GFP mRNA contains only Xpat's ORF and not any UTR 
sequence. The diameter of each oocyte is -1.2 nim. 
Table 3.4 The means and variance of the diameter of Xcat-2 expression in 
Xenopus oocvtes 
Oocyte Mean (epu) Mean (µm) Variance Number of 
expression oocytes (n) 
GFP 20.9 522.5 11.5 14 
XPAT-GFP 17.9 447.5 5.54 11 
equatorially 
XPAT-GFP in 13.7 342.5 1.56 3 
vegetal granules 
Oocytes were injected with 2ng of GFP or Xpat-GFP mRNA and then cultured in vitro for 3 
days. Oocytes were hybridised in situ with an Xcat-2 riboprobe. The diameter of Xcat-2 
expression domain was then measured using an eye-piece graticule in a dissecting 
microscope. The first column shows mean (Y-diameters / n) in epu (eye piece graticule units), 
where n is the total number of oocytes measured. This was converted into pm (after the 
graticule had been calibrated). Variance is (Zdiameters)2/n - mean 
2 and is a measure of the 
differences in the means. The raw data is shown in Appendix 1. 
The means and variance were then converted into T values for use in the Student's T 
test. This test compares two sets of data. Table 3.5 shows which sets of data were 
compared, T values and critical T values. The critical T value is taken at the 95% level 
of significance for the appropriate degrees of freedom from statistical tables (degrees 
of freedom= total number of oocytes (for both sets of data)-2). 
Table 3.5: T values for the Student's T-test comparing Xcat-2 diameter 
(measured after in situ hvhridisation) 
Oocytes/injection T value Critical T value at 
95% level 
Significant? 
GFP cf XG eq 2.606 2.069 
GFP cf XG gran 6.217 2.131 
XG eq cf XG gran 4.15 2.179 
In situ hybridisation was performed after 3 days in culture. GFP= GFP injected oocytes, 
XGeq= oocytes expressing XPAT-GFP in particles at the equatorial region, XG gran= oocytes 
expressing XPAT-GFP in granules at vegetal pole, 4= statistically significant. 
As Table 3.5 shows, there is a statistically significant difference between the size of 
the Xcat-2 expression pattern in oocytes expressing GFP and oocytes expressing 
XPAT-GFP equatorially in particles. Likewise there is also a statistical significance 
between the diameter of Xcat-2 expression domain in oocytes expressing GFP and 
oocytes expressing XPAT-GFP vegetally in granules. Thus, it appears that, 72hours 
after injection, XPAT-GFP does have an effect on Xcat-2 localisation in oocytes when 
91 
compared with Xcat-2 localisation in GFP injected oocytes. Also, a statistically 
significant reduction in size of Xcat-2 expression domain was seen in oocytes 
expressing XPAT-GFP in granules at the vegetal pole, compared with oocytes 
expressing XPAT-GFP equatorially in small particles. 
It is worth noting that no observable difference in diameter of Xcat-2 expression 
domain was seen in oocytes 18 hours after injection with Xpat-GFP compared with 
GFP injection. Thus, the formation of vegetal granules of XPAT-GFP protein after 3 
days in culture affects Xcat-2 expression, as does formation of equatorial particles of 
XPAT-GFP. That is, localisation of XPAT-GFP in oocytes affects endogenous germ 
plasm. Similarly, in many oocytes expressing large granules of XPAT-GFP at their 
vegetal poles, the oocyte's pigment granules are visibly highly disrupted in the area 
where XPAT-GFP is localised. 
Some oocytes which had been injected with Xpat-GFP and GFP were cultured in 
vitro for 72 hours and then in situ hybridised with a probe specific for the 3' UTR of 
Xpat. This was done to determine whether overexpressing XPAT-GFP has any effect 
on the localisation of the endogenous Xpat mRNA. A UTR probe was used since 
Xpat-GFP contains the ORF of Xpat and thus the probe was specific for endogenous 
Xpat. Figure 3.8 shows the results of these in situ hybridisations. As this figure shows, 
overexpression of XPAT-GFP does not affect endogenous Xpat localisation. Xpat is 
expressed in particles in the vegetal pole in both GFP and Xpat-GFP injected oocytes. 
It is worth noting that the Xpat UTR in situ hybridisation probe works less well than 
Xpat ORF in situ hybridisation probe which is why, in Figure 3.9, the signal is weaker 
than in Figures 7.3 and 7.6 (see later). 
It will be interesting to determine whether XPAT-GFP colocalises with the 
endogenous germ plasm. Experiments to ascertain this were attempted using in situ 
hybridisation to various germ plasm mRNAs (DEADSouth, Xcat-2 and Xdazl) and 
subsequent immunostaining of GFP. Due to time constraints, this was attempted on 
only two occasions. Because of the technical difficulties outlined above (at the end of 
Section 3.5) - namely, detection of HRP-conjugated antibodies causing over-staining 
and weak in situ hybridisation signal - it was impossible to draw any conclusions from 
these experiments. 
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3.7 The localisation of XPAT-GFP in Xenopus embryos 
2-cell Xenopus embryos were injected bilaterally in the vegetal region with 0.5ng of 
GFP or Xpat-GFP mRNA, and then cultured in vitro in 10% Barth's saline. Figure 
3.9 shows photographs of embryos expressing GFP or XPAT-GFP protein. Figure 
3.9A shows stage 12 embryos that had been injected with GFP. This figure shows 
GFP expression is patchy, in regions of the embryo fated to become epidermis. 3.9B 
shows stage 12 embryos injected with Xpat-GFP and shows XPAT-GFP protein is 
expressed only in regions of the epidermis. XPAT-GFP is expressed less strongly than 
GFP and in smaller patches- almost in a stripe around the embryo. 3.9C is a 
photograph of a stage 18 embryo which is expressing XPAT-GFP in a band around 
the epidermis. Figures 3.9D and E show the embryo in 3.9C bisected, the XPAT-GFP 
protein expression is very superficial just on the surface of the embryo. This result is 
very strange, the Xpat-GFP mRNA was injected into the vegetal area of 2-cell 
embryos and yet the protein is expressed in the epidermis. It appears that XPAT-GFP 
could be localised in cell nuclei (Figure 3.9C shows this clearly). These results are 
reproducible as the experiment has been performed twice and the same results were 
obtained each time. 
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Figure 3.9 Localisation of XPAT-GFP and (; FP in Xenopus embryos. 
2-cell embryos were injected bilaterally in the vegetal region with 0.5 ng of Xput-GFP or GFP 
mRNA and then allowed to develop in vitro in 10 17( Barth's saline. (A) Shows 3 stage 12 
Xenopus embryos which had been injected with GFP mRNA, GFP expression is patchy in 
regions of embryos fated to become epidermis. (B) Shows 3 stage 12 Xenopus embryos which 
had been injected with Xpat-GFP mRNA, XPAT-GFP is expressed only in regions of 
epidermis. (C) Shows a stage 18 Xenopus embryo which had been injected with Xput-GFP, and 
is expressing ibsion protein in a band around the epidermis. (D) and (E) illustrate that XPAT- 
GFP expression is very superficial. (U) Shows the embryo from (C) bisected and (E) shows a 
closer view of the embryo in (D), arrows highlight XPAT-GFP fluorescence. The scale bar in 
each photograph represents 500 µm. 
3.8 Discussion 
GFP fusion constructs now seem to be so well trusted that the live cell imaging of 
GFP-tagged proteins is used to generate primary data for determining the cellular 
localisation of products from newly cloned genes (Matus, 2001). Thus, to determine 
where XPAT protein localises in vivo, XPAT was fused (at either its carboxy- or 
amino- terminus) with GFP, and the resulting chimeric proteins were expressed in 
Xenopus oocytes. 
GFP-XPAT localised to the nucleus of stage VI Xenopus oocytes; whereas XPAT- 
GFP, in addition to being present in the nucleus, formed small (1 to 2.5 µm) particles 
which aggregated into large granular structures (of 10-50 µm diameter) at the vegetal 
pole. XPAT-GFP was transported to the vegetal pole of full-grown oocytes, but 
whether as particles, or as soluble protein existing in equilibrium with particles, 
cannot be said. The former seems more likely. The particles of XPAT-GFP looked 
exactly like those seen after in situ hybridisation to germ plasm RNAs and the 
granules resembled those seen after immunostaining of fertilised eggs with some 
monoclonal antibodies raised against unknown germ plasm constituents (Denegre et 
al., 1997). In Xenopus, extensive aggregation of the germ plasm islands begins at the 
onset of the first cleavage and continues throughout the early cleavage divisions 
(Ressom and Dixon, 1988; Savage and Danilchik, 1993). Savage and Danilchik 
(1993) performed detailed studies on germ plasm aggregation in Xenopus embryos 
and ascertained that shortly after fertilisation the cytoplasmic islands of germ plasm 
were distributed in a widespread pattern, with granules averaging 11.9 µm in size. In 
the 2-cell embryo, granules averaged 26.8 µm in size and by the 4-cell stage the germ 
plasm patches had an average size of 78.5 µm (Savage and Danilchik, 1993). Thus, 
XPAT-GFP granules, which ranged from 10 to 50 µm in diameter in stage VI oocytes, 
were similar in size to patches of germ plasm observed in 2-cell Xenopus embryos. 
The pattern of XPAT-GFP distribution can hardly be accidental and, although the 
distribution of the endogenous XPAT protein is not yet known, it seems likely that it 
is a germ granule component at some point. It would be a good candidate to support 
formation of granules of germ plasm mRNAs at late stages of oogenesis and/or could 
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potentially aid aggregation during early embryogenesis. At some stage the protein 
may also have a nuclear function. 
Xpat-GFP mRNA is translated at the site of its injection and XPAT-GFP protein must 
be anchored there - otherwise it would diffuse widely, like GFP. Similarly, Xpat-GFP 
mRNA is much more tightly localised than GFP in stage VI oocytes. This could be 
because of cytoplasmic binding of the mRNA or of the nascent peptides. It will be 
interesting to determine whether Xpat-GFP mRNA and the protein it encodes 
colocalise in oocytes. This is currently being investigated by R. Hames, a Ph. D 
student in H. R. Woodland's laboratory. Since GFP-XPAT does not localise, it would 
also be useful to know the distribution of this mRNA after injection. Little expression 
of XPAT-GFP protein was seen in smaller (stage III-V) oocytes, even though the 
injected mRNA contained no Xpat UTRs. These data suggest that either the ORF has 
regulatory sequences, which is most unusual, or XPAT is unstable in some embryonic 
cells, at least when overexpressed. 
It will be important to determine how XPAT forms small granules, how it translocates 
to the vegetal pole and how it forms large aggregates there. In reticulocyte lysates 
translated XPAT-GFP does not form granules nor does it do so in the nucleus. This 
suggests that aggregate formation depends on the proteins with which XPAT interacts. 
(RNAs could be involved, but this does not seem likely because in a vast cell, like a 
Xenopus oocyte, transcription can have little impact during the course of the 
experiment [Woodland, 1982]. Also, suitable RNA targets for the binding of large 
amounts of protein made in an injection experiment are unlikely to exist in the equator 
of the cell). The fact that particles form suggests that, if interacting proteins exist, they 
are abundant cellular components. 
The observation that XPAT-GFP can form granules, whereas GFP-XPAT cannot, 
indicates that the orientation of the GFP in the fusion protein is critical to its function 
and suggests that XPAT is likely to be made up of different domains. For example, it 
is possible that having a GFP tag at the amino terminus of XPAT (as in GFP-XPAT) 
masks an essential localisation domain, thus preventing XPAT from forming granules 
and/or localising to the vegetal pole. Likewise, since GFP-XPAT is present solely in 
the nucleus this indicates a nuclear localisation signal (NLS) is likely to be in the 
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carboxy-terminal half of XPAT (indeed there is a putative bipartite NLS in XPAT- 
see Chapter 5). Alternatively, the location of GFP could have an effect on the overall 
structure of XPAT, or hinder an interaction it is normally involved in. 
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Chanter 4: The effect of cvtoskeletal inhibitors on the localisation of XPAT-GFP 
4.1 Introduction 
Drugs which disrupt microtubules and microfilaments (including nocodazole, 
colchicine and cytochalasin B) were shown to perturb the establishment and the 
stabilisation, respectively, of Vgl mRNA localisation in the Xenopus oocyte (Yisraeli 
et al., 1990; Kloc and Etkin, 1995). In mammalian cells disruption of actin filaments 
prevent actin mRNA localisation, while disruption of microtubules has no effect 
(Sundell and Singer, 1991). These studies suggest that the cytoskeleton is required 
for mRNA localisation. It is plausible, therefore, that the cytoskeleton may also be 
involved in protein localisation. 
To determine whether or not microtubules and microfilaments have a role in XPAT- 
GFP localisation and in the formation of granules of XPAT-GFP, evidence was 
accrued through observation of the effects of the anticytoskeletal drugs colcemid, 
nocodazole and cytochalasin D. To this end, oocytes injected with Xpat-GFP mRNA 
were cultured in vitro in OCM in the presence of the microtubule inhibitors 
nocodazole, an agent that causes microtubule depolymerisation, or colcemid, which 
binds to soluble tubulin and prevents the polymerisation into microtubules. 
Cytochalasin D was employed to assess the role of microfilaments, as this drug 
prevents actin assembly at the barbed ends of microfilaments. 
To expand this analysis, some oocytes were cultured in the presence of taxol, a drug 
that promotes microtubule polymerisation by stabilising microtubules. Oocytes that 
have been treated with nocodazole become virtually devoid of microtubules in 
cortices of both hemispheres of oocytes. Conversely, oocytes treated with taxol show 
striking enrichments of cortical microtubules in both hemispheres (Canman and 
Bement, 1997). 
Nocodazole has been previously used to depolymerise Xenopus oocyte microtubules 
at concentrations of between 3 and 66 pM (Yisraeli et al., 1990; Kloc and Etkin, 
1995; Carman and Bement, 1997; Gard et al., 1997). 3 µM nocodazole was shown 
to cause complete depolymerisation of cortical microtubules - after 48 hours no 
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microtubules were detected (Gard et al., 1997). Yisraeli et al. (1990) determined that 
nocodazole was equally effective at microtubule disruption over a 10-fold range of 
concentrations (3-30 µM). Similarly, 10-53 pM concentrations of colcemid have 
been previously used to effectively disrupt oocyte microtubules (Colman et al., 1981; 
Peter et al., 1991; Gard et al., 1997). 53 pM colcemid causes complete 
depolymerisation of microtubules (Gard et al., 1997) and 10 µM has been shown to 
cause exactly the same morphological changes observed with much higher 
concentrations (up to 53 µM; Peter et al., 1991). 
Cytochalasin D has been used to effectively disrupt oocyte microfilaments at doses 
of between 2 and 10 pM (Peter et at, 1991; Canman and Bement, 1997). 2 µM 
cytochalasin D was observed to cause similar effects to 50 p. M cytochalasin B (Peter 
et al., 1991), which depolymerises both cytoplasmic and cortical F-actin in stage VI 
oocytes (Colman et al., 1981; Roeder and Gard, 1994). 
Concentrations of between 5 and 30. tM taxol have been previously used effectively 
(Jessus et al., 1988; Canman and Bement, 1997). Jessus et al. (1988) showed that an 
external taxol concentration of 5 µM was sufficient to promote tubulin 
polymerisation in stage VI Xenopus oocytes. 
4.2 Expression of GFP in oocytes treated with anti-cytoskeletal drugs 
To analyse the effect of anticytoskeletal drugs on stage VI Xenopus oocytes and on 
their expression of GFP, GFP mRNA was injected into the equatorial region of 
oocytes at a dose of 2 ng per oocyte. The oocytes were then cultured in vitro at 18°C 
in OCM in the presence of the appropriate cytoskeletal inhibitor for up to 3 days. All 
concentrations of inhibitors were chosen based on previous reports in which these 
drugs were effective in oocytes (Jessus et al., 1988; Peter et al., 1991; Gard et al., 
1997- see Section 4.1). Thus, nocodazole was added to a final concentration of 3 
µM, colcemid at 10 µM, cytochalasin D at a concentration of 2 p. M and taxol to 5 
µM. The oocytes were all examined for phenotypic changes, which would indicate 
that the cytoskeletal inhibitors had disrupted their respective monomers, and the 
localisation of GFP was examined by fluorescent microscopy in order to determine 
the effect of the drugs on GFP fluorescence. As previously described in Section 3.3, 
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and shown in Figure 4.1B, control oocytes expressed GFP in an even and non- 
localised distribution after 42 hours in culture. 
Those oocytes expressing GFP that were cultured in the presence of cytochalasin D 
showed diffuse fluorescence (Figure 4.1D). The oocytes appeared mottled, and the 
pigment was rearranged but this is a general observation when oocytes are incubated 
in cytochalasin D (Figure 4.1C, Peter et al., 1991). No particles of GFP were 
observed in any of the oocytes. 
GFP-injected oocytes that were cultured in OCM containing colcemid also displayed 
general fluorescence (Figure 4.1F). The nuclei in these oocytes were visible under 
the surface (Figure 4.1E) and were fluorescent (Figure 4.1F). This was also seen in 
Xpat-GFP-injected oocytes, as the disruption of microtubules causes the nucleus to 
be displaced towards the surface (Colman et al., 1981; Peter et al., 1991). Again, the 
fluorescence was diffuse and non-particulate. 
GFP-injected oocytes that were cultured in the presence of nocodazole also showed 
general, non-localised, diffuse fluorescence as the four oocytes shown in Figure 4.1H 
illustrate. Like the colcemid-treated oocytes, nuclei in these oocytes became 
displaced and were clearly visible under the surface at the animal pole (Figure 4.1 G). 
The nuclei were highly fluorescent as Figure 4.1H illustrates, but the contrast with 
the surrounding area is because the nucleus displaces pigment. 
Oocytes expressing GFP that were incubated in taxol-containing OCM showed 
general and diffuse fluorescence; Figure 4.1J shows four such oocytes. The pigment 
of these oocytes was highly disrupted and had a mottled appearance (Figure 4.1I), a 
known effect of taxol on Xenopus oocytes (Heidemann and Gallas, 1980). There was 
no evidence that GFP formed granules or appeared to localise in a network of 
particles (as XPAT-GFP does in Figure 4.2J). Figure 4.1K shows a higher 
magnification view of a GFP-expressing oocyte incubated in the presence of taxol. 
This photograph shows that the visible fluorescence was totally diffuse and non- 
localised. 
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Figure 4.1 (Opposite): Expression of GFP in oocytes treated with cytoskeletal 
inhibitors 
Stage VI Xenopus oocytes were each injected with 2 ng of GFP mRNA and cultured 
in vitro at 18°C for 42 hours in OCM containing a working concentration of 3 pM 
nocodazole, 10 pM colcemid, 2µM cytochalasin D, 5 µM taxol or no drug. Oocytes 
were then observed using light or fluorescence microscopy. (A) to (E) were 
visualised using light microscopy, and (F) to (K) were photographed using 
fluorescence microscopy, 
(A) Control oocytes, cultured without cytoskeletal inhibitors. 
(B) Four control oocytes expressing GFP evenly throughout cytoplasm. 
(C) Oocytes cultured in the presence of cytochalasin D. The oocytes exhibit 
mottling on their surface as the drug has caused pigment rearrangement. 
(D) Oocytes treated with cytochalasin D showed general GFP expression, 
pigment rearrangement by the drug caused mottling on oocyte surface. 
(E) Oocytes cultured in the presence of colcemid. The oocytes' nuclei are visible 
under the surface of the animal pole (arrowed). Usually the nucleus is 
anchored by microtubules, but colcemid treatment has disrupted the 
microtubule network. 
(F) Four oocytes treated with colcemid showing general GFP expression. The 
nuclei are highly fluorescent and visible under surface of animal pole (one 
such nucleus is arrowed). 
(G) Oocytes treated with nocodazole. As in colcemid-treated oocytes, the cell 
nuclei have been displaced and are clearly visible through the animal pole 
surface (arrowed). 
(H) Four oocytes cultured in presence of nocodazole express GFP in a non- 
localised manner. The nuclei have been displaced, are fluorescent and are 
clearly visible through the surface of the animal pole (one such nucleus is 
arrowed). 
(1) Oocytes cultured in presence of taxol, a microtubule stabiliser. The drug 
causes pigment rearrangement, apparent as mottling on the oocytes' surfaces. 
(J) Four oocytes treated with taxol expressing GFP generally. The pigment of 
these oocytes is highly disrupted. 
(K) View of an oocyte treated with taxol clearly shows that no particles of GFP 
are visible on the surface of the oocyte, and the fluorescence is diffuse. 
The diameter of all oocytes shown is -1.2 mm. 
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Thus, while the cytoskeletal inhibitors had no effect on GFP localisation, the oocytes 
showed obvious signs of pigment disruption or nuclei displacement, as Xpat-GFP 
injected oocytes did when cultured in the presence of anti-cytoskeletal drugs (see 
Section 4.3). These obvious phenotypic alterations indicate that the drugs are 
working and are thus disrupting their intended polymers. 
4.3 The localisation of XPAT-GFP in oocytes treated with anti-cytoskeletal 
drugs 
To analyse the effect of anticytoskeletal drugs on the localisation of XPAT-GFP, 
Xpat-GFP mRNA was injected into the equatorial region of Xenopus oocytes at a 
dose of 2 ng per oocyte. The oocytes were then cultured in vitro at 18°C in OCM in 
the presence of the appropriate cytoskeletal inhibitor for up to 3 days. As for the 
GFP-injected oocytes (Section 4.2), nocodazole was added to a final concentration of 
3 µM, colcemid at 10 µM, cytochalasin D at a concentration of 2 tM and taxol at 5 
µM. Some oocytes were treated with both cytochalasin D and colcemid, each at the 
concentration stated above. The localisation of the translated product was examined 
by fluorescent microscopy, and the oocytes were all scored for localisation of 
fluorescence. The results from three experiments were pooled and are recorded in 
Table 4.1. The experiments summarised in this table were done under identical 
conditions. 
As shown in Table 4.1, XPAT-GFP protein localised in stage VI Xenopus oocytes 
that were cultured with no drugs. On day 1,18 hours after injection, the fusion 
protein was expressed principally in an equatorial domain around the point of 
injection (47.0%). There was diffuse fluorescence in the majority of oocytes, but also 
some small granules of -2.5 p. m in diameter. 14.6% of oocytes expressed XPAT- 
GFP in small particles at the vegetal pole (Figures 4.2A and B). The remaining 
38.4% of oocytes showed no external fluorescence and were thus scored as negative, 
although the nuclei of these oocytes do contain XPAT-GFP (see Section 4.4). 
By 42 hours after injection, 25.8% of control oocytes expressed XPAT-GFP at, or 
just lateral to, the vegetal pole. 49.2% of oocytes still expressed XPAT-GFP in a 
domain around the equatorial injection site and the remaining 25.0% of oocytes were 
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scored as negative. At this stage the fluorescence was mostly punctate, but at the 
vegetal pole the granules were larger. 
As summarised in Table 4.1,66 hours after injection with Xpat-GFP, 40.2% of 
control oocytes still showed equatorial fluorescence around the injection site. 33.6% 
of oocytes showed localisation at the vegetal pole and the remaining 26.2% were 
negative. Those oocytes showing fluorescence expressed large granular aggregates 
of XPAT-GFP at the vegetal pole (of between 30 and 50 pm in diameter) and smaller 
particles up to 2.5 pm at the equator. Figure 4.3A is a photograph of three oocytes 
expressing XPAT-GFP in granules at the vegetal pole. 
4.3.1 The effect of cytochalasin D treatment on localisation of XPAT-GFP 
When oocytes were incubated in the presence of cytochalasin D, as summarised in 
Table 4.1,18 hours after injection XPAT-GFP was expressed principally in an 
equatorial domain around the injection site (63.3% of oocytes). When oocytes 
incubated in cytochalasin D were compared with control oocytes, a higher proportion 
of them showed equatorial expression. Indeed, a much higher percentage of oocytes 
incubated with cytochalasin D (compared to control oocytes) showed fluorescence, 
as only 20.2% were scored as negative. 16.5% of oocytes incubated in the presence 
of cytochalasin D expressed XPAT-GFP at the vegetal pole. The fluorescence was 
diffuse in some oocytes (Figure 4.2C) but some small granules of up to 2.5 pm in 
diameter were seen in most oocytes expressing XPAT-GFP vegetally. One such 
oocyte, expressing small granules of XPAT-GFP is shown in Figure 4.2D. 
15.7% of XPAT-GFP-expressing oocytes that had been treated with cytochalasin D 
showed fluorescence at the vegetal pole in small granules 42 hours after injection. 
These granules were not as large as those seen in control oocytes or as regular. 
Larger (up to 10 µm) granules were seen at the vegetal pole, and smaller (1µm) 
particles surrounded them, but the oocytes were abnormal in pigmentation (and 
possibly starting to die), and localisation was not identical to that seen in control 
oocytes. 33.3% of oocytes incubated in cytochalasin D still showed equatorial 
expression of XPAT-GFP, in small particles. 31.4% of oocytes showed a diffuse, 
general fluorescence and the remaining 19.6% were negative. 
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Of those oocytes injected with Xpat-GFP and incubated in cytochalasin D. 10.7% 
were fluorescent at the equator, 14.3% showed general fluorescence and 28.6% 
showed vegetal localisation of XPAT-GFP 66 hours after mRNA injection. The 
remaining 46.4% were negative, In all oocytes that fluoresced, the fluorescence was 
mainly diffuse with only a few 2.5-10 µm granules at the vegetal pole in those 
oocytes exhibiting vegetal localisation. Figure 4.3B shows three cytochalasin D- 
treated oocytes exhibiting general XPAT-QFP fluorescence. 
Thus, vegetal localisation and particle formation do not require microfilament 
function. Some particles coalesced into larger aggregates in the presence of 
cytochalasin D. but the aggregates appeared less regular and were not as large as 
granules seen in control oocytes (10 µm compared to 50 µm in controls). It is an 
issue whether any residual microfilament function remains in oocytes treated with 
cytochalasin D. 
4.3.2 Localisation of XPAT"GFP In oocytes treated with colcemid 
Oocytes cultured in the presence of colcemid also showed XPAT-GFP localisation 
after 18 hours in culture. As shown in Table 4.1, a high proportion of oocytes 
(40.3%) expressed XPAT-GFP in an equatorial domain around the injection site. The 
majority of the fluorescence in these oocytes was diffuse and non-particulate as 
shown in the three oocytes in Figure 4.2E. 9.1 % of oocytes expressed XPAT-GFP at 
the vegetal pole. These oocytes contained a small number of fluorescent particles (1 
to 2 pm across) as seen in the oocyte shown in Figure 4.2F. However, a higher 
proportion of these oocytes showed no external fluorescence compared with control 
oocytes, indeed 50.6% of colcemid-perturbed oocytes were scored as negative on day 
one. 
As summarised in Table 4.1,24.1% of those oocytes incubated in the presence of 
colcemid showed vegetal localisation 42 hours after injection. In these oocytes a few 
small particles of XPAT-GFP (up to 2 µm in diameter) were seen at the vegetal 
pole, but most of the external fluorescence was diffuse. 24.1% of the colcemid- 
treated oocytes still showed fluorescence at the equator around the injection site, and 
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Figure 4.2 (Opposite) Localisation of XPAT-GFP in oocytes treated with anti- 
cytoskeletal drugs 
Stage VI Xenopus oocytes were each injected at their equator with 2 ng of Xpat-GFP 
mRNA and cultured in vitro for 18 hours in OCM containing a final concentration of 
3µM nocodazole, 10 pM colcemid, 2 pM cytochalasin D, 5 pM taxol or no 
inhibitor. The localisation of XPAT-GFP in oocytes was examined by fluorescent 
microscopy. 
(A) Two control oocytes, the arrowed oocyte is expressing XPAT-GFP in a 
region just lateral to the vegetal pole, the other oocyte is expressing XPAT- 
GFP equatorially. 
(B) A single oocyte expressing XPAT-GFP in small granules at the vegetal pole. 
(C) Five oocytes treated with cytochalasin D expressing XPAT-GFP equatorially 
or vegetally (arrowed). 
(D) An oocyte, treated with cytochalasin D, expressing XPAT-GFP in small 
granules at the vegetal pole. 
(E) Three oocytes treated with colcemid expressing XPAT-GFP equatorially or 
vegetally (arrowed). 
(F) Vegetal view of an oocyte treated with colcemid. This oocyte is expressing 
small particles of XPAT-GFP. 
(G) Four oocytes treated with nocodazole, expressing XPAT-GFP in equatorial 
domains. 
(H) An example of a nocodazole-treated oocyte expressing XPAT-GFP in small 
granules in vegetal pole. 
(I) Three oocytes treated with taxol. These oocytes contain small particles of 
XPAT-GFP, as the closer view in (J) illustrates. 
(J) Vegetal view of an oocyte treated with taxol, small particles of XPAT-GFP 
are visible and appear to be in networks at the vegetal pole. 
(K) An oocyte treated with both cytochalasin D and colcemid shows no 
localisation of XPAT-GFP and no granules are visible. 
(L) An oocyte treated with cytochalasin D and colcemid contains very few 
particles of XPAT-GFP. 
All oocytes shown are -1.2 mm in diameter. 
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5.5% exhibited general fluorescence. The remaining 46.3% of these oocytes were 
scored as negative. 
Oocytes incubated in the presence of colcemid were mostly (55%) negative for 
XPAT-GFP fluorescence after 3 days in culture. 15% of oocytes showed vegetal 
XPAT-GFP localisation, 17.5% fluoresced equatorially and 12.5% were generally 
fluorescent (Table 4.1). The fluorescence in all positive oocytes was diffuse with 
only a few particles of up to 1µm visible at the very vegetal pole. However, there 
were particles present inside those oocytes that exhibited external fluorescence (this 
is shown later, in Section 4.4). Figure 4.3C shows four oocytes expressing XPAT- 
GFP in a general way- the nuclei are fluorescent and visible under the surface at the 
animal pole in all of these oocytes which indicates that colcemid treatment is 
working. These results suggest that vegetal transport depends, at least in part, on 
microtubule function, but particle formation seems relatively resistant. It is an issue 
whether any microtubule function remains in oocytes treated with colcemid. 
4.3.3 The effect of nocodazole treatment on XPAT-GFP localisation 
As summarised in Table 4.1,41.1% of Xpat-GFP-injected oocytes that were 
incubated in the presence of nocodazole expressed XPAT-GFP in a domain around 
the equatorial injection site 18 hours after injection. The fluorescence in these 
oocytes was diffuse, as shown in the four oocytes in Figure 4.2G. 9.6% of oocytes 
expressed XPAT-GFP at the vegetal pole. The fluorescence in these oocytes was 
mostly diffuse but some particles (1 to 2 µm in diameter) were visible, as the oocyte 
in Figure 4.2H illustrates. The remaining 49.3% were scored as negative. 
As Table 4.1 indicates, 15.1% of those oocytes incubated in nocodazole, showed 
vegetal fluorescence after 42 hours in culture. In these oocytes, like those treated 
with colcemid, a few 1 p. m particles of XPAT-GFP could be seen at the vegetal pole, 
but the majority of the fluorescence was diffuse. 24.5% of these oocytes showed 
equatorial fluorescence and 34.0% were generally fluorescent. In all these oocytes, 
the fluorescence was diffuse and not granular. The remaining 26.4% of oocytes 
showed no external fluorescence. 
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66 hours after mRNA injection, 21.05% of X1 AT-GFP-expressing oocytes that had 
been treated with nocodazole showed vegetal localisation, 21.05% showed equatorial 
fluorescence and 23.7% were generally fluorescent. The remaining 34.2% of oocytes 
were scored as negative. The fluorescence in all positive oocytes was highly diffuse, 
only the oocytes showing vegetal localisation expressed small (1 µm) particles at the 
very vegetal pole. Figure 4.3D shows six fluorescent oocytes that were incubated in 
nocodazole. The nuclei in all six oocytes were highly fluorescent and visible under 
the animal pole surface. 
Thus, as might be expected, nocodazole gives results broadly like those for colcemid. 
4.3.4 Localisation of XPAT"GFP in oocytes treated with taxol 
18 hours after injection, of the oocytes incubated in taxol: 31.9% showed equatorial 
fluorescence, 4.25% expressed XPAT-GFP at the vegetal pole, 12.8% were generally 
fluorescent and the remaining 51.05% showed no external fluorescence and were 
thus scored as negative (Table 4.1). In all oocytes exhibiting external fluorescence, 
the fluorescence was mainly diffuse but contained some small (1-2 µm) particles as 
seen in the three oocytes shown in Figure 4,21. One such oocyte is shown at a higher 
magnification in 4.2J; from this photograph it is obvious that there are small particles 
(up to 2 µm in diameter) of XPAT-GFP that appear to be forming networks of tracks 
of fluorescence. These networks were easily visible under a dissecting 
stereomicroscope. 
Only 3.6% of XPAT-GFP-expressing oocytes showed vegetal localisation after 42 
hours when treated with taxol. 50% of oocytes showed equatorial fluorescence, 
32.1% general expression and the remaining 14.3% were negative (Table 4.1). In 
those oocytes showing equatorial fluorescence, the fluorescence was diffuse. 
However, in oocytes expressing XPAT-GFP vegetally or generally small particles 
were visible that appeared to form networks of fluorescent tracks. Association with 
tracks suggests that the particles associate with microtubule tracts. This does not 
exclude the possibility that the tubules orient another cytoskeletal component. 
Clearly particles form, supporting the idea that microtubules are not needed for their 
formation. The reduction in vegetal localisation, coupled with the considerable 
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pigment re-organisation, suggests that taxol effects are stronger than those of the 
microtubule dissociators. It indicates integrity of microtubule function is needed for 
XPAT-GFP localisation. 
Table 4.1 summarises that 35.1% of XPAT-GFP-expressing oocytes incubated in 
taxol showed vegetal fluorescence 66 hours after injection. 45.6% of oocytes showed 
general fluorescence and the remaining 19.3% were negative. In all positive oocytes, 
diffuse fluorescence was visible as well as particles of XPAT-GFP, 2.5µm in 
diameter. These particles formed a visible network of fluorescence, throughout the 
oocyte, but especially obvious in the vegetal pole. An oocyte expressing such a 
pattern of XPAT-GFP localisation is shown in Figure 4.3E. 
4.3.5 Localisation of XPAT-GFP in oocytes treated with both cytochalasin D 
and colcemid 
Table 4.1 shows that, 18 hours after injection of Xpat-GFP, 66.7% of oocytes 
incubated in the presence of both cytochalasin D and colcemid expressed XPAT- 
GFP ubiquitously. The remaining 33.3% of oocytes were scored as negative. Thus, 
none of these oocytes showed any localisation of XPAT-GFP around the injection 
site or at the vegetal pole. The fluorescence seen in these oocytes was almost entirely 
diffuse (as illustrated by the oocyte shown in Figure 4.2K). There were a small 
number of 1µm particles visible in these oocytes, but as shown in Figure 4.2L, these 
particles were difficult to distinguish and certainly not as abundant as those seen in 
control XPAT-GFP expressing oocytes. 
66 hours after injection of Xpat-GFP, 50% of those oocytes incubated in both 
cytochalasin D and colcemid showed a general and diffuse fluorescence, the other 
50% were negative. A photograph of one generally positive oocyte is shown in 
Figure 4.3F. 
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Figure 4.3 (Opposite): Localisation of XPAT-GFP in oocytes treated with 
cytoskeletal inhibitors 
Stage VI Xenopus oocytes were injected equatorially with 2 ng of Xpat-GFP mRNA 
and cultured in vitro in OCM at 18°C in the presence of anti-cytoskeletal drugs. 
After 72 hours in culture, XPAT-GFP localisation was visualised using a fluorescent 
microscope. 
(A) Three oocytes cultured with no drugs expressing large granules of XPAT- 
GFP at their vegetal poles (arrowed). 
(B) Three oocytes, which have been cultured in the presence of cytochalasin D, 
express XPAT-GFP in an even and general distribution. Fluorescence is 
diffuse in all these oocytes. 
(C) Four oocytes treated with colcemid express XPAT-GFP generally. 
Fluorescence is diffuse and nuclei are visibly fluorescent under surface of all 
oocytes. 
(D) Six oocytes injected with Xpat-GFP and cultured in the presence of 
colcemid. The nuclei of all six oocytes are fluorescent and visible under 
surface. 
(E) An oocyte treated with taxol after injection of Xpat-GFP. A network of 
small granules of XPAT-GFP is visible all over this oocyte's surface. 
(F) An oocyte treated with both colcemid and cytochalasin D expressing XPAT- 
GFP. The XPAT-GFP is non-localised; the nucleus is fluorescent and visible 
under surface of the animal pole (arrowed), and the pigment is disrupted. 
Each oocyte is -1.2 mm in diameter. 
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Thus, both particle formation and vegetal localisation are affected when both 
microtubules and microfilaments are disrupted. Thus, either microtubules and 
microfilaments are both necessary for translocation, or one of them only is involved 
but one of the anti-cytoskeletal drugs used is only partially effective at disrupting its 
respective polymers. 
The results described above (all summarised in Table 4.1) indicate that oocytes 
incubated in inhibitors became sicker than control oocytes. Consequently, substantial 
numbers of oocytes began to lose fluorescence and thus be scored as negative. By 
day 2, the numbers of negative oocytes decreased when compared with day 1 scores. 
This was because oocytes scored as negative on day 1 typically became sick and 
died, thus were removed and not scored on day 2. During the course of days 2 and 3, 
more oocytes became sick and lost fluorescence, thus on day 3 high numbers of 
oocytes were scored as negative. 
None of the Xpat-GFP-injected oocytes incubated in the presence of cytoskeletal 
inhibitors displayed any large granules; only small (1 to 2.5 µm) particles were seen 
in these oocytes. This was in contrast to control oocytes that expressed large (up to 
50 gm across) granules of XPAT-GFP protein. 
4.3.6 To confirm that anticytoskeletal drugs affect the size of XPAT-GFP 
particles in oocytes 
In order to gain a better perception of exactly what was happening to the particles 
and granules of XPAT-GFP in oocytes, a higher magnification microscope was used 
(Figure 4.4). Figure 4.4A shows a higher magnification view (x200) of large granules 
of XPAT-GFP protein in control oocytes formed 42 hours after injection. These 
granules are up to 50 µm in size and seem to be large aggregates of smaller particles 
(of -5 µm diameter). Figure 4.5B is a high power view (x200) of particles of XPAT- 
GFP protein in control oocytes, formed 16 hours after mRNA injection. These 
particles are 1-2 gm in diameter. 
Figure 4.4C is a high power picture (200x magnification) of the vegetal region 
localisation of XPAT-GFP in oocytes treated with cytochalasin D, 42 hours after 
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injection. The largest of the particles were 7 µm in size. The oocyte shown in this 
figure is a typical example of a cytochalasin D-treated oocyte and its largest granules 
are much smaller than the largest granules seen in control oocytes. 
Figure 4.4D is a high magnification view (x200) of the vegetal region of an oocyte 
expressing XPAT-GFP that had been treated with colcemid. This photograph was 
taken 42 hours after injection. The particles in this oocyte were 1 µm in diameter, 
and these were the largest seen in any Xpat-GFP-injected oocyte cultured in 
colcemid. 
Figure 4.4E shows a high magnification view (x200) of the particles seen at the 
vegetal pole of an oocyte treated with nocodazole. The particles were mostly 1 µm in 
diameter, but a few were up to 4 pm. The photograph was taken 42 hours post Xpat- 
GFP injection, and this oocyte was typical of all such nocodazole-treated oocytes. 
Figure 4.4F is a high magnification view (x200) of the vegetal pole of an oocyte 
cultured in the presence of both cytochalasin D and colcemid. Very few particles 
were seen in this oocyte, the vast majority of fluorescence was diffuse and non- 
granular. The oocyte shown in 4.4F had been injected with Xpat-GFP 42 hours 
previously and was a typical example of an oocyte treated with both inhibitors. 
Figure 4.4H is a high power picture (200x magnification) of the particles seen in 
Xpat-GFP-injected oocytes treated with taxol. The particles were between 1 and 3 
µm in diameter and appeared to be forming tracks of fluorescence in a tubule-like 
pattern. The tracks were long and stretched for lengths of greater than 300 µm. 
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Figure 4.4 (Opposite): Anti-cytoskeletal drugs prevent the formation of large 
aggregates of XPAT-GFP in oocytes 
Oocytes were injected with 2 ng of Xpat-GFP mRNA equatorially and cultured in 
vitro in OCM in the presence of anti-cytoskeletal drugs. After 42 hours, the vegetal 
localisation of XPAT-GFP was examined using high magnification fluorescent 
microscopy. In (A) - (F) the scale bar represents 50 µm, in (G) it represents 250 µm 
and in (H) it represents 30µm. 
(A) Vegetal view of a control oocyte expressing large granules of XPAT-GFP up 
to 50 µm in size. 
(B) Vegetal view of a control oocyte expressing XPAT-GFP in particles of 
between 1-2 gm diameter. This photograph was taken 16 hours after mRNA 
injection and is shown for comparison with the particles seen in oocytes 
treated with anti-cytoskeletal drugs. 
(C) Oocyte treated with cytochalasin D expressing granules of XPAT-GFP at the 
vegetal pole, up to 7 pm in diameter. 
(D) Vegetal view of an oocyte, cultured in the presence of colcemid, expressing 
particles of XPAT-GFP -1 pm in diameter. 
(E) Oocyte treated with nocodazole expressing small granules of XPAT-GFP at 
the vegetal pole, these granules were up to 4 µm in diameter. 
(F) Vegetal view of an oocyte cultured in the presence of both cytochalasin D 
and colcemid. Very few particles of XPAT-GFP are visible in this oocyte, 
the fluorescence is diffuse. 
(G) An oocyte treated with taxol after injection of Xpat-GFP. A network of small 
granules of XPAT-GFP is visible all over this oocyte's surface. 
(H) High magnification view of the boxed region of (G). Granules of XPAT- 
GFP visible at the vegetal pole in an oocyte treated with taxol. These 
granules were between 1 and 3 µm in diameter and appear to be localised in 
tracks of fluorescence. 
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4.4 The internal and nuclear localisation of XPAT-GFP In oocytes treated with 
cytoskeletal inhibitors 
To determine whether granules and particles of XPAT-GFP were purely superficial 
or not and to see whether nuclei were fluorescent, Xpat-GFP-injected oocytes that 
had been cultured in the presence of cytoskeletal inhibitors were viewed internally. 
Oocytes were fixed by heating to 75-85°C in Barth's saline for 30 seconds and then 
cut open using a scalpel, Figure 4.5 shows oocytes dissected this way. 
Figure 4.5B to E show GFP-injected oocytes, treated with drugs (controls are shown 
in Figure 4.5A), which were all bisected 48 hours after injection. In all these oocytes, 
fluorescence was diffuse, no particles of GFP were seen and the nuclei in all oocytes 
were fluorescent. The oocyte in Figure 4.58 appears to have a negative nucleus but 
this was not the case however, the nucleus was in the other (unphotographed) half of 
the oocyte. Fluorescence was quite strong in all oocytes except taxol-treated ones 
(Figure 4.5E) that were quite weakly fluorescent, because the fluorescence was 
mostly superficial and not present inside the oocytes. 
Figure 4.5F to J show Xpat-GFP injected oocytes that had been treated with 
inhibitors and bisected after 48 hours in culture. Figure 4.5F is a control (untreated) 
oocyte, expressing particles of XPAT-GFP in a domain stretching from the equator 
to just lateral to the vegetal pole. These granules were not purely superficial, they 
were present inside the oocyte in the cytoplasm and the nucleus also contained non- 
particulate XPAT-GFP. 
Figure 4.5G is a photograph of an XPAT-GFP expressing oocyte that had been 
treated with cytochalasin D and bisected 48 hours post-injection. Again, it is obvious 
that the particles of XPAT-GFP protein were not purely superficial, they were 
present in the cytoplasm inside the oocyte and were spread out over quite a large 
area. Unlike control oocytes, the particles appeared irregular in arrangement and 
were present in patches. The majority of particles were present just under the surface 
near the equator, but there were other particles present throughout cytoplasm even 
near the nucleus. The nucleus of this oocyte was also fluorescent and there was a lot 
of general diffuse fluorescence throughout the oocyte. 
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Figure 4.5H shows an XPAT-GFP-expressing oocyte that had been treated with 
colcemid and bisected after 48 hours in culture. The fluorescence in this oocyte was 
quite patchy and mainly present equatorially and in the deeper cytoplasm. The small 
particles of XPAT-GFP were not purely superficial; where they were visible on the 
oocyte surface at the equator, they were also present inside the oocyte in a cluster in 
the same region. The particles were similar in arrangement to those seen in control 
oocytes. 
Figure 4.51 shows a bisected XPAT-GFP expressing oocyte that had been cultured 
for 48 hours in vitro in the presence of nocodazole. The fluorescence in this oocyte 
was in the vegetal region, and the small particles visible at the vegetal pole surface 
were not purely superficial. There was a patch of particles present in the cytoplasm 
reaching from the vegetal pole towards the nucleus. The particles extended further 
towards the nucleus than those seen in control oocytes. 
Figure 4.5J shows a high magnification photograph of a bisected XPAT-GFP 
expressing oocyte that had been treated with taxol and cultured in vitro for 48 hours. 
The particles visible at the surface of this oocyte were not totally superficial but 
much more so than with other treatments. They were present inside the cytoplasm 
and appeared to form linear rows of particles under the oocyte's surface, extending 
for lengths of -250 µm. The particles also extended inside the oocyte towards the 
nucleus. 
The oocytes that had been treated with anti-cytoskeletal drugs were generally less 
healthy than control oocytes. Thus, dissections were more difficult to perform and 
generally looked less neat, regular and sharp than controls, as the photographs in 
Figure 4.5 illustrate. 
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Figure 4.5 (opposite): Internal and nuclear localisation of XPAT-GFP and GFP 
in oocytes treated with cytoskeletal Inhibitors 
Stage VI Xenopus oocytes were injected with 2 ng of Xpat-GFP or GFP mRNA and 
cultured in vitro in OCM in the presence of anti-cytoskeletal drugs -3 µM 
nocodazole, 10 µM colcemid, 2 f1M cytochalasin D or 5 µM taxol. After 48 hours in 
culture, oocytes were fixed by heating to 75 to 85 °C in Barth's saline for 30 seconds 
and then cut open using a scalpel, The internal localisation of XPAT-GFP (or GFP) 
was then examined by fluorescent microscopy, 
(A) A control GFP-injected oocyte expressing GFP throughout nucleus and 
cytoplasm. 
(B) An oocyte treated with eytochalasirr D expressing GFP throughout the 
cytoplasm. The nucleus of this oocyte was also fluorescent but is not shown 
in this photograph. 
(C) An oocyte treated with colcemid expressing GFP throughout its cytoplasm 
and nucleus. 
(D) Oocyte cultured in the presence of nocodazole expressing GFP throughout 
the nucleus and cytoplasm. 
(E) Oocyte cultured in presence of taxol expresses GFP weakly throughout 
cytoplasm and nucleus, 
(F) An untreated oocyte which had been injected with Xpat-GFP expressed 
particles of XPAT-GFP on surface in a domain stretching from the equator 
to just lateral to the vegetal pole. XPAT-GFP granules are present inside the 
oocyte and the nucleus also contains fusion protein. 
(G) An XPAT-GFP expressing oocyte that has been treated with cytochalasin D. 
Particles of XPAT-GFP are present in cytoplasm over a large domain but 
are irregular in arrangement. The nucleus also contains XPAT-GFP. 
(H) An oocyte treated with colcemid expressing XPAT-GFP equatorially in 
patches throughout the cytoplasm (arrowed). 
(I) An oocyte cultured in presence of nocodazole. Particles of XPAT-GFP are 
present at the vegetal pole surface and throughout cytoplasm towards the 
nucleus (arrowed). 
(J) An oocyte treated with taxol, expressing XPAT-GFP in granules at the 
oocyte surface and inside the cytoplasm. The particles appear to form linear 
rows in the cytoplasm and towards the nucleus (arrowed). 
Each oocyte shown is -1.2 mm in diameter. 
120 
G FP 
Control 
Cytochalasin D 
GºIcemid 
Nocudazole 
Taxol 
X PA T-(; }'P 
4.5 Do inhibitors of the cytoskeleton affect localisation of endogenous Xpat 
mRNA? 
Stage VI Xenopus oocytes were treated with cytochalasin D, colcemid, nocodazole or 
taxol as previously described (Section 4.2). These oocytes were cultured in vitro in 
OCM for 42 hours at 18°C and then fixed. In situ hybridisation showed that, in all 
cases, the distribution of endogenous Xpat mRNA was the same as in control oocytes 
and was thus unaffected by these treatments (results not shown). This experiment 
focused on the steady state distribution of endogenous mRNA in fixed cells. This in 
an equilibrium condition and as such may not be directly relevant to understanding 
the mechanism of RNA (or indeed protein) localisation, since RNA localisation is a 
dynamic process (Ainger et al., 1993). However, what could be determined from this 
experiment was that endogenous Xpat mRNA localisation had not been altered by 
drug treatment. By stage VI, Xpat inRNA had already localised and thus, from these 
results, once Xpat mRNA has localised in oocytes none of the anti-cytoskeletal drugs 
can disrupt it. Experiments have not yet been done to determine whether injected 
Xpat or Xpat-GFP mRNA localisation is affected by the use of cytoskeletal 
inhibitors. 
4.6 Discussion 
Preliminary experiments on the mode of localisation of XPAT-GFP have been 
conducted, using cytoskeletal inhibitors. These indicate that microtubules, but not 
microfilaments, are essential for transport from the equator to the vegetal pole; 
neither are needed for the small punctate particles to form. Larger aggregates of 
XPAT-GFP do not form when either microtubules or microfilaments are disrupted. 
This is obvious since equivalent levels of vegetal localisation of XPAT-GFP are seen 
in cytochalasin D-treated oocytes when compared with control oocytes. However, 
the result from oocytes treated with both cytochalasin D and colcemid is most 
convincing. This implies that to completely prevent vegetal localisation or any 
localisation around the injection site, both microtubule and microfilament destruction 
is necessary. Also, when both are destroyed, not even small particles of XPAT-GFP 
can form. Although intermediate filaments as a class cannot be targeted with 
inhibitors, they are disrupted by depolymerising microtubules. It is unlikely though 
that intermediate filaments can direct transport of XPAT-GFP, indeed no motor 
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proteins are known for intermediate filaments and they have not been shown to 
transport mRNAs. However, intermediate filaments are required for the cortical 
anchoring of Vgl RNA (Yisraeli et al., 1990; Kloc and Etkin, 1995), and could 
likewise be involved in the anchoring of Xpat-GFP mRNA or the protein it encodes. 
Colcemid- and nocodazole-treated oocytes exhibited a reduced frequency of XPAT- 
GFP localisation, but these inhibitors did not totally prevent localisation. This could 
be because total disruption of all oocyte microtubules would not be possible in 24 
hours, or could indicate that these drugs were not totally effective in disrupting all 
oocyte microtubules at the concentrations used in these experiments. Thus, 
microtubules may be required for vegetal localisation of XPAT-GFP - it depends 
how many remain intact in colcemid- and nocodazole-treated oocytes; in fact, y- 
tubulin is not disrupted by nocodazole. A second possibility is that the inhibitors are 
working efficiently but microfilaments, in addition to microtubules, are functional in 
vegetal localisation of XPAT-GFP. 
High magnification photographs (x200) indicate that fluorescent granules of XPAT- 
GFP appear to be closely associated with microtubules when they had been stabilised 
by taxol. It is possible that they are transported along microtubule bundles but there 
is no direct evidence of this. ytubulin is asymmetrically distributed along the AN 
axis, with foci of ? -tubulin concentrated at the vegetal cortex of Xenopus oocytes 
(Gard, 1994; Gard et al., 1995). The majority of microtubules have their minus ends 
directed towards the oocyte cortex (Pfeiffer and Gard, 1999). Thus, there might be a 
population of microtubules nucleated by y-tubulin at the vegetal pole, with their 
minus ends at the vegetal cortex in stage VI oocytes; any transport of XPAT-GFP 
along these tubules would probably involve dynein, a minus end-directed motor (Fox 
and Sale, 1987; Paschal and Vallee, 1987; Paschal et al., 1987; Schroer et al., 1989; 
Schnapp and Reese, 1989). In order to gain more information on possible 
microtubular transport of XPAT-GFP, rhodamine-labelled tubulin monomers could 
be used to determine whether XPAT-GFP can colocalise with the rhodamine labelled 
tubulin. This was attempted, but the method was not optimised due to time 
restrictions. 
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The velocity of movement of XPAT-GFP protein (600 µm over 24 hours) is slower 
than microtubule-based, kinesin-driven transport (Okabe & Hirokawa, 1989; Vallee 
& Bloom, 1991; Ainger et al., 1993). Ainger and colleagues found that granules in 
such processes underwent sustained directional movement with a velocity of 
-0.2µm/s along microtubules. This is equivalent to 720 µm per hour (Ainger et al., 
1993). Similarly, most organelles move toward the minus ends of centrosome 
microtubules (dynein-driven transport) at an average velocity of 0.5±0.2 tm/s 
(Schroer et al., 1989), again faster than the observed movement of XPAT-GFP 
towards the vegetal pole. 
There are three possible mechanisms of intracellular localisation: 
1) Diffusion plus local binding 
2) Diffusion plus degradation (P-granules localise this way in C. elegans; 
Strome and Wood, 1982,1983) 
3) Active transport. 
However, the results presented in this study indicate that XPAT-GFP is transported 
and the protein is not degraded. This is evident because XPAT-GFP fluorescence is 
visible at the injection site even when mRNA is injected at the animal pole, and 
oocytes remain fluorescent for at least 3-4 days post-injection. 
XPAT-GFP could bind to an RNA that, in turn, binds to the cytoskeleton. This is 
unlikely to be an endogenous mRNA since such large quantities of XPAT-GFP 
protein, as are present in these injected oocytes, would be expected to saturate such 
an endogenous pathway. However, it is possible that it could bind to Xpat-GFP 
mRNA that could then be localised by microtubules. However, proteins usually bind 
to 3'UTR sequence and Xpat-GFP mRNA does not contain any of Xpat's UTR. Most 
germ plasm localised molecules have been discovered to be RNA-binding proteins 
(such as Xdazl; Houston et al., 1998). Chapter 6 looks at the RNA-binding properties 
of XPAT. 
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Chapter 5: The localisation of XPAT-GFP deletion proteins in Xenopus oocvtes 
5.1 Introduction 
XPAT-GFP localises to the vegetal pole of stage VI Xenopus oocytes, and forms 
small particles that aggregate over time to form larger granules (20-50µm in 
diameter) reminiscent of the germ plasm (see Chapter 3). It also enters the nucleus. It 
was decided that it would be useful to produce several protein isoforms in order to 
establish what regions of XPAT are involved in these processes. These proteins were 
deletion variants of XPAT that were fused in frame with GFP at their C-termini. 
Three variants lacking amino acids at the amino-terminus of XPAT - ON1 lacking 
the first 61 amino acids, iN2 lacking the first 92 amino acids and iN3 lacking N- 
terminal 159 amino acids, were produced. Also, a C-terminal deletion protein, 
lacking the last 128 amino acids of XPAT, was generated and tagged in frame with 
GFP at its carboxy-terminus. These proteins were all expressed in stage VI Xenopus 
oocytes and examined for their localisation in the oocyte. This was done in order to 
try to determine which domains in XPAT are responsible for its vegetal localisation 
and if the same amino acids also cause it to form granules. It was also thought that 
these proteins would serve as a useful control to show that all proteins do not localise 
in the same manner as full-length XPAT when C-terminally tagged with GFP. 
5.2 Production of AN1, AN2, AN3 and AC! deletion proteins 
Fluorescently tagged deletion variants of XPAT were prepared using pSPJC2L-cGFP 
as a vector (see 3.2.2 for details of construction). This vector contained restriction 
sites that could be used to create cDNAs encoding proteins tagged with GFP at their 
C-termini. The DNA containing the required region of the Xpat ORF was amplified 
from a cDNA library clone with primers designed to create 5' and 3' Bg1II sites. In 
each case, the resulting fragment was cloned into the Bgll site of pSPJC2L-cGFP, 
generating N-terminal deletion variants ANI, AN2, AN3 and a C-terminal deletion 
AC1. The proteins encoded by these constructs are shown schematically in Figure 
5.1A. This figure indicates which amino acids of XPAT are included in each variant 
protein and also shows full-length XPAT-GFP. Each of the AN deletions was 
designed to start at a genuine methionine in XPAT (see appendix 2) and AC I and 
AN1 have 6 amino acids in common. 
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(A) Constructs used in this study. In each protein illustrated GFP is shown in green and parts of XPAT are 
shown in blue. To make XPAT-GFP deletions, XPAT was truncated and GFP fused in-frame. The numbers 
indicate amino acid residues of XPAT included in each fusion protein. 
(B)An autoradiograph of in vitro transcription and translation reactions. Coupled in vitro transcription 
and translation reactions were performed using Xpat-GFP, . N1, AN2, . N3, Cl Oor 
GFP cDNA as a template 
in rabbit reticulocyte lysate. 1/10 of each reaction was then resolved by SDS-PAGE and autoradiographed. 
The size markers are indicated (on left). 
In order to check that each deletion construct contained an insert and that the 
orientation of Xpat was correct in each case, PCR was performed on colonies 
resulting from each ligation/transformation step. For each deletion construct, only a 
colony that gave a PCR product of the expected size was subsequently used to 
prepare DNA from. Once the constructs were made, appropriate restriction digests 
were performed on the DNA to confirm that each insert was present in the correct 
orientation (results not shown). 
Following restriction digestion, in vitro coupled transcription and translation 
reactions were performed using ANI, ON2, ON3 or Cl ODNA as a template. A 
fraction of each reaction was resolved on a protein gel, alongside translations of both 
Xpat-GFP and GFP. An autoradiograph of this gel is shown in Figure 5.1B, and 
indicates that the AN deletion constructs have increasingly smaller molecular 
weights. All are, as expected, smaller in molecular weight than XPAT-GFP (which 
has an apparent molecular weight of 65 kDa), but larger than GFP (which is 30kDa). 
ANI has an apparent molecular weight of 59 kDa, ON2 of 56 kDa, AN3 47.5 kDa 
and Cl O50 kDa (see Figure 5.1B). These molecular weights correspond with the 
expected sizes of the proteins. 
5.3 The localisation of AN1, AN2, ON3 and AC1 in stage VI Xenopus oocytes 
To analyse how deleting regions of XPAT protein affect its subcellular localisation, 
the chimeric mRNAs were injected into the equatorial region of Xenopus oocytes, at 
a dose of 2 ng per oocyte, and these oocytes were then cultured in vitro in OCM for 
up to 72 hours. The localisation of the translated product was examined by 
fluorescent microscopy. Table 5.1 shows the localisation of these fusion proteins in 
stage VI Xenopus oocytes after up to 42 hours in culture. The results from 2 
experiments were pooled and are recorded in Table 5.1. The experiments 
summarised in this table were done under identical conditions. 
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Table 5.1: The exnreccinn of rieietinn variants of YPAT. (-FP in Yonnn. ic nnwtpc 
ANI AN2 AN3 OC1 GFP X at-GFP 
G: 74.4% G=94.1% G=90.1% G=94.6% G=91.7% V=13.0% 18 60 1 
hours -=25.3% -=5.9% -=9.9% -=5.4 -=8.3% 
E_ 
. n=83 n=85 n=91 n=93 n=48 n-238 
G=66 7% G=85.3% G=48 7% G=94.7% G=85.7% 
V=20.3% 
42 . . E=46.8% 
hours -=33.3% -=14.7% -=51.3% -=5.3% -=14.3% -_. 9 n=43 n=45 n=39 n=38 n=28 n=143 
G=general fluorescence, -=no external fluorescence, V=vegetal specific 
fluorescence, E=equatorial fluorescence, n= number of oocytes scored. 
As previously shown, XPAT-GFP protein localised in stage VI Xenopus oocytes. On 
day 1 (18 hours after injection), the fusion protein was expressed principally in an 
equatorial domain around the point of injection (60.1% of oocytes- Table 5.1). There 
was diffuse fluorescence in most oocytes (as illustrated in Figure 5.2A) but also 
some small particles of -2.5 µm in diameter. 13.0% of oocytes expressed XPAT- 
GFP in small particles at the vegetal pole and 26.9% of oocytes showed no external 
fluorescence and were thus scored as negative (Table 5.1). By 42 hours after 
injection, in 20.3% of oocytes most of the fluorescence was found at, or just lateral 
to, the vegetal pole. At this stage the fluorescence was mostly particulate, but at the 
pole the granules were larger. 46.8% of oocytes expressed XPAT-GFP in small 
particles equatorially around the point of injection and the remaining 32.9% of 
oocytes were apparently negative. Figure 5.2B shows five oocytes expressing XPAT- 
GFP 42 hours after injection. 
As Table 5.1 shows, 18 hours after equatorial injection of GFP, used as a control, 
91.7% of oocytes showed a general fluorescence throughout the oocyte. By day 2 (42 
hours after injection) this figure had reduced to 85.7%. This reduction is probably 
related to the health of oocytes, since the remaining 14.3% are apparently negative. 
As can be seen in Figures 5.2C and 5.2D, control GFP mRNA injection into Xenopus 
oocytes resulted in an even and non-localised distribution of GFP fluorescence 
within the oocyte, and homogeneous signals in the cytoplasm. 
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As Table 5.1 summarises, stage VI Xenopus oocytes appeared generally fluorescent 
when injected with ANI (74.7% general after 18 hours in culture). Numbers of 
oocytes showing general fluorescence reduced slightly to 66.7% after 42 hours in 
culture but this was again due to oocyte health as the remaining 33.3% were 
negative, showing no external fluorescence. As a general rule, sick oocytes lose 
fluorescence, thus appearing negative and then die. Figure 5.2E shows oocytes 
expressing ANI after 18 hours in culture, the very strong patches of fluorescence 
visible in the animal pole are likely to be the nuclei inside the oocytes, as they are 
highly fluorescent (see Section 5.4). By day 2 (42 hours after injection) the 
fluorescence was very strong, as shown in Figure 5.2F. In some oocytes (-20% of 
those showing external fluorescence), the fluorescence appeared slightly stronger on 
the side of the oocyte that had been injected. This was only apparent on day 1, and 
only obvious in oocytes that expressed AN 1 less strongly than others, by day 2 when 
the fluorescence was generally stronger, this was not seen. This is not obvious in the 
photographs shown in Figure 5.2, as it was quite a difficult phenomenon to capture. 
As Table 5.1 shows, 18 hours after equatorial injection of AN2,94.1% of oocytes 
showed general fluorescence, by day 2 this had decreased to 85.3% (due to health of 
oocytes). The remaining 14.7% were scored as negative on day 2. This fluorescence 
was evenly distributed throughout the oocyte, like GFP, as shown in Figure 5.2G and 
Figure 5.2H. Likewise, AN3 (Figures 5.21 and J) and OC1 (Figures 5.2K and L) were 
expressed ubiquitously in oocytes. They showed an even and non-localised 
distribution of fluorescence, which looked identical to GFP expression. As a general 
rule, oocytes that expressed AN3 were less fluorescent than those expressing ANI 
and AN2. 
Thus, by external appearance, deletion of between 61 and 159 N-terminal amino 
acids or 128 C-terminal amino acids of XPAT causes its localisation in Xenopus 
oocytes to be disrupted. 
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Figure 5.2 (Opposite): Expression of deletion variants of XPAT-GFP and GFP 
in stage VI Xenopus oocytes 
Oocytes were each injected with 2 ng of mRNA and were then cultured in vitro in 
OCM at 18°C. 18 hours after injection (day 1) and 42 hours post-injection (day 2), 
photographs were taken under a fluorescent microscope using a digital camera. 
(A) Equatorial localisation of XPAT-GFP in four oocytes 18 hours after 
injection. 
(B) Five -oocytes demonstrating localisation of XPAT-GFP after 42 hours in 
culture. Oocytes arrowed show vegetal expression, whereas other oocytes 
show equatorial/lateral expression. 
(C) General diffuse fluorescence in five oocytes expressing GFP. 
(D) Non-localised distribution of fluorescence in oocytes 42 hours after GFP 
injection. 
(E) Five oocytes expressing . 
N1 18 hours after mRNA injection. 
(F) 42 hours after injection of uNl mRNA, five oocytes express AN1 in a non- 
localised distribution. 
(G) Five oocytes expressing ON2 18 hours after mRNA injection. 
(H) 42 hours after injection with AV2 mRNA, four oocytes express AN2 in a 
general, non-localised manner. 
(I) Six oocytes express iN3 18 hours after mRNA injection. 
(J) Four oocytes show fluorescent expression of ON3 42 hours after mRNA 
injection. Some oocytes (such as the one arrowed) were scored as negative 
since they exhibited no external fluorescence. 
(K) Six oocytes 18 hours after ACl mRNA injection exhibit general distribution 
of AC I. 
(L) Six oocytes expressing OC1 after 42 hours in vitro. 
Each oocyte shown is -1.2 mm in diameter. 
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In order to gain a better perception as to whether ANI, AN2, ON3 or AC1 proteins 
formed particles which were not easily visible under low magnifications, a higher 
magnification was used to view oocytes after 42 hours in culture (Figure 5.3). Figure 
5.3F shows a higher magnification view of the vegetal region localisation of XPAT- 
GFP protein after 42 hours in culture. This photograph clearly shows small punctate 
spots of XPAT-GFP protein aggregating into larger granular structures. 
Figure 5.3A shows a high power view of the fluorescence seen in an oocyte 
expressing ANI. This figure clearly shows that ON1 is not expressed in granules in 
this oocyte, and this is true of 95.2% of those oocytes fluorescing, it is expressed in a 
diffuse manner. However, in a small number of oocytes expressing ANI (4.8% of 
those with external fluorescence) a small projection of cytoplasm could be seen at the 
injection site on the equator. In this small protrusion, small punctate fluorescent 
particles of iN1 could be seen (Figure 5.3B shows one such oocyte). Such 
projections would trap the injected mRNA and prevent movement of its product to 
the interior of the oocyte. Thus, although not normally apparent on the surface of the 
majority of oocytes, ON1 was expressed in tiny particles (of -1 µm diameter). At no 
time were any larger granules seen, certainly none of the same size (10-50 µm 
diameter) as XPAT-GFP granules. Thus, ANI can form particles, but these do not 
seem to show cortical anchoring. 
Figure 5.3C shows a high power view of an oocyte expressing AN2. This figure 
shows that AN2 is not expressed in particles or granules and its fluorescence is 
evenly distributed throughout the oocyte. 
Figure 5.3D is a high magnification view of an oocyte expressing AN3. This 
photograph clearly shows that AN3 fluorescence is diffuse, even and non-localised. 
Thus, ON3 does not localise or form particles in stage VI Xenopus oocytes. The same 
is true of ACI (Figure 5.3E). 
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Figure 5.3 (Opposite): To illustrate the diffuse nature of ON1, zN2, AN3 and 
OC1 fluorescence in stage VI Xenopus oocytes 
Stage VI Xenopus oocytes were each injected with 2 ng of mRNA and cultured in 
vitro in OCM at 18°C. 42 hours after injection, oocytes were viewed under a 
fluorescent microscope at high magnification. These photographs illustrate the 
diffuse nature of the fluorescent expression. In each photograph the original 
magnification was x10 and the scale bar represents 100 pm. 
(A) A typical ON 1 oocyte expressing AN 1 in a diffuse, non-granular pattern. 
(B) An example of one of the 4.8% of fluorescent oocytes expressing AN 1 that 
had small protrusions of cytoplasm visible near to the equator at the site of 
injection. In this projection small particles of ANI can be clearly seen. 
(C) An oocyte expressing AN2, no particles are visible in the cytoplasm as the 
fluorescence is totally diffuse. 
(D) An oocyte injected with AN3. The fluorescence is diffuse and no particles are 
visible in the oocyte's cytoplasm. 
(E) View of an oocyte expressing AC L AC I does not form granules and thus the 
fluorescence is diffuse. 
(F) An oocyte expressing particles and small granules of XPAT-GFP in a 
localised domain at the vegetal pole. 
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5.4 The nuclear localisation of . N1, AN2, ON3 and OC1 
To determine whether AN1, AN2, AN3 or iC1-injected oocytes contained any 
internal particles or granules and to see if their nuclei were fluorescent, oocytes that 
had been cultured for 42 hours in vitro were fixed by heating to 75-85°C in Barth's 
saline for 30 seconds and then cut open using a scalpel. Figure 5.4A depicts an 
oocyte that expressed ANI and was bisected, the nucleus was fluorescent, as was the 
area immediately surrounding it. However, the rest of the oocyte was not. Figure 
5.4B shows an oocyte that expressed AN2 and was bisected. It can be seen that the 
nucleus was highly fluorescent but the rest of the oocyte was not, thus the nucleus 
contained the majority of AN2. Figure 5.4C illustrates an oocyte that expressed AN3 
and was bisected. The nucleus of this oocyte is highly fluorescent and thus contains 
AN3, but the rest of the oocyte is negative. Figure 5.4D is a photograph of a bisected 
oocyte expressing OC1. This oocyte is highly fluorescent throughout its cytoplasm 
and also in the nucleus. Thus, the entire oocyte is expressing AC at high levels, and 
the nucleus also contains high levels of fusion protein. None of the deletion proteins 
formed granules inside oocytes. The yolk concentration has an effect on the 
distribution of proteins in oocytes. There is a gradient of yolk from the vegetal to the 
animal pole in oocytes, the highest concentration being present in the vegetal 
hemisphere. Yolk excludes soluble proteins, thus GFP (see Figure 3.5) and AC 1 
(Figure 5.4D) fluorescence appears slightly more concentrated at the animal pole 
than at the vegetal pole when oocytes are cut open. Similarly, there is no yolk in the 
nucleus, thus OC1 appears to be expressed slightly more strongly there than in the 
rest of the animal pole. 
After three days in culture, the majority of oocytes that had been injected with AV], 
zN2 or iN3 showed no external fluorescence (that is would be scored as negative). It 
was thus decided to determine whether the GFP fusion proteins were still present or 
were no longer being translated. One possible explanation for the large numbers of 
apparently negative oocytes was that all of the fluorescence was actually present in 
the nucleus. The results shown in Figures 5.4 A to C (bisection of oocytes expressing 
ANI, iN2 or AN3) indicate this is true. To quantify what was occurring, nuclei were 
removed from several oocytes that had been injected with 1N1, AV2 or iN3 and yet 
appeared negative. All nuclei removed were positive for fluorescence and thus 
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Figure 5.4 (Opposite): To determine where deletion variants of XPAT-GFP 
localise within Xenopus oocytes following microinjection of mRNA 
Stage VI Xenopus oocytes were injected with AN], 1N2, AN3 or 1C1 mRNA and 
cultured in vitro in OCM for 42 hours. Some oocytes were fixed and bisected in 
order to determine whether any fluorescence was visible inside the oocyte (A, B, C 
and D). The nuclei from other oocytes were removed (E, F, G and H) to ascertain 
whether the nuclei contained fusion protein. 
(A) An oocyte with no visible external fluorescence that had been injected with 
dNl. After bisection, fluorescence is clearly visible in and around the 
nucleus. 
(B) ON2 is expressed in the nucleus of an oocyte that appeared negative prior to 
dissection. 
(C) An oocyte injected with AN3 contains fusion protein in its nucleus. 
(D) An oocyte injected with zlC1 mRNA expressed OC1 throughout its 
cytoplasm and also contains fusion protein in its nucleus. 
(E) An oocyte expressing ANI that has had its nucleus removed. This 
photograph is a dual exposure of white light and UV and shows that the 
nucleus is highly fluorescent. 
(F) An oocyte injected with AN2 that has had its nucleus removed. The nucleus 
is highly fluorescent (photograph is a dual exposure of UV and white light). 
(G) An oocyte expressing AN3 that has had its nucleus removed. Again, the 
nucleus contains fusion protein. 
(H) An oocyte expressing OC1 that appears generally fluorescent externally. 
Nuclear removal shows that the nucleus also contains AC I. 
Each oocyte shown is -1.2 mm in diameter. 
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contained GFP fusion protein (as shown in Figures 5.4E to G). In total, 5/5 nuclei 
from superficially negative AV]-, 5/5 nuclei from superficially negative LN2- and 
5/5 nuclei from superficially negative dN3-injected oocytes were fluorescent. After 3 
days in culture, the majority of oocytes that had been injected with ACl still 
appeared externally generally fluorescent. The nuclei were removed from five 
oocytes that expressed AC1 and all five were fluorescent. Figure 5.4H shows the 
nucleus from one of these oocytes. By observation, it appeared that the nuclei 
removed from OC1-expressing oocytes were less strongly fluorescent than the nuclei 
of oocytes injected with 1N1. 
5.5 To show the subcellular localisation of ON3 and OC1 by in vivo 
radiolabelling 
It was decided to use a more quantitative approach to investigate the localisation of 
iN3 and LC1 within Xenopus oocytes. ON3 and OC1 were chosen since they are 
deletions of opposite ends of XPAT protein and have only a six amino acid region in 
common. To this end, stage VI Xenopus oocytes were injected with 20 ng of AC], 
zN3, Xpat-GFP or Xpat mRNA. The oocytes were then cultured overnight at 18°C 
in the presence of 35S-methionine. This is taken up by oocytes and radiolabels all 
newly translated proteins. The following day, nuclei were removed from some of 
these oocytes and homogenised (N fraction) and the remaining cytoplasm and 
membranes were homogenised and centrifuged to give a cytosol (soluble, Cs) 
fraction and a cytoplasm insoluble (pellet, Ci) fraction. Particles would be expected 
to enter the Ci fraction. Some oocytes were homogenised whole to give an oocyte 
total protein (T) sample. 
These fractions were then resolved on an acrylamide gel, alongside control 
(uninjected) oocyte fractions that were prepared in the same way. The gels were then 
autoradiographed. An extra protein band (of expected size) was seen in fractions 
from each of the injected oocyte samples when compared with control oocyte 
fractions. Figure 5.5 shows autoradiographs of these protein gels. 
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Figure 5.5: To determine the subcellular localisation of AN3 and OC1 by in vivo 
radiolabelling. 
Stage VI Xenopus oocytes were injected with 20ng of Xpat-GFP, AN3, ACI or Xpat mRNA, 
or left uninjected. They were cultured over-night in the presence of ; 5S-methionine. The 
following day, oocytes were homogenised to give a Total protein sample (T), nuclei were 
removed from oocytes to give a nuclei (N) fraction. The remaining membranes and cytoplasm 
were homogenised and centrifuged (13K rpm, 5 minutes) to give a cytosol soluble fraction 
(Cs) and a pellet of insoluble cytoplasm (Ci). These fractions were resolved by SDS-PAGE. 
On each gel all 4 control (uninjected) oocyte samples were run alongside 4 fractions from one 
of the injected oocytes. Gels were then autoradiographed and these autoradiographs are 
shown: (A) XPAT-GFP, (B) . N3, (C) AC 1 (D) 
XPAT. Size markers are shown on the left 
hand side (sizes in kDa). The letters above each gel indicate which sample was loaded. 
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As previously shown (Section 3.4) XPAT-GFP (65 kDa) is seen in all fractions, but 
it is a faint band in the nucleus and the soluble fraction of the cytosol, whereas the 
majority of the protein is seen in the cytoplasm insoluble fraction (Figure 5.5A). As 
Figure 5.5B shows, AN3 (47.5 kDa) is found in the nuclear and cytosolic soluble 
fractions of the oocyte but is not seen in the cytoplasmic insoluble fraction thus it 
does not form granules. The AN3 band is strongest in the nuclear fraction, which 
corresponds to its fluorescent localisation (Figure 5.4C). AC1 (50 kDa) is present 
mainly in the cytosolic soluble and nuclear fractions, but is stronger in cytosolic 
fraction (Figure 5.5C), which indicates that AC1 is not localised or forming 
(insoluble) granules - again similar to the fluorescence data. Thus, AN3 is present in 
the nucleus to a greater extent than OCl, XPAT-GFP or XPAT. This closely 
resembles fluorescence data (Figure 5.4) and indicates that the C-terminus of XPAT 
contains a nuclear localisation domain. The localisation of AC1 resembles the 
expression pattern shown, using this method, by XPAT (although not XPAT-GFP, 
see Section 3.4), which is presented again in Figure 5.5D. These results suggest that 
nuclear entry is opposed by particle formation and/or anchoring. The domains of 
XPAT that cause particle formation, but not particle anchoring, are likely to be found 
in the N-terminal portion of XPAT protein. However, this is not true of the vegetal 
localisation domains since EC1 does not localise to the vegetal pole, unlike XPAT- 
GFP. 
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5.6 XPAT contains a putative NLS 
Xpat is a novel gene that encodes a 35 kDa protein with no known homologies. 
Although XPAT has no homology to any proteins, particular domains are of note. 
Figure 5.6 shows the amino acid sequence of XPAT; in this figure, basic and acidic 
residues are highlighted. The carboxyl terminal region of XPAT protein is rich in 
basic residues; indeed 15/53 amino acids at the C-terminus are basic. A basic region 
is a common characteristic of nuclear proteins such as transcription factors and 
histones, which bind to DNA. In the amino terminal half, XPAT contains a high 
number of acidic residues (aspartic acid and glutamic acid). 
Figure 5.6: XPAT contains a putative NLS 
MALKAEDSFD IYSQLIQSFC RYAENTTVSE SQSPAFNAQK EFQTCc? DHAC CTHSEAHTHI 60 
LMQQWQLLEE QWEYIDHLKT DVAALKQLLH GFMNSLSGTD SGMEGTNHFL PPHQNPTLLK 120 
DEEIVASALN RPSVDINGFE ENITTGAQIH AAFTKSPKKM PATSTPRKSE VLWSCSPTLA 180 
TDGYFMLPDI ILNPLDGKKL VSMLRSSNYE PHRFAELLFQ HHVPHSLFQL WANKVNFDGS 240 
RGKLGLPRNL MIDILHQTS®FVLGP1KEKR KIKT NLLL RTRQDRAWWD VGL 
The amino acid sequence of XPAT. XPAT contains a predicted putative bipartite NLS (blocked). Basic residues 
are highlighted in green, acidic residues in red, and leucine residues in blue. The C-terminal portion of XPAT is 
particularly rich in basic residues, which is a common feature of nuclear proteins. In contrast, the N-terminal 
region contains multiple acidic residues. 
Experiments with GFP-tagged XPAT indicate that XPAT protein could naturally be 
a nuclear protein. In particular, the ON proteins, which all lack the N-terminal region 
of XPAT protein, are localised specifically to the nucleus suggesting that XPAT 
contains a NLS in its carboxy-terminal portion. This is supported by sequence data 
(Figure 5.6), as XPAT contains a putative bipartite NLS in its C-terminal half. 
XPAT's putative NLS has features common to proven nuclear targeting sequences; 
these are typically short, generally less than 12 amino acids long, and contain one or 
two essential clusters of basic amino acids (Dingwall et al., 1982; Robbins et al., 
1991; Dingwall and Laskey, 1991). These structural and localisation features suggest 
that XPAT is a nuclear component, possibly functioning in germ plasm-specific 
transcriptional regulation. This hypothesis is further supported by in vitro binding 
assays (Chapter 6), which indicate that both XPAT and XPAT-GFP bind dsDNA. 
In contrast to the AN proteins, AC1 protein, which lacks the carboxy-terminal region 
of XPAT protein, is present in both the cytoplasm and the nucleus of Xenopus 
oocytes. This suggests that XPAT might contain a Nuclear Export Sequence (NES) 
in its amino-terminal half, in addition to an NLS in its carboxy-terminal half. NES 
motifs are typically leucine-rich and have a consensus sequence of 
LXLX(X)LXXLXUI (Nakielny and Dreyfuss, 1997; Feng et al., 1999). Whilst 
XPAT protein is very leucine-rich (35 out of its 293 amino acids are leucines - 
highlighted in blue in Figure 5.6), there is no obvious NES consensus sequence in its 
amino terminal half, or indeed anywhere in the protein. 
5.7 Discussion 
XPAT contains a putative bipartite NLS sequence in its carboxyl terminal half. It is 
also rich in basic residues, particularly in its carboxyl terminus, which is a common 
feature of nuclear proteins. Several large N-terminal deletions and one C-terminal 
deletion of XPAT protein were made to investigate possible XPAT domain structure. 
The C-terminal deletion protein, which lacked the putative NLS, was evenly 
distributed throughout the nucleus and cytoplasm. The N-terminal deletions became 
predominantly localised to the nucleus. None showed vegetal transport or granule 
formation, but 4.8 % of ANI expressing oocytes, which had a small protrusion of 
cytoplasm at the injection site, contained small particles (1-2 µm). Thus, particles 
can form with a small N-terminal deletion, but ANI cannot form larger granules or 
be transported to the vegetal pole. These two processes might therefore be coupled. 
One hypothesis is that ANI forms particles in protrusions because they cannot enter 
the nucleus. In the cytoplasm, particulate material gradually enters the nucleus 
(XPAT-GFP; see Section 3.3.3), but nuclei only contain soluble proteins. These 
observations suggest that nuclear entry is opposed by particle formation and/or 
anchoring, i. e.: 
Particle 4-> soluble protein -4 nucleus 
If ON1 particles were less stable than those of wild-type XPAT this might account 
for the progressive movement of fluorescence to the nucleus. It will be interesting to 
perform oocyte enucleation experiments with iN1 to assess where ANI protein will 
localise if nuclear entry is abrogated. 
142 
These results indicate that XPAT is not composed of totally independent domains 
and suggest that both the N-terminal and C-terminal regions of XPAT are required 
for its stable localisation to the vegetal pole. These data emphasise that nuclear entry 
is opposed by binding to cytoplasmic components, most likely microtubules, and 
possibly microfilaments. The ON deletion proteins presumably have enhanced 
nuclear localisation due to less cytoplasmic binding activity. These structural 
features, when taken in context with the localisation of wild-type XPAT, which also 
enters the nucleus, suggest that XPAT may be a nuclear component of Xenopus 
oocytes or PGCs. 
It is possible that the N-terminus and the C-terminus of XPAT are located spatially 
close to each other and form a microtubule- or microtubule-associated protein- 
binding surface. The finding that the deletion of either the N-terminus or the C- 
terminus affects localisation to the vegetal pole may also suggest that the stable 
localisation of XPAT to the vegetal pole requires optimal binding activity to 
microtubules or multiple interactions with cytoskeletal structures. Possibly there 
could be a microtubule and also a microfilament binding sequence in different parts 
of the protein. It could be that the overall conformation is affected. Particle formation 
may involve intermediate filaments or non-cytoskeleton protein(s). 
AC1 protein is less concentrated in the nuclei of oocytes than any of the AN proteins. 
Cytoplasmic fluorescence and localisation as determined by in vivo radiolabelling 
experiments indicate that AC1 is very strongly localised in the cytoplasm, much more 
so than any of the AN proteins. This implies that AC1 may enter the nucleus 
passively, whereas the ANs could be directed into the nuclei of Xenopus oocytes 
using XPAT's putative nuclear localisation signal. Another possibility is that AC I 
could contain a nuclear export signal so it is pushed back out into the cytosol, 
although no consensus NES has been found anywhere in XPAT. 
143 
Chanter 6: Functional studies withXPAT Part 1: RNA binding assays 
6.1 Introduction 
The common theme amongst germ plasm proteins and those encoded by germ plasm 
mRNAs is actual or postulated RNA-binding properties. For example, Xdazl 
contains an RNP domain implying an RNA-binding function and has subsequently 
been shown to function as an RNA-binding protein in vitro (Houston et al., 1998). 
Despite lack of homology to other RNA binding proteins, it was decided to do some 
preliminary experiments to determine whether XPAT could bind RNAs. 
Since potential in vivo RNA targets of XPAT are unknown, it was decided to test 
whether XPAT could function as an RNA-binding protein in vitro by using 
homopolymeric RNAs bound to beads. This assay has been used to characterise the 
RNA-binding properties of a variety of proteins (Swanson and Dreyfuss, 1988; 
Siomi et al., 1993). In order to do this, it was first necessary to clone the Xpat ORF 
into a vector which could be used to generate Xpat mRNA for use in in vitro 
translation reactions and also further experiments described in Chapter 7. 
6.2 The cloning of Xpat into a transcription vector 
In order to clone Xpat into a vector to enable its transcription, the ORF of Xpat was 
amplified from a cDNA library clone by PCR using primers that created 5' and 3' 
HindIII sites. The resulting PCR fragment was cloned into the Hindu site of 
pSPJC2L. Following ligation and transformation into DH5a cells, colony PCR was 
performed using a vector-specific upstream primer (SP6) and an insert-specific 
downstream primer. This was in order to determine whether Xpat had inserted into 
the vector and check its orientation in the vector was correct. Once the construct was 
made, restriction digests were performed on the DNA to confirm the orientation of 
the insert. The miniprep DNA was then sequenced on both strands to check whether 
any PCR-induced mutations had occurred. The sequence of this clone matched that 
of the cDNA library clone. Thus, in vitro coupled transcription and translation 
reactions were performed using Xpat DNA as a template. A fraction of this reaction 
was then resolved on a protein gel; this showed that XPAT had an apparent 
molecular weight of 35kDa, as expected (results not shown). 
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6.3 RNA binding properties of XPAT 
In order to test whether XPAT could function as an RNA-binding protein in vitro, an 
assay using homopolymeric RNAs bound to beads was used. This is the 
conventional approach to test RNA binding proteins (Swanson and Dreyfuss, 1988). 
To test the specificity of the assay, Xdazl was included as a positive control. Xdazl 
was previously shown to bind primarily to poly(G) and poly(U) at 100 mM NaCl 
and also weakly bind to poly(A) RNA sequences in the homopolymer assay 
(Houston et al., 1998). Xdazl behaved accordingly in experiments conducted at the 
same time as XPAT (Figure 6.1A), which were all performed in binding buffer at 
moderately high salt concentration (1 M NaCI). Xdazl was also seen to bind dsDNA 
in this assay. ß-galactosidase was included as a negative control for the assay (Figure 
6.1B), and bound none of the homopolymeric RNAs or dsDNA. These assays were 
originally attempted using binding buffer containing a lower salt concentration (100 
mM NaCI), however, non-specific binding to Sepharose 4B control beads was 
observed for both Xdazl and XPAT (data not shown). Thus, more stringent 
conditions were used (1 M NaCl) and these results are presented here. 
XPAT bound primarily to poly(C), poly(A) and poly(U) RNAs in 1M NaCl, and 
bound poly(G) RNA sequences and dsDNA at a level -3 times less than poly(C). 
XPAT did not bind to Sepharose 4B control beads (Figure 6.1C). XPAT was also 
able to bind poly(C) sequences in higher salt conditions (2M NaCl, data not shown) 
suggesting that the binding is mediated partially through base-specific hydrophobic 
interactions. From these experiments it is concluded that XPAT can function as an 
RNA-binding protein and may bind to C-, U- or A-rich RNAs in vivo. 
145 
A 
16 
148 
98 
B 64 
50 
50 
C 36 
22 
Figure 6.1 XPAT protein can bind RNA. 
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In vitro translated Xdazl, a previously characterised RNA-binding protein (A), 0- 
galactosidase, a negative control (B), or XPAT (C) were incubated with various 
homopolymeric RNA, dsDNA or control beads (Sepharose 4B) in binding buffer 
containing IM NaCl. After washing, eluted proteins were separated by SDS-PAGE and 
visualised by autoradiography. Mr (in kDa) is shown at the left of each autoradiograph. 
(T), aliquot of the initial translation corresponding to 20% of the input per binding 
reaction. A lower Mr Xdazl translation product was consistently generated- this product 
was most likely the result of translation initiation at an alternative methionine and 
bound homopolymeric RNAs with the same specificity as the full-length protein. 
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6.4 RNA binding properties of XPAT-GFP 
In vitro translated XPAT-GFP, iC1, ON3 or GFP (a negative control) were 
incubated with various homopolymeric RNA, dsDNA or control beads (Sepharose 
4B) in moderately high salt (1M NaCI). After washing, eluted proteins were 
separated by SDS-PAGE and visualised by autoradiography (shown in Figure 6.2). 
XPAT-GFP bound to poly(A), poly(U), poly(C) and poly(G) RNAs and also to 
dsDNA (Figure 6.2A); appearing to bind poly(C) at a level approximately 2-fold 
higher than the other homopolymeric RNAs. GFP bound to none of the 
homopolymeric RNAs or dsDNA (Figure 6.2B) and was thus a useful negative 
control for XPAT-GFP. iC1, which contained only the first 165 amino acids of 
XPAT, bound homopolymeric RNAs in a very similar manner to XPAT-GFP 
(Figure 6.2C). It bound poly(C) and poly(A) RNAs at a level approximately 2-fold 
higher than poly(G) or poly(U) and also bound dsDNA. It did not bind to control 
beads (Sepharose 4B). However, AN3 (lacking the first 159 amino acids of XPAT) 
bound all homopolymeric RNAs and dsDNA to equal levels. In contrast to all other 
proteins tested, AN3 also bound Sepharose 4B control beads at a similar level to 
RNA. This suggests that AN3 may be so variant and lacking in critical domains, or is 
so misfolded, that it binds non-specifically to beads. A lower Mr AN3 translation 
product was consistently generated; this product was most likely the result of 
translation initiation at an alternative methionine. Intriguingly, this lower Mr product 
bound homopolymeric RNAs, but not Sepharose 4B beads, with the same specificity 
as the full length ON3. Quite what can be concluded from this observation is not yet 
apparent. 
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Figure 6.2: XPAT-GFP, OC1 and ON3 proteins can bind RNA. 
In vitro translated XPAT-GFP (A), GFP- a negative control (B), Cl A(C), or ON3 (D) were 
incubated with various homopolymeric RNA, dsDNA or control beads (Sepharose 4B). After 
washing in buffer containing 1M NaCl, eluted proteins were separated by SDS-PAGE and 
visualised by autoradiography. Mr (in kDa) is shown at the left. (T), aliquot of the initial 
translation corresponding to 20% of the input per binding reaction. A lower Mr AN3 translation 
product was consistently generated - this product was most likely the result of translation initiation 
at an alternative methionine and bound homopolymeric RNAs (though not Sepharose 4B control 
beads) with the same specificity as the full-length protein. 
6.5 Discussion 
Preliminary experiments indicate that XPAT and XPAT-GFP proteins bind RNAs 
and can therefore function as RNA-binding proteins in vitro. Both proteins bound to 
all homopolymeric RNAs tested in vitro, but particularly strongly to poly (C) RNA. 
Indeed, XPAT could bind to poly (C) RNA in high salt conditions (2M NaCl). This 
suggested that the binding was mediated partially through base-specific hydrophobic 
interactions. XPAT and XPAT-GFP also bound to dsDNA in vitro. It is possible that 
ssDNA is a target of XPAT in vivo. 
The next step will be to determine if XPAT binds sequence specifically. One 
approach is to use the PCR-based SELEX method (Nieuwlandt et al., 1995; Klug 
and Famulok, 1994) to determine a consensus binding site. A disadvantage of this 
procedure is that, if successful, it will find the highest affinity sites, which may not 
be those used in vivo. However, this is still probably the most obvious approach and 
finding a specific sequence would confirm that XPAT is a novel RNA binding 
protein. There are a large number of maternal Xenopus ESTs on the database now 
and these could be searched for the relevant sites. It is likely that the target(s) would 
be a known or novel germ plasm RNA. A more complex approach is to use the 
yeast-3-hybrid system (SenGupta et al., 1996) but this would be more difficult to set 
up. 
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Chapter 7: Functional studies with Xpat Part II: Depletion and overexnression 
of Xpat mRNA in vivo 
7.1 Introduction 
Maternal Xpat mRNA is localised in the germ plasm of the full-grown oocyte 
(Hudson and Woodland, 1998). To address the function of maternal Xpat it was 
decided to attempt to use depletion analysis. This is frequently used to study the 
function of mRNAs in vivo, since one limitation of the Xenopus system is the 
inability to disrupt the function of a gene based on sequence alone, as is possible in 
mice through homologous recombination in embryonic stem cells. 
Two different methods were undertaken to attempt the depletion of Xpat from 
oocytes: 
(a) Depletion by antisense oligodeoxynucleotides (oligos). 
(b) The use of double-stranded RNA to silence gene expression. 
7.1.1 Depletion of Xpat mRNA by antisense oligodeoxynucleotide injection 
This method is frequently used to cause the specific depletion of mRNAs in vivo. For 
example, the elimination of maternal VegT mRNA was achieved by injection of 
antisense oligos into the vegetal poles of defolliculated oocytes (Zhang et al., 1998). 
In total, 12 antisense oligos were designed that were complementary to regions of the 
Xpat Open Reading Frame (ORF). It was necessary to design a number of oligos 
because it was not possible to predict which would work. It is not uncommon to find 
that many do not; for example, Zhang et al. (1998) designed a total of 12 oligos to 
attempt degradation of VegT, and only one was able to deplete this mRNA 
substantially. The oligos were all 18-mers, and were synthesized in a more stable 
modified form in which the 5' and 3' terminal four bases were linked by 
phosphorothioate linkages instead of the conventional phosphodiester bonds. 
Each oligo was injected into stage VI oocytes, which were then cultured in 50% 
Leibowitz medium for 42 hours to allow formation and consequent degradation of 
the oligo: RNA hybrid. Total RNA was then extracted and RT-PCR analysis was used 
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to determine whether any of the oligos reduced Xpat mRNA levels significantly, 
compared to control oocyte levels. 
Firstly, 5 oligos were tested (asXpat 1-5) to determine whether they could inhibit 
Xpat expression. Duplex PCR was performed using primers for ornithine 
decarboxylase (ODC) as a loading control and Xpat PCR primers in the same 
reaction. None of these oligos caused any obvious reduction in Xpat mRNA levels 
(Figure 7.1A). Thus, another 6 oligos were tested. None of these oligos caused a 
reduction in the amount of endogenous Xpat mRNA assayed by RT-PCR (Figure 
7.1. B). In this next set of duplex PCRs, EFIa was used as a loading control, because 
a greater size difference between the Xpat and EFla PCR products was discernible 
compared to Xpat and ODC PCR products. 
A twelfth oligo (designed by A. Chan) was shown by triplex quantitative RT-PCR 
analysis (Figure 7.1. C) to noticeably reduce the amount of endogenous Xpat mRNA, 
when injected into oocytes. As a control to show that the injection procedure was 
working, an antisense oligo to VegT was used. This oligo had previously been shown 
by Zhang and co-workers (Zhang et al., 1998) to deplete VegT from Xenopus 
oocytes. And, in this experiment, the same effect was seen when assayed by RT-PCR 
(Figure 7.1. C). EFIa was again used as a loading control in this triplex PCR 
reaction. 
7.1.2 The use of dsRNA to attempt to deplete Xpat mRNA from oocytes 
A second way to deplete mRNAs in vivo is to introduce double-stranded RNA into 
organisms to interfere with gene function. The term RNA interference (or "RNAi", 
Reviewed by Sharp, 1999) was initially coined by Fire and co-workers to describe 
the observation that dsRNA can potently and specifically inhibit gene activity when 
introduced into the nematode Caenorhabditis elegans (Fire et al., 1998). Their 
discovery was built upon the previous observation that sense and antisense RNAs 
were equally effective in suppressing specific gene expression (Guo and Kemphues, 
1995), a paradox resolved by the discovery that small amounts of dsRNA 
contaminate sense and antisense preparations (Fire et al., 1998). RNAi has since 
been discovered in a wide variety of organisms including Drosophila (Kennerdell 
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Figure 7.1: Attempts to deplete Xpat mRNA by antisense oligodeoxynucleotide injection. 
(A) 5 oligos designed to Xpat (asXpatl -5) were injected into stage 
VI Xenopus oocytes each at l Ong per oocyte. After 42 
hours in culture, RNA extraction, cDNA synthesis and duplex PCR (using primers to Xpat and 
ODC) were performed. PCRs 
were run on 2% agarose gels. (B) 6 further oligos (asXpat 6-11)and dsXpat RNA were all injected 
into oocytes at IOng per 
oocyte and PCRs performed as in (a) using primers to EFIa and Xpat. (C) asVegT and asXpat12 oligos were 
injected into 
oocytes at lOng per oocyte. Triplex RT-PCRs were done as in (a) using primers to EFla, VegT and 
Xpat. (D) asVegT and 
dsXpat were injected into oocytes at lOng per oocyte. Oocytes were cultured and triplex RT-PCR done as 
in (a), using 
primers to EFIa, VegT and Xpat. 
and Carthew, 1998), zebrafish (Wargelius et al., 1999) and mice (Wianny and 
Zernicka-Goetz, 2000) and appears to be related to gene silencing phenomena in 
plants ("cosuppression"). dsRNA homologous to a target gene can direct the 
sequence specific degradation of mRNA and dramatically decrease endogenous gene 
expression; thus, this process of RNAi occurs post-transcriptionally (Montgomery et 
al., 1988). The biochemical mechanism of RNAi is still unclear, with recent 
advances including the reconstitution of interference in vitro (Tuschl et al., 1999). 
However, dsRNA might be a useful method to determine gene function in Xenopus 
laevis. 
To determine whether dsRNA-mediated interference could be used to knock-out 
Xpat, dsRNA specific for the entire ORF of Xpat was synthesized in vitro. Sense and 
antisense RNAs for Xpat were synthesized simultaneously from a single PCR 
derived template. This was achieved by the use of primers that contained T7 
promoter sequences on their 5' ends. It was unnecessary to perform an annealing 
reaction on RNA products that were derived from the double T7-PCR templates, 
since RNAs self-anneal during synthesis (Kennerdell and Carthew, 1998). The ORF 
region of Xpat was chosen as a template to generate dsRNA since dsRNA segments 
corresponding to coding regions produce RNAi whereas non-coding regions (such as 
promoters and introns) do not (Fire et al., 1998). Xpat has no known homologies it is 
thus unlikely that its ORF region will interfere specifically with any other DNA. 
The dsRNA for Xpat was injected into stage VI Xenopus oocytes at a dose of 10-50 
ng per oocyte. The oocytes were cultured in vitro for 42 hours and then total RNA 
was extracted and Xpat mRNA analysed by RT-PCR. The Xpat primers used were 
specific for endogenous Xpat, since the template for dsRNA contains Xpat's ORF 
only, and the PCR primers used to detect Xpat are within the 3'UTR region. Duplex 
PCR, using EFlct as a loading control, (Figure 7.1. B) initially showed that dsRNA 
was able to substantially reduce the level of endogenous Xpat mRNA compared to 
control levels. Quantitative triplex RT-PCR was then performed using primers to 
VegT, EFI a and Xpat (Figure 7.1. D). RNA extracted from oocytes depleted of VegT 
was also used in one of these triplex PCR reactions as a control. These triplex PCRs 
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confirm that dsRNA can substantially reduce endogenous levels of Xpat, to 
approximately 25% of the level seen in uninjected (control) oocytes. 
7.1.3 RT-PCR analysis of other germ plasm mRNAs in oocytes depleted of Xpat 
Since antisense oligo asXpat12 gave the best reduction in Xpat mRNA levels, it was 
decided to use this method of depleting Xpat from oocytes in further experiments. 
This was also the best method to use as the VegT antisense oligo gives a useful 
control for the experiment. The VegT results show that the effects of the asXpat oligo 
are specific to that oligo, and are not a consequence of the injection or toxicity of the 
oligo. The results obtained when dsXpat was injected are shown for comparison, but 
this approach was not pursued because it appeared less effective. 
The next set of experiments was to determine the effect that Xpat depletion had on 
other RNAs within the Xenopus oocyte. Stage VI Xenopus oocytes were injected 
with either long asXpatl2, long asVegT or long dsXpat and then cultured in vitro in 
50% Leibowitz medium for 42hours. RNA was extracted and RT-PCR used to 
analyse the effect of the depletion on other localised RNAs. Figure 7.2 shows the 
results of these quantitative RT-PCRs. ODC was used as a loading control and it 
should be noted that slightly less cDNA was added to each of the asXpat PCRs 
compared to the control samples. 
The PCRs indicate that VegT mRNA levels have, as expected, been reduced 
substantially in oocytes injected with asVegT (to less than 10% compared to 
uninjected control). None of the other mRNA levels (Xpat, /3-catenin, fatvg, Xcat-2, 
DEADsouth, Xdazl or XVLG1) seem affected, with the exception of Vg1. Levels of 
Vg1 mRNA are increased to 4 times their control level, in oocytes that have been 
depleted of VegT. The implication of this result is not known, although VegT, like 
Vg1, is localised by the late pathway (Kloc and Etkin, 1995; Lustig et al., 1996; 
Stennard et al., 1996; Mang and King, 1996; Horb and Thomsen, 1997). It has also 
been reported recently that VegT mRNA has been detected in the germ plasm in 
cleavage stage embryos (unpublished, cited in Chan et al., 2001). 
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Figure 7.2: RT-PCR analysis to determine the effects of depleting Xpat mRNA from 
oocytes. 
Xenopus oocytes were injected with either l Ong of asVegToligo, l Ong of asXpat12 oligo, l Ong 
of dsXpat RNA or left uninjected. The oocytes were cultured in vitro in 50% Leibowitz 
medium at 18° for 42 hours and then RNA was extracted, cDNA synthesised and PCRs 
performed and resolved on 2% agarose gels. Each PCR set included 3 negative controls to 
show there was no contamination (-RT, -cDNA and -RNA) and 4 linearities to show 
PCRs 
were in the exponential phase and thus quantitative. 
The asXpat PCRs show that, as expected, Xpat levels are reduced, again to less then 
10% that of uninjected control amounts. However, levels of VegT, Vgl, ß-catenin, 
fatvg, Xcat-2 and Xdazl seem unaffected by the depletion of Xpat mRNA, whereas 
amounts of DEADsouth and XVLGI mRNAs seem reduced in asXpat-injected 
oocytes, to 50% of the level seen in the control (uninjected) oocytes. 
However, the dsXpat injection has given somewhat unexpected results, completely 
different to those shown by the asXpat injection. It is interesting to note that the 
reduction in levels of Xpat by dsRNA is less noticeable in the single PCRs (shown in 
Figure 7.2) than in the multiplex PCRs (shown in Figure 7.1), despite the fact that 
exactly the same cDNA was used. This is the opposite effect to what is seen with the 
asXpat. In Figure 7.2 the asXpat depletion of Xpat is more noticeable than in Figure 
7.1 as fewer cycles were used in the single PCR than in the multiplex to ensure that 
the PCRs were quantitative and in log phase. So, although the dsXpat RNA has 
caused a reduction in Xpat levels, it is only to about 70% that of the control. 
Amounts of fl-catenin, DEADsouth and XVLG1 have been unaffected by the 
injection of dsXpat. However, VegT, Vgl and Xcat-2 levels have substantially 
increased (to between 2 and 4 times control levels); and fatvg and Xdazl levels have 
also increased by about 50% in dsXpat-injected oocytes. Thus, the dsXpat RNA 
seems to be a having a more extreme and widespread effect in the oocyte than the 
antisense oligo, and results in a fairly ubiquitous alteration in mRNA content, 
including non-germ plasm determinants. These results imply that the introduction of 
dsRNA into Xenopus oocytes has a non-specific effect, as reported in zebrafish 
(Oates et al., 2000; Zhao et al., 2001b). In order to confirm that the introduction of 
any dsRNA (and not simply dsXpat) has this effect, a control dsRNA would need to 
be made and introduced into oocytes and assayed in the same way. However, the 
dsRNA approach was not followed further. In contrast, the antisense method has 
been shown to give good depletion of Xpat and causes specific reduction in levels of 
two germ plasm-specific mRNAs (XVLGI and DEADsouth), thus the antisense oligo 
(asXpatl2) was used in in situ hybridisation experiments. 
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7.1.4 In situ hybridisation analysis of germ plasm mRNAs in oocytes depleted of 
Xpat 
Stage VI Xenopus oocytes were each injected with 10 ng of asXpatl2 to deplete Xpat 
mRNA. These oocytes, and some uninjected controls, were then cultured in OCM for 
42 hours at 18°C and fixed. In situ hybridisation to germ plasm-specific molecules 
was then performed to analyse the effects of this depletion on other localised 
mRNAs. Figure 7.3 shows results of these in situ hybridisations. 
In situ hybridisation to Xpat mRNA was performed using an antisense riboprobe 
containing the ORF of Xpat. Control oocytes show a disc of fine particles of Xpat 
expression in the vegetal pole, as expected. Oocytes injected with asXpatl2 show no 
expression of Xpat mRNA in the oocyte at all. Thus, Xpat mRNA has been depleted 
(Figure 7.3). This result agrees with the RT-PCR result shown in Figure 7.2. 
Xcat-2 nmRNA is localised in a very similar disc on the vegetal pole in control 
oocytes. This is smaller than that of Xpat expression (see Tables 7.1 and 7.2 in 
Section 7.2.4). In Xpat-depleted oocytes, Xcat-2 expression looks the same as in 
control oocytes; that is, the disc of expression appears to be the same size, as do the 
particles themselves. 
Likewise, Xdazl mRNA is expressed in a disc of particles on the vegetal pole of 
uninjected oocytes. In Xpat-depleted oocytes, Xdazl mRNA is expressed in the same 
pattern, and the domain of expression is the same size. 
DEADsouth is expressed in the vegetal pole of control oocytes in fine particles that 
form a disc. In Xpat-depleted oocytes, DEADsouth expression is not detectable by in 
situ hybridisation. This confirms the RT-PCR result (Section 7.1.4), that removal of 
Xpat mRNA also reduces DEADsouth mRNA levels. 
mtlrRNA is expressed in the vegetal pole of oocytes in fine particles. These do not 
always appear in a disc shape and in the photograph shown in Figure 7.3, the 
expression domain is shaped like a tear-drop. In Xpat-depleted oocytes, mtlrRNA is 
still expressed in fine particles in the vegetal region, again in a pattern that is not 
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Figure 7.3 in situ hybridisation analysis of various germ plasm mRNAs in oocytes depleted of 
Xpat mRNA. 
Stage VI Xenopus oocytes were each injected equaUxially with 10 ng of asXpul-12 oligo and 
cultured in vilro at 18°C fror 42 hours in 50 (I Leibowitz medium. Oucytes were then fixed and in 
sirrt hybridisation was performed using a riboprohe specific for Xput, Xrut-2, Xdu,. l, 1)LAI)South or 
nºNrRNA (as indicated at the left hand side of photographs). Each oocyte is -1.2 mm in diameter. 
Control (uninjected) 
always disc-like in shape. In the photograph in Figure 7.3 the domain is lateral to the 
vegetal pole, in a disc shape. It is not likely that Xpat depletion has affected the 
localisation of mtlrRNA, simply that there is a natural variation of mtirRNA 
expression between oocytes. 
7.1.5 Xpat mRNA elimination in embryos 
Phosphorothioate oligos used in depletion studies in oocytes are toxic and unstable in 
fertilised eggs (Kofron et al., 1997) and so the experiments involved injecting such 
oligos into oocytes. Injected defolliculated oocytes can be cultured in vitro and then 
fertilised using the host-transfer technique (Heasman et al., 1991). This technique 
has not been widely used because it is difficult and is not applicable to zygotic 
mRNAs. However, A. Chan and L. Etkin have attempted this technique and have 
fertilised oocytes that have been depleted of Xpat (by asXpat 12). They saw no 
obvious germ cells in embryos resulting from such fertilisations and a rescue 
experiment using Xpat mRNA is currently being attempted. 
7.1.6 Use of a morpholino oligo- an in vitro assay to determine if translation of 
Xpat can be inhibited 
An alternative loss-of-function approach is to use a "morpholino" oligo (Summerton 
and Weller, 1997) directed against Xpat mRNA. This acts, not by degrading RNA, 
but by preventing translation of protein. Such morpholino oligos are not toxic to 
embryos (Heasman et al., 2000). Morpholino oligos have substitutions of the 
riboside moieties with nitrogen-containing morpholine moieties and are 
phosphorodiamidate linked (Summerton and Weller, 1997). These oligos are very 
stable and the mRNA/morpholine complex is not recognised by RNAse H and thus 
not degraded. Morpholino oligos work solely by a steric translational block 
mechanism. 
An in vitro assay was designed which was a variation on the standard rabbit 
reticulocyte lysate (RRL) in vitro translation system. The rationale was to assay 
whether the presence of a morpholino oligo designed to prevent translation from a 
particular mRNA could do so directly and specifically in this system. Each mRNA 
and morpholino was allowed to interact directly for 15 minutes at 30°C, then the 
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standard RRL in vitro reaction mix (including 35S-methionine) was added and the 
translation allowed to continue for a further 90 minutes. The translation products 
were then resolved on a standard 12% acrylamide gel and autoradiographed. 
Firstly, it was necessary to determine whether this system actually worked. 
Therefore, a morpholino oligo designed to a region of the 5' UTR of Xsoxl7ß, and 
mRNA to Myc-tagged Xsoxl7ß (Xsoxl7fi-myc) that contained its 5'UTR region, 
were annealed in vitro (this construct was provided by D. Clements). Xsoxl7ß was 
chosen as it had previously been shown, by immunoprecipitation using an anti-myc- 
antibody, that the Xsox17(3 morpholino had inhibited translation of the Xsoxl7ß-myc 
mRNA in Xenopus embryos (D. Clements, unpublished data). 
3 different morpholino oligos were separately reacted with each mRNA used in this 
system. These morpholino oligos were: 
(a) Xsox17 (3 morpholino, 
(b) Xpat morpholino, 
(c) Standard control morpholino (designed by Gene Tools LLC). 
These were used so that it could be determined whether inhibition of translation was 
specific or simply due to the presence of the morpholino side chain. For each mRNA 
used, two different ratios of mRNA: morpholino were used: 
0.02 µg mRNA: 0.25 µg morpholino (a 10 excess of morpholino) and, 
0.02. tg mRNA: 2.5 tg morpholino (a 100-fold excess of morpholino oligo). 
Figure 7.4A shows an in vitro translation assay using Xsox17ß mRNA as a template. 
0.25 . tg and 2.5 µg of control morpholino and 0.25 µg and 2.5 µg of Xpat 
morpholino have no effect on translation of Xsoxl7ß compared with control 
translation levels (with no morpholino). However, 0.25µg Xsoxl7ß morpholino 
reduces translation to 10% of control and 2.5 µg of Xsox17(3 morpholino reduces 
translation to 1% of control levels. This mimics the in vivo results, namely that in the 
presence of Xsoxl7(3 morpholino translation of Xsoxl7ß mRNA is specifically 
reduced. 
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Thus, this assay appears to be a useful tool in determining whether a morpholino 
oligo has a specific effect in vitro and is thus likely to be useful to specifically inhibit 
translation in vivo. 
Figure 7.4B shows an in vitro translation assay using Xpat mRNA as a template. The 
mRNA generated contained the 5' UTR and ORF of Xpat since the Xpat morpholino 
is complementary to 25 nucleotides in the 5' UTR region. 0.25 pg and 2.5 µg of both 
control and Xsoxl7ß morpholinos have no effect on translation compared to control 
translation levels (no morpholino). However, 0.25 µg Xpat morpholino reduces 
translation to 50% of control levels and 2.5 tg Xpat morpholino only reduces 
translation to -- 30% of control levels (Figure 7.4B) 
Thus, it does not seem that this morpholino, designed to inhibit translation of Xpat 
mRNA, is having any great effect. This assay was repeated several times in vitro, and 
each time, the same results were seen. Since the morpholino has no real effect in an 
assay where mRNA and morpholino interact directly, there seems little likelihood of 
the morpholino having an effect in a much more complex system in vivo in a 
Xenopus oocyte. Indeed, on injection of this morpholino oligo into both cells of a 2- 
cell stage embryo and subsequent in situ hybridisation for Xpat in stage 36 and stage 
44 embryos (as Xpat is the only useful known marker for PGCs at these stages) no 
change in phenotype was seen. PGC numbers were unaffected and PGCs localised 
correctly. Thus, it appears this morpholino is not a useful tool to aid elucidation of a 
role for XPAT protein specifically in germ plasm or PGCs of Xenopus. It is 
important to note that correspondance between cell free and in-cell activities of 
morpholinos has been previously reported (Taylor et al., 1996). 
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Figure 7.4: In vitro translation reactions using (A) Xsox17ß(B) Xpat mRNA as a template. Prior to 
addition of translation reagents (rabbit reticulocyte lysate plus 35S-methionine), 0.02µg of mRNA was 
allowed to react with 0.25µg or 2.5µg of morpholino oligo (as indicated) for 15 minutes. Three 
different morpholinos were used, one specific for the 5' UTR of Xpat (Xpat morpho), one for 
XSox 170 (Sox morpho) and a Control morpholino. The reactions were resolved by 12% SDS-PAGE 
and autoradiographed. 
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7.2 Overexpression of Xpat mRNA in Xenopus 
7.2.1 The use of overexpression studies 
Overexpression studies are another useful tool for determining the role of mRNAs in 
development. In Xenopus embryos, studies of the genes and activities responsible for 
patterning are based mainly on gain-of-function experiments by injection of synthetic 
mRNAs in either whole embryos or explants. Such studies can show that a gene is 
sufficient to carry out a certain function, but not whether it is required in vivo. Taken 
together, overexpression and depletion analysis can reveal a lot about the potential 
functions of a gene in vivo. 
7.2.2 The effect of Xpat overexpression in embryos 
Overexpression studies were attempted in embryos. Both cells of 2-cell stage 
Xenopus embryos were injected vegetally with 0.5 ng Xpat ORF mRNA. Embryos 
were then fixed and assayed at subsequent stages of development (stages 36 and 44). 
In situ hybridisation analysis was performed, using antisense Xpat UTR as a 
riboprobe. No alteration in PGC numbers or migration was detected when compared 
with control embryos of the same developmental stage; in fact, no obvious phenotype 
was seen. 
7.2.3 The effect of overexpressing Xpat mRNA in oocytes 
Stage VI Xenopus oocytes were each injected with -20 ng Xpat mRNA and then 
cultured in 50% Leibowitz medium for 42 hours at 18°C. RNA was extracted and 
RT-PCR used to analyse the effects of this overexpression on other localised RNAs. 
Figure 7.5 shows results of these quantitative RT-PCRs. ODC is used to show that 
loading is equal for each sample used. 
The Xpat mRNA injected contains only Xpat ORF- not its 5' or 3' UTR. Thus, PCR 
using primers specific to Xpat's ORF show that there is much more Xpat ORF in the 
injected than in uninjected oocytes. Similarly, PCR using primers specific to Xpat's 
3'UTR show that there are equal amounts of Xpat UTR in both control (uninjected) 
oocytes and in the sample containing over-expressed Xpat ORF mRNA. VegT levels 
are equal in both samples as are Vgl, fl-catenin and fatvg. Of the germ plasm- 
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Figure 7.5: RT-PCR analysis to determine the effect of over-expressing Xpat mRNA in 
Xenopus oocytes. 
20ng of Xpat mRNA was injected per oocyte, oocytes were cultured in vitro in 50% 
Leibowitz medium at 18°C for 42 hours and then RNA was extracted, cDNA synthesised and 
PCRs performed and run on 2% agarose gels. Negative controls were included in each set of 
PCRs (-RT, -RNA and -cDNA). Linearity curves were run for each marker used (as shown in 
figure 7.2) to show that RT-PCRs were all in exponential phase and thus quantitative. 
specific clones sampled, Xcat-2 and Xdazl had the same levels in control oocytes as 
in oocytes overexpressing Xpat. However, a two-fold increase in the level of both 
DEADsouth and XVLG-1 was observed in oocytes injected with Xpat mRNA, 
compared to controls. 
7.2.4 In situ hybridisation of other germ plasm markers in oocytes 
overexpressing Xpat 
Stage VI Xenopus oocytes were each injected with 20 ng of Xpat mRNA, cultured in 
50% Leibowitz medium for 42hours at 18°C, and then fixed. In situ hybridisation to 
germ plasm-specific molecules was then performed to analyse the effects of this 
overexpression on other localised RNAs. Figure 7.6 shows the results of these in situ 
hybridisations. 
The injected Xpat mRNA contains only Xpat's ORF. Thus, in situ hybridisation to 
Xpat was performed using an antisense riboprobe containing only the ORF of Xpat. 
This probe detects both endogenous and injected Xpat mRNA. Control (uninjected) 
oocytes show a disc of fine particles of Xpat expression in the vegetal pole, as 
expected. Oocytes overexpressing Xpat contain much larger granules of Xpat mRNA 
spread over a much wider area (Figure 7.6). These overexpressing oocytes also 
contain a patch of injected Xpat mRNA, similar to that seen in oocytes injected with 
Xpat-GFP (see Section 3.5 and Figure 3.7). 
Xcat-2 expression is again found in a very similar disc on the vegetal pole in control 
oocytes. However, it does appear to be more compact than Xpat expression. The 
expression pattern of Xcat-2 in oocytes overexpressing Xpat appears very similar to 
that of control Xcat-2 expression. However, the particles of Xcat-2 expression do 
appear slightly larger in oocytes overexpressing Xpat than in control ones (Figure 
7.6). 
Expression of Xdazl mRNA in uninjected oocytes was again seen in a disc of 
particles at the vegetal pole, similar in area to Xpat. Xdazl mRNA expression in 
oocytes overexpressing Xpat is again across the vegetal pole, but in many oocytes 
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Figure 7.6 In situ hybridisation analysis of various germ plasm mRNAs In ooocytes uverexpressing Xpat. 
Stage VI Xenupu. e o cytes were each injected equatorially with 20ng o(Xput mRNA and cultured in i ilru in 50 r7r Leibowitz 
medium for 42 hours at 18"C. Oocytes were then fixed and in situ hybridisation was performed using a rihoprobe specific for 
Xput ORF, Xeat-2, Xduzl, DIA/). South or rntlrRNA (as indicated at the left hand side ul photograph). Xput ORF rihupmhe was 
designed to hybridise to both endogenous Xpat and injected Xpat mRNA. When oocytes overexpressing Xput were hybridised in 
situ with Xpat ORF rihuprobe, background staining was very dark and no particular expression pattern was ubviuus. These 
oocytes were all cleared in Murray's and no internal Xput expression was seen. On subsequently placing oocytes into IIXM% 
methanol, granules of Xput mRNA were visible, but staining became purple in colour and thus appeared different to other 
x cytes hybridised in . situ with other rihoprobes. Each oocyte 
is -1.2 mm in diameter. 
this region appeared wider spread than control Xdazl expression. The particles were 
similar in size in both cases. DEADsouth mRNA forms a disc in control oocytes of 
around the same area as Xdazl and Xpat expression. However, in oocytes 
overexpressing Xpat, DEADsouth expression seems to be over a smaller area and 
there appear to be more particles of DEADsouth mRNA but they are smaller in size 
than those particles seen in control oocytes (Figure 7.6). 
mt1rRNA (mitochondrial RNA) expression was also studied. mtlrRNA expression is 
not in a disc, but is seen in different shapes on the vegetal pole. For example, in 
Figure 7.6, a tear-drop shaped pattern of expression is seen in the control oocyte. 
Likewise, in Xpat-overexpressing oocytes, the expression pattern is not in a disc, but 
in a kind of elongated oval. It does not seem that overexpressing Xpat has any effect 
on mt1rRNA, the particles are the same size and density it is more likely that the 
pattern of mtlrRNA expression is naturally variable. 
In order to determine whether the differences that were seen in expression pattern 
diameter of these molecules is statistically significant, the student's T-test was 
performed. Firstly, the diameter of the disc of expression in oocytes was measured 
using an eye-piece graticule on a dissecting microscope. The eye-piece graticule was 
calibrated using a micrometer slide. 
Table 7.1 shows the mean diameter of expression of Xcat-2, Xdazl and DEADsouth 
in control and Xpat-overexpressing oocytes. The raw data is presented in Appendix 
1. 
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Table 7.1: Means and variance for germ plasm diameter in Xenopus oocytes 
injected with Xpat mRNA 
This was determined by in situ hybridisation to various germ plasm components. 
OOCYTE: ISH probe Mean 
(epu) 
Mean 
(m) 
Variance Number of 
oocytes (n) 
CONT: Xcat-2 20.9 522.5 11.5 14 
XPAT: Xcat2 18.6 465.0 7.44 15 
CONT: Xdazl 26.9 672.5 11.57 8 
XPAT: Xdazl 29.0 725.0 9.43 21 
CONT: DEADsouth 26.5 662.5 12.25 2 
XPAT: DEADsouth 20.4 510.0 2.44 10 
CONT: X pat ORF 27.0 675.0 15.2 20 
Control (uninjected) oocytes or oocytes injected with 2 ng of Xpat mRNA were cultured in vitro for 
42 hours and then in situ hybridisation was performed. CONT= control (uninjected) oocytes, XPAT= 
oocytes overexpressing Xpat mRNA. ISH probe= riboprobe used in in situ hybridistion, Xcat-2=Xcat- 
2 riboprobe, Xdazl=Xdaz1 riboprobe, DEADsouth=DEADsouth riboprobe, Xpat ORF= riboprobe 
specific for Xpat's ORF. The diameter of the expression domain of each germ plasm RNA was 
measured using an eye-piece graticule in a dissecting stereomicroscope. The first column shows mean 
(Idiameters / n) in epu (eye piece graticule units), where n is the total number of oocytes measured. 
This was converted into p. m (after the graticule had been calibrated). Variance is (Ediameters)2/n - 
mean2 and is a measure of the differences in the means. Raw data is shown in Appendix 1. 
The means and variance were then converted into T-values for use in the student's T- 
test. This test compares 2 sets of data. Table 7.2 shows which sets of data were 
compared and also T-values and critical T values. The critical T value is taken at the 
95% level of significance for the appropriate degrees of freedom from statistical 
tables, (degrees of freedom = total number of oocytes (for both sets of data) -2). 
Table 7.2: T values for student's T-test, comparing germ plasm diameter 
OOCYTEIISH robe T-value Critical T-value Significant? 
CONT: Xdazl +X pat 0.067 2.056 X 
CONT: Xcat-2 + Xpat 4.88 2.042 
CONT: Xdazl + Xcat-2 3.984 2.086 
CONT: Xdazl + Dsouth 0.145 2.306 X 
CONT: Dsouth +X pat 0.191 2.086 X 
CONT: Dsouth + Xcat-2 2.125 2.145 X 
XPAT+ CONT: Xcat-2 2.00 2.052 X 
XPAT+CONT: Dsouth 2.417 2.228 4 
XPAT+CONT: Xdazl 1.525 2.052 X 
CONT= control (uninjected) oocytes, XPAT= oocytes overexpressing Xpat mRNA. 
ISH probe=riboprobe used in in situ hybridisation, Xdazl= Xdazl riboprobe, Xpat= riboprobe specific 
for Xpat's 3'UTR, Xcat-2=Xcat-2 riboprobe, Dsouth= riboprobe specific for DEADsouth. 4= statistically significant, X=NOT statistically significant. 
Thus, there is no significant difference between the diameter of expression of Xdazl 
and Xpat in control oocytes; likewise, comparing diameter of expression domains of 
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Xdazl + DEADsouth, Xpat + DEADsouth and Xcat-2 + DEADsouth in control 
oocytes shows no significant difference in diameter (Table 7.2). 
However, comparing Xcat-2 and Xpat diameters in control oocytes shows there is a 
significant difference. That is, the Xcat-2 expression domain is significantly smaller 
then Xpat's. Also, comparing Xcat-2 and Xdazl diameter in control oocytes, a similar 
result is obtained. That is, Xcat-2's expression domain is significantly smaller than 
Xdazl's. 
The same is NOT seen for DEADsouth and Xcat-2, but this could be due to the fact 
that only two oocytes were scored for DEADsouth control diameter. Thus, the 
variance is quite large and degrees of freedom smaller than might otherwise be seen. 
A greater number of control oocytes that have been in situ hybridised for DEADsouth 
mRNA expression need to be scored to be confident of a significant result. 
These findings are likely to be important. This is because it seems that Xcat-2 is 
expressed in only a subset of the granules that express Xpat and Xdazl and this has 
not been noted before. It is not self evident from the results presented here, or indeed 
any published, that any germ plasm RNAs are localised in the same granules. Double 
in situ hybridisation will be necessary to clarify this point. 
Comparing Xcat-2 expression domains in control oocytes and those overexpressing 
Xpat shows no significant size difference (Table 7.2). Likewise, for Xdazl there is no 
significant difference between control and Xpat overexpressing oocytes. However, 
when comparing DEADsouth in control oocytes and those overexpressing Xpat, a 
significant difference in diameter is seen. Thus, the diameter of DEADsouth 
expression is less in Xpat overexpressing oocytes than in control oocytes. Since 
DEADsouth expression diameter is not different from Xcat-2, Xpat or Xdazl domains 
in control oocytes, this result does appear to be a significant one. 
These results are different from those seen in oocytes injected with Xpat-GFP 
mRNA (see Table 3.5), where overexpression of XPAT-GFP has a significant effect 
on Xcat-2 expression 72 hours after injection. This difference could be due to the fact 
that the Xpat-GFP injected oocytes were fixed 72 hours after injection, not 42 hours. 
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Also, 10 times more mRNA was injected into oocytes in the experiments described 
here than in those in Section 3.6 and Xpat-injected oocytes were not cultured in the 
presence of serum, unlike Xpat-GFP-injected oocytes. 
7.3 Discussion 
Two different methods were attempted to deplete Xpat mR. NA from Xenopus 
oocytes- the use of antisense oligodeoxynucleotides and dsRNA. asXpatl2 was more 
effective than dsXpat at this depletion and dsXpat caused nonspecific changes to 
levels of mRNA. Since the gene dosage is too small in an oocyte to have a significant 
impact on maternal mRNAs (Woodland, 1982), it is possible that levels of mRNAs 
in oocytes decrease naturally with increasing time in culture; although actual levels 
of mRNAs after various times in culture were never directly compared. Thus, 
possibly dsXpat has a general stabilisation effect in cultured oocytes and prevents 
mRNA degradation, whereas Xpat mRNA, or the protein it encodes, could have a 
specific stabilising effect on DEADSouth and XVLGJ mRNAs. Xpat (or XPAT 
protein) could therefore stabilise DEADSouth and XVLG1 and prevent their normal 
degradation by nucleases in the oocyte. Since injection of asXpat12 has the opposite 
effect to injection of Xpat mRNA on DEADSouth and XVLGJ, it is hypothesised that 
removal of Xpat mRNA from the oocyte (by asXpatl2-induced degradation) causes 
the stabilising effect of Xpat on DEADSouth and XVLG1 to be removed. These 
mRNAs thus become subject to attack by nucleases. 
In situ hybridisation and RT-PCR analysis gave the same result for DEADSouth. It 
would be interesting to determine whether in situ hybridisation to XVLG1 in Xpat- 
depleted oocytes would confirm the RT-PCR result. When Xpat mRNA was 
overexpressed in oocytes, more particles of DEADSouth were detected by in situ 
hybridisation than in controls. Similarly, RT-PCR indicated that increased levels of 
DEADSouth mRNA were present in oocytes overexpressing Xpat. RT-PCR revealed 
increased levels of XVLG1 mRNA in oocytes injected with Xpat mRNA; in situ 
hybridisation analysis has not yet been performed. 
The in situ hybridisation results presented in this chapter suggest that there are 
distinct sets of granules within the germ plasm. Where endogenous granules behave 
differently (i. e. the distribution of Xcat-2 looks different to that of Xpat and Xdazl), 
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the only reasonable interpretation is that there are different sorts of granules. This 
model fits the distribution of some of the granules discussed here, although it will be 
necessary to perform double in situ hybridisation analysis to confirm this hypothesis. 
Conversely, where an effect is seen after injection of Xpat mRNA into oocytes (e. g. 
greater numbers of DEADSouth granules and larger granules of Xpat mRNA) this 
implies that either the injected Xpat mRNA, or the protein it encodes, is interacting 
with some component that influences the distribution of that RNA. Interestingly, 
DEADSouth has recently been stated not to be present on the germ granules (M. L. 
King, unpublished; cited in Houston and King, 2000a). L. Etkin has reported that 
Xpat mRNA is peripheral on granules, whereas Xcat-2 is central (Etkin, 2000). There 
is no evidence that injected Xpat mRNA colocalises with endogenous granules of 
Xpat mRNA, as double in situ hybridisation analysis has not been performed. 
It is worth noting that the culture conditions used in these experiments were different 
from those used for XPAT-GFP localisation experiments (in Chapters 3 and 4). All 
oocytes injected with asXpatl2, dsXpat or Xpat mRNA were cultured in 50% 
Leibowitz medium (with no added serum), and these conditions were found to be 
suboptimal for XPAT-GFP localisation (see Section 3.3.2). Since lack of serum in 
culture medium affects XPAT-GFP protein localisation, it is likely that it can also 
affect the distribution of endogenous and overexpressed mRNA components. 
A morpholino oligo specific for the 5' UTR region of Xpat does not appear to reduce 
the translation of Xpat mRNA substantially when assessed by in vitro assay. Whilst 
injection of the morpholino into 2-cell embryos and subsequent in situ hybridisation 
at stages 36 and 44 of development shows no reduction in PGC numbers or affect on 
migration, this could be the correct result that inhibition of Xpat translation has on 
development after fertilisation. Until an antibody that is able to detect endogenous 
levels of XPAT is produced this result cannot be confirmed. However, it is important 
to note that correlation between in-cell and cell-free behaviour of morpholinos has 
previously been reported (Taylor et al., 1996). This suggests that since the Xpat 
morpholino is incapable of substantially inhibiting Xpat translation in vitro it will be 
unable to do so in oocytes either. 
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Chapter 8: Raising anti-XPAT peptide antisera to determine endogenous XPA'1' 
protein expression 
8.1 Introduction 
In order to determine at which stages of development and in which region of the 
Xenopus oocyte and/or embryo XPAT protein is expressed it is necessary to raise 
antisera against XPAT. Clare Hudson had previously attempted to generate antisera 
against an XPAT peptide and a GST-XPAT fusion protein in rabbits. However, these 
antibodies could not detect endogenous levels of XPAT protein. To determine 
whether the localisation of injected XPAT-GFP is identical to the expression pattern 
of endogenous XPAT in Xenopus oocytes, two more peptides were manufactured 
and used to raise antisera in both rabbits and mice. 
8.2 Design of peptides for XPAT antisera production 
Two different regions of XPAT sequence were chosen which were proline-rich and 
had low hydrophobicity (and were therefore likely to be present on the outside of the 
protein and not facing inside), had a high antigenic index and high surface 
probability. These two chosen regions are highlighted in Figure 8.1: peptide A in red 
and peptide B in green. The sequences chosen were, peptide A: PPHQNPTLLKDEE 
and peptide B: PKKMPATSTPRK. Also highlighted in blue in Figure 8.1 is the 
sequence of the peptide Clare Hudson used to generate antisera previously. These 
sequences were manufactured as multi antigenic peptides (MAPs). These peptides 
were purified and used to immunise rabbits and mice every four weeks. 
Fi2ure 8.1: Seauences of XPAT peptides used to raise antisera 
MALKAEDSFD IYSQLIQSFC RYAENTTVSE SQSPAFNAQK EFQTCQDHAC CTHSEAHTHI 60 
LMQQWQLLEE QWEYIDHLKT DVAALKQLLH GFMNSLSGTD SGMEGTNHFL P}'HýNf''I'I, 1 K 120 
DEEIVASALN RPSVDINGFE ENITTGAQIH AAFTKSPKKM PATSTPRKSE VLWSCSPTLA 180 
TDGYFMLPDI ILNPLDGKKL VSMLRSSNYE PHRFAELLFQ HHVPHSLFQL WANKVNFDGS 240 
RGKLGLPRNL MIDILHQTSK RFVLGPKEKR KIKTRLNLLL RTRQDRAWWD VGL 
The amino acid sequence of XPAT. The sequences of peptides used to immunise rabbits and mice are 
highlighted: peptide A in red and peptide B in green. The sequence of a peptide previously used by 
Clare Hudson to immunise rabbits is highlighted in blue. Peptides A and B were chosen as they are 
proline-rich, have low hydrophobicity, high antigenic index and high surface probability. 
8.3 Characterisation of antisera resulting from immunisations of rabbits 
8.3.1 ELISA-Enzyme Linked Immunosorbent Assay 
Two weeks after each immunisation, a small sample of blood was taken from each 
rabbit and serum was isolated and characterised, firstly by ELISA. This was to 
determine whether the rabbit had responded to the injected peptide and generated 
appropriate antibodies. If antisera showed good responses in ELISA they were then 
further characterised. Antisera raised against both peptide A and peptide B showed 
good responses when tested in ELISA. Peptide B showed non-specific binding with 
antisera raised against both peptides and also pre-immune serum and thus gave high 
background measurements in all cases. 
8.3.2 Dot-blots 
Following ELISA, the peptide antisera were tested on dot-blots of the peptide and 
GST-XPAT on nitrocellulose membranes alongside equal amounts of BSA as a 
control. (The cloning and expression of GST-XPAT is described in 8.4.2). Pre- 
immune serum from the rabbit injected with peptide B reacted with peptide B 
(Figure 8.2A), as shown previously in ELISA. This was because peptide B (when 
present at concentrations higher than 0.15µg/µl) was 'sticky' and could bind non- 
specifically to antisera. Pre-immune serum did not detect BSA or GST-XPAT. 
The peptide B antiserum was able to detect down to 15ng of peptide and 20ng of 
GST-XPAT by the final bleed (Figure 8.2B). Antiserum raised against peptide A 
was able to detect down to 1.5ng of peptide by the final bleed but was not able to 
detect GST-XPAT (Figure 8.2C). Obviously this was unsatisfactory, as it was 
unlikely that either antiserum could detect endogenous levels of protein on a western 
blot or by immunoprecipitation. However, both sera were next tested by 
immunoprecipitation on over-expressed XPAT. 
8.3.3. Immunoprecipitations using over-expressed XPAT in RRL and oocytes 
In order to test the translatability of XPAT, oocytes were injected with 20ng Xpat 
mRNA, cultured in Barths' saline over-night in the presence of 35S-methionine and 
then proteins were extracted. Concomitantly, Xpat mRNA was translated in vitro 
using RRL plus 35S-methionine. Proteins were resolved using SDS-PAGE and 
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Figure 8.2: Characterisation of antisera raised against XPAT peptides in rabbits using dot blots. 
(A). A dotblot of peptide B: (1) 150ng, (2) 15ng, (3) 1.5ng, (4) 0.15ng, (5) 15pg, (6) 1.5pg, (7) 0.1 Spg. 
GST-XPAT and BSA each at: (1) 2µg (2) 0.2µg, (3) 20ng, (4) 2ng, (5) 0.2ng, (6) 20pg, (7) 2pg. 
This dot blot was hybridised with pre-immune serum from a rabbit injected with peptide B, diluted I/100. 
(B). A dotblot of peptide B, GST-XPAT and BSA: amounts exactly as described in (A). This nitrocellulose membrane 
was hybridised with serum from the final bleed of a rabbit immunised with peptide B, diluted 1/100. 
(C). A dotblot of peptide A: (1) 150ng, (2) 15ng, (3) 1.5 ng, (4), 0.15ng, (5) 15pg, (6) 1.5pg, (7) 0. l5pg. 
GST-XPAT and BSA each at: (1) 2µg, (2) 0.2µg, (3) 20ng, (4) 2ng, (5) 0.2ng, (6) 20pg, (7) 2pg. 
This dot-blot was hybridised with serum from the final bleed of a rabbit immunised with peptide A, diluted 1/100. 
On all of these dot blots, for denatured proteins and peptides, proteins and peptides were heated at 95°C for 3 minutes 
prior to spotting on nitrocellulose. Native peptides were simply spotted directly onto the membrane prior to 
hybridisation. 
autoradiography. As Figure 8.3A shows, XPAT translated in stage VI Xenopus 
oocytes (indicated by the extra band present in the protein profile of Xpat-injected 
oocytes when compared with uninjected controls) and also in RRL. The apparent 
molecular weight of XPAT was 35kDa when translated both in vitro and in vivo. 
The peptide anti-sera were tested on over-expressed XPAT in RRL and in oocytes. 
In the case of RRL-translated XPAT, peptide B antiserum specifically detected 
XPAT, whilst pre-immune serum from this rabbit did not (Figure 8.3B). However, 
anti-peptide A antiserum could not detect XPAT. Similarly, immunoprecipitations 
using anti-peptide B antiserum were able to specifically detect XPAT in 
radiolabelled stage VI oocytes expressing XPAT after 3 nights exposure of the X-ray 
film (Figure 8.3C). However, anti-peptide A antiserum could not detect protein in 
radiolabelled oocytes expressing XPAT. Peptide B antisera could not detect 
endogenous levels of XPAT in stage VI oocytes (if present), as Figure 8.3C shows. 
Unfortunately, anti-peptide antisera were also unable to detect endogenous levels of 
the protein (if expressed) in stage 10.5 embryos injected with 35S-methionine (not 
shown). 
8.3.4 Western blot analysis 
When anti-peptide A antiserum was tested on oocytes overexpressing XPAT using 
western blot analysis, no specific reaction was detected (not shown). This was 
discouraging as peptide raised antisera are considered most likely to work on the 
denatured proteins in western blots than in other techniques where the proteins are 
not denatured. Peptide B antisera, however, did show a reaction when tested by 
western blot analysis. Total protein extractions from several stages of Xenopus 
oocyte and embryo were resolved by SDS-PAGE and then stained with Coomassie 
blue to check that the amounts of protein were approximately equal in all samples 
(results not shown). An identical SDS-PAGE gel was then run and blotted onto 
nitrocellulose and western blot analysis using anti-peptide B antiserum was 
performed (Figure 8.3D). In every developmental stage of Xenopus tested (stage I, 
II, V and VI oocytes and stage 3,9,13,26 and 36 embryos) a clear, strong band was 
seen. The apparent molecular weight of the protein detected was between 30 and 
36kDa. Whilst this result appeared encouraging, it was difficult to ascertain whether 
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Figure 8.3 (Opposite): To test specificity of rabbit antisera using 
immunoprecipitations and western blot analysis 
(A). An autoradiograph of an SDS-PAGE run to determine translatability of Xpat. 
C and XP lanes contain proteins that were extracted from oocytes incubated in the presence 
of 35S-methionine. C is the protein profile of control (uninjected) stage VI Xenopus oocytes. 
XP is a protein profile of Xenopus oocytes injected with 20ng of Xpat mRNA. R represents 
1/20 of an in vitro RRL translation reaction that contained no added mRNA. RX is 1/20 of 
an RRL reaction that used Xpat mRNA as a template for translation. The arrow indicates 
XPAT protein, which has an apparent molecular weight of 35kDa after translation in vivo 
and in vitro. Protein sizes (on left) are given in kDa. 
(B). An autoradiograph of immunoprecipitations carried out with antisera raised 
against XPAT peptide 
In vitro translated XPAT was incubated with serum (all used at 1/100 dilution) and protein 
A Sepharose. After washing, eluted proteins were separated by SDS-PAGE and visualised 
by autoradiography. The letters indicate which immunoprecipitation reaction was loaded. 
Letter designations are as follows: T, aliquot of the initial XPAT RRL translation, 
corresponding to 20% of the input per immunoprecipitation reaction; P-A, pre-immune 
serum, taken from rabbit prior to immunisation with peptide A; P-B, pre-immune serum 
taken from rabbit prior to immunisation with peptide B; A3, antiserum taken from rabbit 
immmunised with peptide A. it was taken from the final bleed following the 3rd boost; B3, 
antiserum taken from rabbit immunised with peptide B, it was taken from the final bleed 
following the 3rd boost; -, no serum. Protein sizes (on left) are given in kDa. 
(C). An autoradiograph of immunoprecipitations carried out with antisera raised 
against XPAT peptides 
Stage VI Xenopus oocytes were cultured in vitro in the presence of 35S-methionine and then 
proteins were extracted. The oocyte proteins were then incubated with sera (all used at 1/100 
dilution) and protein A Sepharose. After washing, eluted proteins were separated by SDS- 
PAGE and then visualised by autoradiography. In the immunoprecipitations, pre-immune 
sera were also used on the radioactive oocytes and control immunoprecipitations were 
carried out on radioactive oocytes that were not overexpressing XPAT (C). The letters 
indicate which samples were loaded and their designation is as follows: C, control 
(uninjected) oocyte samples; X, oocytes injected with 20ng Xpat mRNA; T. aliquot of the 
initial sample of proteins extracted from oocytes corresponding to 20% of the input per 
immunoprecipitation; p. pre-immune serum; A, rabbit antiserum taken from the final bleed 
after 3d boost of peptide A; B rabbit antiserum taken from the final bleed following the 3rd 
boost of peptide B. 
(D). Western blot analysis of serum raised against peptide B 
Proteins were extracted from various stages of Xenopus oocytes and embryos and were 
separated by SDS-PAGE. The gel was then blotted onto nitrocellulose membrane and the 
western blot was incubated with serum taken from rabbit immunised with peptide B. The 
serum was diluted 1/100 and was taken from the final bleed following the 3'd boost. The blot 
was then incubated with Goat Anti-Rabbit IgG HRP conjugate and visualisation of reactivity 
was performed by addition of DAB substrate. Protein samples were extracted from: I, stage I 
oocytes; III (stage III oocytes); V. stage V oocytes; VI, stage VI oocytes; 3, stage 3 
embryos; 9, stage 9 embryos; 13, stage 13 embryos; 26, stage 26 embryos; 36, stage 36 
embryos. The letters above the blot indicate which samples were loaded. 
(E) Control western blot 
A gel was loaded exactly as in (D), resolved by SDS-PAGE then transferred onto 
nitrocellulose membrane. The western blot was incubated with 1/100 pre-immune serum 
taken from a rabbit prior to immunisation with peptide B. The blot was then incubated with 
Goat Anti-Rabbit IgG HRP conjugate and visualisation of reactivity was performed by 
addition of DAB substrate. The letters above the blot indicate which samples were loaded 
[as indicated in (D)]. 
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the protein that the antisera detected was indeed XPAT. Whilst protein markers can 
be resolved imprecisely by SDS-PAGE sometimes, the size of the protein detected in 
this case was apparently less than 35kDa. It was theoretically possible that anti- 
peptide B antiserum was specifically detecting a protein with a similar molecular 
weight to XPAT, with a common region of 13 amino acids (peptide B). To try and 
resolve this issue, a competition assay with peptide B was attempted. This failed to 
resolve the uncertainty as this peptide was 'sticky' and reacted non-specifically with 
antisera thus uninterpretable data (not shown) was obtained. Next, 2-Dimensional 
gel electrophoresis followed by western blot analysis was attempted. Results were 
again difficult to interpret (not shown) as high background was seen on the blots. 
Finally, it was decided to tag XPAT with 6 myc epitopes at its amino terminus thus 
generating a distinct protein with a greater molecular weight than XPAT but that still 
contained XPAT. This protein was then used for further characterisation of the 
antisera. 
8.3.5 Cloning of myc"tagged XPAT for use in Immunoprecipitations 
In order to construct myc-Xpat, the coding region for Xpat was amplified by PCR 
from a cDNA library clone with primers that created 5' Bgll and 3' XhoI sites. The 
resulting PCR fragment was then cloned into the Bg1II and XhoI sites of pCS3+MT 
which contained 6 myc epitope tags. This generated myc-Xpat, Xpat tagged with 
myc at its amino terminus. Once this construct was made, appropriate restriction 
digests were performed on the DNA to confirm that Xpat was present. Following 
restriction digestion, an in vitro coupled transcription and translation reaction was 
performed using myc-Xpat DNA as a template. A fraction of the reaction was 
resolved by SDS-PAGE and autoradiography confirmed that myc-XPAT had an 
apparent molecular weight of 50kDa, as expected. 
Myc-Xpat was then transcribed and this mRNA was injected into stage VI Xenopus 
oocytes, which were cultured in vitro in the presence of 35S-methionine. Proteins 
were extracted from these oocytes and immunoprecipitation using an anti-myc 
antibody confirmed that this protein could be detected. The immunoprecipitation 
reactions were resolved by SDS-PAGE and an autoradiograph of the gel is shown in 
Figure 8.4A. This figure confirms that myc-XPAT is translated in oocytes with an 
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apparent molecular weight of 5OkDa. This is obvious as the protein profile of myc- 
Xpat- injected oocytes has one extra band of 50kDa when compared with the protein 
profile of uninjected control oocytes (Figure 8.4A). The immunoprecipitation 
reaction was able to detect protein in radiolabelled oocytes expressing myc-XPAT 
whereas it was not able to detect protein in radiolabelled uninjected controls. Several 
break-down proteins were observed in the immunoprecipitation reaction. 
Next, immunoprecipitation reactions using anti-peptide B antisera were attempted. 
Immunoprecipitation was able to detect protein in radiolabelled oocytes expressing 
myc-XPAT after 1 night exposure of the X-ray film (Figure 8.4B). However, this 
autoradiograph did not show any detection of XPAT by the peptide antiserum in 
radiolabelled oocytes expressing XPAT. Thus, the gel was exposed to X-ray film for 
3 nights (Figure 8.4C). In this figure, XPAT and myc-XPAT were detected in 
overexpressing radiolabelled oocytes by anti-peptide B antiserum. However, the pre- 
immune serum from this rabbit also detected myc-XPAT, indicating that possibly the 
rabbit had previously encountered. myc epitope. The. immunoprecipitation reactions 
indicated that the antiserum worked, but poorly. Unfortunately, myc-XPAT 
production did not allow any conclusions to be drawn regarding specificity of 
peptide B antiserum. Further western blot analysis was performed using myc-XPAT 
expressing oocytes but background staining prevented interpretation (not shown). 
Western blot analysis of immunoprecipitations did not aid clarification of the 
problem. 
Finally, whole-mount immunostaining of various stages of oocytes and embryos was 
attempted with both peptide antisera. Whole mount analysis did not give any specific 
staining pattern (results not shown). Thus, no further experiments were performed 
with these antisera. 
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Figure 8.4 (Opposite): The use of myc tagged XPAT to determine the specificity 
of antipeptide antisera 
(A) Autoradiograph of immunoprecipitation reactions that had been resolved by 
SDS-PAGE. Protein sizes (on left) are given in kDa. The letters above the 
autoradiograph indicate which samples had been loaded. The letter designation is 
as follows: CT, control (uninjected) stage VI Xenopus oocytes which had been 
cultured in vitro in the presence of 35S-methionine for 18 hours, this aliquot 
corresponded to 20% of the input per immunoprecipitation reaction; MT, stage 
VI oocytes which had been injected with 20ng of myc-Xpat mRNA and then 
cultured in vitro for 18 hours in the presence of 35S-methionine, this aliquot 
corresponds to 20% of the input per immunoprecipitation reaction; CaM, 
immunoprecipitation reaction, proteins extracted from control oocytes were 
interacted with 1/100 anti-myc antibody and protein A Sepharose, then washed; 
MaM, immunoprecipitation reaction, proteins extracted from myc-Xpat-injected 
oocytes were interacted with an anti-myc antibody and then washed. 
(B) Autoradiograph of immunoprecipitation reactions that had been resolved by 
SDS-PAGE. This gel was exposed to X-ray film for 18 hours. Stage VI Xenopus 
oocytes were cultured in the presence of 35S-methionine and total protein 
extractions were performed. The oocyte proteins were then incubated with 
antisera and protein A Sepharose. After washing, eluted proteins were separated 
on a 12% acrylamide gel and visualised by autoradiography. Protein sizes (on 
left) are given in kDa. The letters above the autoradiograph indicate which 
samples were loaded. Letter designations are as follows: C, control (uninjected) 
oocytes; X, oocytes injected with 20ng Xpat mRNA; M, oocytes injected with 
20ng myc-Xpat mRNA; T, aliquot of total protein extraction corresponding to 
20% of the input per immunoprcipitation ' reaction; p, immunoprecipitation 
reaction using 1/100 pre-immune serum; B, immunoprecipitation reaction using 
1/100 antiserum taken from final bleed of rabbit immunised with peptide B. 
(C) Autoradiograph of immunoprecipitation reactions resolved by SDS-PAGE. 
This is the same as the gel shown in (B), however, the gel was exposed to X-ray 
film for 72 hours in this case. 
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8.4 Characterisation of antisera resulting from immunisation of mice 
Peptide A and peptide B were each used to immunise 10 mice every four weeks. 
Small amounts of blood were taken 2 weeks after each immunisation and the 
resulting sera were characterised. 
8.4.1 ELISA 
As described for rabbit antisera (in 8.3.1) the serum taken from each mouse was 
isolated and characterised by ELISA. If antiserum showed a good response to 
peptide in ELISA they were then further characterised. Only 3/20 antisera showed 
good responses, all three were from mice immunised with peptide A and were 
named 1-1,1-2 and 1-5. It was next determined whether any of these antisera could 
detect GST-XPAT on western blots. 
8.4.2 The production of a GST-XPAT fusion protein 
One of the reasons for producing GST-XPAT fusion protein in bacteria was that this 
could be detected non-radioactively and would not be contaminated with any oocyte 
proteins. This meant it would be useful for western blot analysis and any antisera 
which could detect it would be specific for XPAT and not a different Xenopus 
protein of the same molecular weight. 
In order to make a GST-XPAT fusion protein, the entire ORF of Xpat was cloned 
into the expression vector pGEX-2T. The coding region for Xpat was amplified by 
PCR using primers that created 5' and 3' BgIII sites. The resulting PCR fragment was 
cloned into the BamHI site of pGEX-2T, generating GST-Xpat. The pGEX-2T 
vector allows expression in bacteria, it contains GST downstream from a IacI 
promoter therefore expression of this fusion protein is IPTG inducible. The plasmid 
also encodes ampicillin resistance. Once the construct was made, an EcoRI digest 
was performed on the DNA to confirm that the orientation of the insert was correct. 
pGEX-Xpat was transformed into three types of cells: DH5a, BL21 and AD202. 
Induction with IPTG was carried out at 37°C and bacterial samples were taken after 
4 hours and assayed for protein production. The protein profiles of bacterial extracts 
changed only with respect to the induced protein, thus the presence of one extra band 
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was easily identified. The results of XPAT induction in DH5(% cells are shown in 
Figure 8.5A. Similar results were seen for expression in all other cell types 
The protein gel shows that GST-XPAT is readily expressed in bacteria and runs at a 
similar size to that predicted - 62.5kDa (35kDa for XPAT plus 27.5kDa for GST). 
The protein is readily IPTG inducible, expressed to high levels and is stable. 
However, high levels of GST-XPAT protein were seen in the insoluble fractions but 
were indetectable in the soluble fractions (Figure 8.5A). Thus, GST-XPAT is 
insoluble and was found to be so in all bacterial cell types tested. However, GST 
control had high levels in the soluble fractions and low levels in the insoluble (see 
Figure 8.5B). 
8.4.3 To characterise the antisera using GST-XPAT and western blot analysis 
Three anti-peptide antisera from mice (1-1,1-2 and 1-5) were tested by western blot 
analysis on bacteria overexpressing GST-XPAT. 1-2 showed a strong specific 
reaction to GST-XPAT; however, 1-1 and 1-5 did not detect GST-XPAT specifically 
(not shown). 
1-2 antiserum was then used for further western blot analysis. Proteins from Xenopus 
oocytes overexpressing XPAT and myc-XPAT and embryos were resolved by SDS- 
PAGE alongside expressions of GST-XPAT and GST in DH5a cells. One such gel 
was stained with Coomassie blue and is shown in Figure 8.5C. The samples were all 
equalised so that equivalent amounts of protein were present in each lane. A 
duplicate gel was then run and blotted onto nitrocellulose and tested with 1-2 
antiserum. The results of this western blot are shown in Figure 8.5D. Unfortunately, 
1-2 could only detect GST-XPAT and was unable to detect protein in overexpressing 
oocytes or in embryos. Autoclaving the nitrocellulose prior to detection did not 
increase the sensitivity of detection, nor did increasing the concentration of primary 
or secondary antibody. 
These results were discouraging as peptide raised antisera are considered to be more 
likely to work on the denatured proteins on western blots than in other techniques 
where the proteins are not denatured. Despite this, whole mount 
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Figure 8.5 (Opposite): The use of GST-XPAT to determine specificity of anti. 
peptide antisera raised in mice 
(A) Bacterial expression of GST-XPAT 
An SDS-PAGE gel that has been stained with Coomassie blue. lOµ1 of each sample was 
loaded onto the gel- thus each lane contains an equivalent amount of protein. M indicates 
protein size markers; the numbers on the left of the gel are the sizes in kDa of the protein 
size markers. The letters indicate which sample was loaded, in brackets after each letter 
designation is the volume of bacterial culture proteins were extracted from. For each sample: 
U, uninduced culture of DH5a (lml); I, DH5a culture induced with IPTG (lml); T, total 
protein (lml); P, pellet (equivalent to lml); S, soluble fraction (equivalent to lml culture). 
Arrow indicates induced protein. 
(B) Expression of GST in DH5a cells 
This figure shows an SDS-PAGE gel that has been stained with Coomassie blue. 10µl of 
each sample was loaded onto the gel and each lane contains an equivalent amount of protein. 
The DH5a culture was induced with IPTG and 4 hours later samples were taken. M 
indicates protein size markers, the numbers on the left of the gel are sizes in kDa of the 
protein markers. The letters indicate which sample was loaded, in brackets after each letter 
designation is the volume of bacterial culture proteins were extracted from. For each sample: 
T, total protein (lml); P. pellet (equivalent to lml); S, soluble fraction (equivalent to lml 
culture). Arrow indicates induced protein. 
(C) Coomassie blue stained SDS-PAGE gel of Xenopus oocyte proteins, GST 
and GST-XPAT 
Proteins were extracted from various stages of Xenopus oocytes and proteins from the 
equivalent of 'h an oocyte were loaded onto a gel. GST (1% of a lml DH5(x culture) and 
GST-XPAT (1% of a lml DH5a culture) were also resolved on the gel. The numbers above 
the gel indicate which sample was loaded. The samples were as follows: 1, control stage VI 
Xenopus oocytes; 2, stage VI Xenopus oocytes injected with 20ng Xpat mRNA; 3, control 
stage VI Xenopus oocytes; 4, stage VI Xenopus oocytes injected with 20ng myc-Xpat 
mRNA; 5, DH5a cells expressing GST; 6, DH5a cells expressing GST-XPAT; 7, control 
stage III Xenopus oocytes; 8, control stage IV Xenopus oocytes; 9, control stage V Xenopus 
oocytes. 
(D) Western blot analysis of serum raised against peptide B 
A gel was loaded exactly as in (C) and resolved by SDS-PAGE. The gel was then 
transferred onto nitrocellulose membrane. The western blot was then incubated with serum 
(1-2) taken from a mouse immunised with peptide A. The serum was diluted by 1/100 and 
was taken from the final bleed following the 3`d boost. The blot was then incubated with 
Rabbit Anti-Mouse IgG HRP conjugate and visualisation of reactivity was performed by 
addition of DAB substrate. The numbers indicate which sample was loaded onto the original 
gel, as in (C). 
(E) Control western blot 
A gel was loaded with protein samples, prepared as described in (C), resolved by SDS- 
PAGE and then transferred onto nitrocellulose membrane. The western blot was then 
incubated with 1/100 pre-immune serum taken from a mouse prior to immunisation with 
peptide A. The blot was then incubated with Rabbit Anti-Mouse IgG HRP conjugate and 
visualisation of reactivity was performed by addition of DAB substrate. The numbers above 
the blot indicate which sample was loaded onto the original gel, as follows: 1, DH5a cells 
expressing GST; 2, DH5a cells expressing GST-XPAT; 3, control stage VI oocytes; 4, stage 
VI oocytes injected with 20 ng Xpat mRNA. 
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immunohistochemistry on Xenopus oocytes and embryos were attempted. Whole 
mount analysis did not give any specific staining pattern with any of the antisera 
raised in mice. 
8.5 Discussion 
Attempts to generate antisera raised against two different peptides in both mice and 
rabbits were unsuccessful. None of the antisera generated were able to detect XPAT 
in whole-mount immunohistochemistry, which is the technique most useful in 
determining whether XPAT protein is localised in the germ plasm and PGCs of 
Xenopus. The antisera raised to peptide B in rabbits could detect XPAT only in 
radiolabelled oocytes overexpressing XPAT. This did show that it was possible to 
raise antibodies to this peptide and they were capable of binding to the native 
protein. However, this protein was over-expressed in oocytes and was therefore 
present at much higher levels than endogenous XPAT would be. The antibody raised 
was also able to detect a protein by western blot analysis. This is not surprising for a 
peptide, as it is not in a native conformation and therefore one might expect that it 
would be capable of detecting a denatured protein rather than the native protein in 
immunoprecipitation assays. 
Thus, the antisera raised were not very useful. This may be due to very low 
production of antibodies to the immunogen, the antibodies produced having only a 
low affinity, or inaccessibility of the protein. For example, it is possible that, like 
overexpressed XPAT and XPAT-GFP proteins, endogenous XPAT is in an insoluble 
complex in the germ plasm, much as Xcat-2, Xcat-3 and Vg1 RNAs are present in 
the insoluble fraction of oocyte extracts (Elinson et al., 1993). GST-XPAT was also 
seen to be insoluble when expressed in all bacterial strains tested. 
Currently, Richard Hames, a PhD student working with Hugh Woodland, is 
attempting to raise antisera to His-tagged XPAT. Antisera generated from this 
immunogen may be more likely to work on non-denatured proteins in such 
techniques as whole mount immunostaining. An antibody would be very desirable 
for future work, because knowing where and when the protein is expressed would 
aid clarification of its function and would allow experiments to be more effectively 
designed to perturb or increase the function of XPAT during development. An 
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XPAT antibody could also be used for a direct study of endogenous XPAT to try and 
determine any possible binding partners. For example, a pull-down assay of oocyte 
RNA and XPAT protein using an antibody could be performed and the 
immunoprecipitate could then be assayed for candidiate RNAs that could be bound 
by XPAT, using PCR analysis. Also, to be totally confident that the localisation of 
XPAT-GFP is identical to the endogenous XPAT expression pattern in Xenopus 
oocytes, it will be necessary to obtain an antibody that can detect XPAT. However, 
at present, XPAT's endogenous expression pattern remains unknown. 
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Chapter 9: Concluding Discussion 
9.1 The expression pattern and localisation properties of XPAT 
GFP fusion constructs have been thoroughly validated and the live cell imaging of 
GFP-tagged proteins is now used to generate primary data for determining the 
cellular localisation of gene products (Matus, 2001). Thus, in order to determine the 
expression pattern and localisation properties of XPAT protein in Xenopus oocytes, 
Xpat was tagged (at either its carboxy- or amino-terminus) with GFP and the 
resulting fusion proteins were expressed in Xenopus oocytes. GFP-XPAT localised 
predominantly to the nuclei of stage VI oocytes. However, XPAT-GFP, in addition 
to being present in the nucleus, formed small (1-2.5µm) particles which aggregated 
at the vegetal pole into larger (10-50µm) granules over the course of 3 days in 
culture. XPAT was transported to the vegetal pole of full-grown oocytes, but whether 
as particles, or as soluble protein existing in equilibrium with particles, cannot be 
said. The former seems more likely. The XPAT-GFP localisation data suggests that 
XPAT protein, at least when overexpressed, localises in a manner consistent with it 
being a component of the germ plasm. The granules of XPAT-GFP are larger than 
endogenous germ plasm granules seen in stage VI oocytes; they are more consistent 
with those observed in 2-cell embryos during germ plasm aggregation (Ressom and 
Dixon, 1988; Savage and Danilchik, 1993). 
This is of considerable interest as no other known proteins have been observed to 
localise in this manner in Xenopus. Whilst Denegre et al. (1997) generated 3 
monoclonal antibodies that recognised antigens localised to the vegetal cortex, which 
partially overlapped with germ plasm, the identity of the proteins recognised by these 
antibodies remains to be established. 
The pattern of fusion protein distribution can hardly be accidental and, although the 
distribution of the endogenous protein is not yet known, the implication is that it is a 
germ granule component at some point. Thus, the data suggest that Xpat is present in 
germ granules at some stage, both as an RNA (Hudson and Woodland, 1998) and as 
a protein. The only other known gene whose products do this in any animal is oskar, 
which is a crucial effector of PGC formation in Drosophila. oskar RNA and the 
protein it encodes are both essential for germ granule formation and can direct its 
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ectopic development (Ephrussi et al., 1991; Smith et al., 1992; Ephrussi and 
Lehmann, 1992). An RNA-binding role has been suggested for Oskar, but is 
unproven. An intriguing parallel with Xpat, for which no homologues exist, is that 
there are no known oskar homologues outside the genus Drosophila. As far as germ 
lineage development is concerned, this is also true of the C. elegans protein PIE-1, 
which associates with the cytoskeleton and is also found in the nucleus (Mello et al., 
1996). It is related only to RNA-binding proteins (e. g. MEX- 1, which is not nuclear), 
but is essential for germ line repression of transcription (Seydoux et al., 1996) and it 
contains a functional transcriptional repressor domain (Batchelder et al., 1999). 
Little expression of XPAT-GFP was seen in smaller oocytes even though the injected 
mRNA contained no Xpat UTRs. Thus, either the Xpat ORF has regulatory 
sequences, which is most unusual, or XPAT protein is unstable in some embryonic 
cells, at least when overexpressed. Indeed, the stability of XPAT-GFP in stage VI 
oocytes was also greatly affected by changes in culture conditions. When XPAT- 
GFP-expressing oocytes, which had been cultured for three days in OCM, were 
transferred into Barth's saline for photography, the majority of XPAT-GFP 
expression disappeared very rapidly. 
Since Xpat-GFP mRNA is also much more tightly localised than GFP mRNA this 
implies Xpat mRNA is anchored at its injection site. Xpat-GFP mRNA is translated 
at the site of its injection and XPAT-GFP protein must be anchored there, otherwise 
it would diffuse widely, like GFP. Particles would diffuse more slowly than non- 
particulate material, but this does not account for the fact that even non-particulate 
XPAT-GFP was tightly localised. It is possible that either Xpat mRNA or nascent 
peptides can bind to the cytoskeleton and thereby anchor XPAT protein at the 
injection site. This anchoring is likely to involve microfilaments, which anchor 
Xlsirts, Xcat-2 and Xwnt-11 mRNAs (Kloc and Etkin, 1995), and/or intermediate 
filaments, which are required for cortical anchoring of Vg1 RNA (Yisraeli et al., 
1990; Kloc and Etkin, 1995). Vg1RBP is hypothesised to be involved in both Vgl 
mRNA transport and anchoring and can bind to microfilaments (Havin et al., 1998; 
Deshler et al., 1998). It is possible that XPAT protein could bind to Xpat mRNA (in 
vitro RNA-binding activity of XPAT has been demonstrated) and also to 
microfilaments and thus anchor Xpat mRNA at the vegetal pole. This hypothesis 
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could be tested by investigating sequence-specific RNA-binding activities of XPAT. 
The most obvious approach would be to use the PCR-based SELEX method (Klug 
and Famulok, 1994; Nieuwlandt et al., 1995) to determine a consensus binding site. 
A more complex approach would be to use the yeast-3-hybrid system (SenGupta et 
al., 1996), but this would be more difficult to set up. 
Preliminary experiments on the mode of XPAT-GFP localisation were conducted 
using cytoskeletal inhibitors. This study indicated that microtubules, but not 
microfilaments, are essential for transport of XPAT-GFP from the equator (the site of 
mRNA injection) to the vegetal pole. When microtubules are disrupted, most XPAT- 
GFP becomes located in the nucleus. y-tubulin is asymmetrically distributed along 
the AN axis, with foci of y-tubulin concentrated at the vegetal cortex of Xenopus 
oocytes (Gard, 1994; Gard et al., 1995). The majority of microtubules have their 
minus ends directed towards the oocyte cortex (Pfeiffer and Gard, 1999). Thus, there 
could be a population of microtubules nucleated by y-tubulin at the vegetal pole with 
their minus ends at the cortex in stage VI oocytes. This microtubule network could 
localise XPAT-GFP; transport of XPAT-GFP (and hence XPAT) along these tubules 
would likely involve dynein, a minus end-directed motor (Fox and Sale, 1987; 
Paschal and Vallee, 1987; Paschal et al., 1987; Schroer et al., 1989). 
There are 3 usual mechanisms for intracellular localisation of mRNAs and proteins: 
(1) Diffusion plus local binding 
(2) Diffusion plus degradation 
(3) Active transport 
Mechanism (2) seems unlikely for localising XPAT, as it cannot build up a 
concentration above that seen with diffusion alone. The granules of XPAT-GFP were 
more intense than the fluorescence seen with GFP or the deletion variants of XPAT- 
GFP. XPAT-GFP protein is not degraded since oocytes remain fluorescent for at 
least 3-4 days post-injection, irrespective of injection site. Although the protein is not 
unstable, it is possible that Xpat mRNA is unstable when in the wrong place (i. e. not 
in germ granules). RNA localisation is an important mechanism by which proteins 
become spatially restricted in cells (St Johnston, 1995; King, 1996; King et al., 
1999), although anchorage of proteins to localised binding sites or directed transport 
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of proteins are other mechanisms that cells use to localise proteins (St Johnston, 
1995). Normally, Xpat mRNA is inside the germ granules (Eikin, 2000), and XPAT- 
GFP data indicates that XPAT protein can similarly form granules in oocytes (unlike 
unfused GFP). Thus, the localisation of Xpat mRNA to the germ plasm could cause 
restriction of XPAT protein to the same location, but XPAT-GFP data indicate that 
XPAT protein can itself assist in this process without RNA localisation. 
9.2 XPAT can enter the nucleus 
XPAT contains a putative bipartite NLS at its carboxy-terminus. Several large N- 
terminal deletions of XPAT protein were constructed and, like GFP-XPAT, these 
became predominantly localised to the nucleus. ON1, which lacked the first 61 amino 
acids of XPAT, can form small particles, but these persist only when the mRNA is 
trapped in small protrusions of cytoplasm. This implies that ANI particles are less 
stable than those of XPAT and thus a proportion of ANI is non-particulate and 
progressively moves into the nucleus: Indeed XPAT-GFP that does not bind to the 
cytoskeleton enters the nucleus, as shown by using cytoskeletal inhibitors. These data 
imply that XPAT could be a nuclear component of Xenopus oocytes or PGCs, and 
suggest that nuclear entry of the fusion proteins is opposed by particle formation 
and/or binding to cytoplasmic components. The amino-terminal deletion proteins 
presumably have enhanced nuclear localisation due to less cytoplasmic binding 
activity. 
At first glance, the localisation of XPAT to both vegetal granules and the nucleus 
seems hard to reconcile. In the early C. elegans, Drosophila and amphibian embryos, 
the germ line granules are found in the cytoplasm. However, at other stages of the 
life cycle the germ line granules can be associated with nuclei. In Drosophila, polar 
granules become associated with nuclei once the pole cells are formed (Mahowald, 
1971; Hay et al., 1988a). In C. elegans, P granules remain associated with germ cell 
nuclei as the gonad forms during larval and adult development, and then detach from 
the nuclei and become cytoplasmic once again in oocytes (Strome and Wood, 1982, 
1983). The ultrastructure of the nuclear-associated P granules has been examined in 
gonads of adult C. elegans hermaphrodites (Pitt et al., 2000). In germ nuclei at the 
pachytene stages of meiosis, each P granule appears to be associated with a cluster of 
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nuclear pores (Pitt et al., 2000). Since about 75% of all nuclear pores are in these 
clusters, P granules could potentially have functions related to the RNAs that exit 
from, or enter through, those pores. In a similar manner, the germ granules of 
amphibians are associated with nuclei prior to becoming cytoplasmic (Eddy and Ito, 
1971; Mahowald and Hennen, 1971). Thus, germ line granules are localised to nuclei 
through much of development, and so these granules may have nuclear-related 
functions. Thus, it is quite feasible for XPAT, likewise, to have a nuclear role. 
The association of germ plasm with the nuclear transport suggests a role for germ 
plasm in the PGC-specific regulation of nuclear transport. For example, the 
Drosophila protein Gcl is a nuclear pore component in pole cells (Jongens et al., 
1994). Also, P granules have been shown to associate with nuclear pore material in 
the adult germ cells and retain this material in the cytoplasm after their detachment 
from the nuclear envelope (Pitt et al., 2000). Whether this interesting observation is 
also true for Xenopus and Drosophila remains to be established. 
9.3 The effect of XPAT-GFP expression on the endogenous germ plasm 
In situ hybridisation revealed that XPAT-GFP expression in oocytes (when 
compared with GFP) significantly reduced the mean diameter of the disc of Xcat-2 
mRNA expression, which was used as a marker of the germ plasm. Granules of 
XPAT-GFP at the vegetal pole reduce this domain more than particles of XPAT-GFP 
expressed equatorially although, perhaps somewhat surprisingly, equatorial particles 
can affect endogenous germ plasm (at the vegetal cortex). It is possible that XPAT- 
GFP causes endogenous Xcat-2 particles to aggregate and move closer together, thus 
causing a reduction in germ plasm diameter. If equatorial expression of XPAT-GFP 
can also cause this, the process might involve binding of XPAT-GFP to a cellular 
component. The sizes of the individual particles were not measured during this 
experiment, thus it will need to be repeated and granule diameter measured to 
confirm this hypothesis. 
9.4 The effect that destruction of Xpat mRNA has on other germ plasm 
components in vivo 
A different approach to analyse the role of Xpat in the germ plasm was to examine 
the effect degrading Xpat mRNA had on other germ plasm molecules. Injection of an 
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antisense oligo was able to specifically deplete Xpat mRNA from stage VI oocytes. 
This depletion appeared to have a specific effect on DEADSouth and XVLGI 
mRNAs, causing their levels to decrease; this was the exact opposite to the effect on 
these mRNAs following Xpat overexpression. Since the gene dosage in an oocyte is 
too small to have a significant impact on maternal mRNAs (Woodland, 1982), the 
only reasonable explanation for the observed changes in mRNA levels is that Xpat 
mRNA, or the protein it encodes, has a specific stabilising effect on DEADSouth and 
XVLG1. As XPAT protein can bind RNAs in vitro, it is perhaps more likely that 
XPAT protein could bind to DEADSouth and XVLG1 transcripts and prevent their 
normal degradation by nucleases in the oocyte. Testing for sequence specific RNA 
binding properties of XPAT would confirm this hypothesis. 
9.5 Does germ plasm contain different sorts of granules? 
Data obtained whilst performing overexpression and depletion studies with Xpat 
suggest that there are different sorts of granules within the germ plasm of stage VI 
oocytes; Xcat-2 appeared to have a significantly smaller RNA expression domain 
than both Xpat and Xdazl. To confirm this hypothesis double in situ hybridisation 
analysis of Xcat-2 and Xpat/Xdazl would need to be performed. The localisation of 
Xcat-2 to the periphery of the mitochondrial cloud during stage I of oogenesis has 
been reported previously (Kloc and Etkin, 1995; Kloc et al., '2000a). This is in 
contrast to the distribution of both Xlsirts and Xpat RNAs, which cover the entire 
mitochondrial cloud area (Kloc and Etkin, 1995; Hudson and Woodland, 1998). 
Thus, both the early expression patterns of Xcat-2 and Xpat and the diameter of the 
disc of RNA distribution at stage VI are different. These data indicate that Xcat-2 and 
Xpat do not localise to the same granules, although a second possibility is that the 
individual granules, which formed in different domains in oogenesis aggregate to 
form the germ granules seen in fertilised eggs and embryos. Xlsirts are thought to 
have a structural role in the germ plasm, but are not found in the germinal granules 
(Kloc and Etkin, 1995). Hudson and Woodland (1998) suggested that Xpat might 
also have a structural role in the germ plasm. Although the similar patterns of 
localisation of Xpat and Xlsirts may support this hypothesis, after stage II their 
expression domains are different. Unlike Xlsirts, which is non-granular (Kloc et al., 
1998), Xpat is found as defined granules in a disc at the vegetal pole (Hudson and 
Woodland, 1998). However, the XPAT-GFP expression data do point to a role for 
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XPAT protein in forming, and perhaps structurally supporting, the germ granules 
during late oogenesis and/or supporting aggregation in early embryogencsis. 
9.6 Roles of RNA-binding proteins 
The RNA binding ability of XPAT protein was shown in an in vitro assay. The 
protein bound mostly to poly(C) suggesting that XPAT might also bind to C-rich 
RNAs in vivo. The ability of XPAT to bind RNA may be necessary for its function 
and could involve germ line-specific regulation of RNA processing, translation, 
storage or transport. It is not unexpected to find that the localised mRNA Xpat 
encodes a putative RNA-binding protein. RNAs for Nanos and Vasa, both implicated 
in RNA-binding and in establishing the germ cell lineage, are long-studied 
components of Drosophila pole plasm (reviewed in Rongo and Lehmann, 1996). 
Specifically in Xenopus, a nanos-like gene (Xcat-2; Mosquera et al., 1993), a 
translation initiation factor-like putative RNA hchcase (DEADSouth; MacArthur et 
al., 2000) and Xdazl, an RNA encoding a putative RNA-binding protein (Houston et 
al., 1998) are also expressed in the germ plasm. Thus, the presence of RNAs coding 
for RNA-binding proteins seems to be a common theme in germ cell determination 
by maternal cytoplasmic localisation. How the inheritance of these molecules 
establishes the germ line is still unknown, but the mechanism may involve 
translational inhibition or germ cell-specific regulation of mRNA splicing or 
stability. 
Recently, it was shown that translational suppression by nanos is essential for entry 
of PGCs into the Drosophila gonad (Kobayashi et al., 1996). The maternal RNA 
localisation of Xpat, combined with its continued presence in the PGCs after all other 
known markers cease to be expressed, suggest that it may function to specify the 
PGCs. However, Xpat may not be translated until after specification has occurred 
and may function in the later aspects of germ cell differentiation. 
RNA-binding proteins in germ plasm could control gene expression at the post- 
transcriptional level. Analysis of nanos and pos-1 mutants supports this hypothesis 
and indicates that translational regulation is important for the formation of PGCs 
(Tabara et al., 1999). Similarly, Vasa (Carrera et al., 2000) and Xdazl (Houston and 
King, 2000b) have been implicated in regulation of translation. Moreover, cyclinB 
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and gcl, both localised to Drosophila pole plasm (reviewed in Williamson and 
Lehmann, 1996), and Xcat-2 (MacArthur et al., 1999) and Xdazl (I louston and King, 
2000b), germ plasm-specific RNAs in Xenopus, are under translational repression. It 
is thought that suppression of translation in the germ plasm prevents the expression 
of specific proteins, thus allowing the germ-line to be established. 
An essential mechanism of post-transcriptional regulation of gene expression, 
utilised by germ cells of vertebrates and invertebrates, is the packaging of maternal 
mRNAs into stable non-translated cytoplasmic messenger ribonucleoprotein particles 
(Yurkova and Murray, 1997). Indeed there are specific germ line proteins responsible 
for packaging and repressing these RNAs (Standart and Jackson, 1994; Yurkova and 
Murray, 1997). Thus, a possible role for XPAT could be in binding to and packaging 
RNAs, such as Xcat-2 or Xdazl, and preventing their translation. It will be necessary 
to obtain an antibody capable of detecting XPAT, and thus determine the spatial and 
temporal distribution of XPAT protein. Unfortunately, attempts to generate antisera 
capable of detecting endogenous levels of XPAT have so far been unsuccessful. 
9.7 Summary: A role for XPAT? 
In summary, the expression pattern of endogenous XPAT protein remains unknown, 
but the protein is likely to be a constituent of germ granules and to be important in 
the aggregation of germ plasm to form large granules. It could also be involved in the 
formation of the disc of granules of germ plasm mRNAs during late stages of 
oogenesis as the protein itself can form granules. Ultimately, the protein probably 
has functions in the nucleus of Xenopus oocytes or PGCs involving RNA binding. 
XPAT forms large aggregates in the cytoplasm, but not in the nucleus, so this 
process probably involves interactions with other abundant cytoplasmic components. 
It also interacts with the cytoskeleton, its long-range transport involving 
microtubules. Etkin (2000) has reported that Xpat mRNA is peripheral on the 
granules whereas Xcat-2 is central. It is conceivable that the mRNA itself has no 
essential role after oocyte maturation, but that previously synthesised XPAT protein 
does. Obviously, light would be shed on this by knowing when Xpat is translated. 
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Appendix 1 
Raw data: diameters of expression domain of germ plasm RNAs 
Diameter of expression domain of each germ plasm RNA was measured using an eye- 
piece graticule in a dissecting stereomicroscope. Numbers correspond to diameter of 
RNA expression domain per oocyte, measured in epu (eye-piece units). 
In each case 40 epu=lmm; lepu =25µm 
For Section 7.2.4 
CONT= control (uninjected) oocytes; XPAT= oocytes injected with Xpat mRNA. 
Xcat-2= in situ hybridisation to Xcat-2; Xdazl= in situ hybridisation to Xdazl; 
DEADSouth= in situ hybridisation to DEADSouth; Xpat ORF= in situ hybridisation to 
Xpat. 
CONT Xcat-2: 23,20,18,20,25,18,19,21,27,24,16,22,19,21. 
XPAT Xcat-2: 20,19,19,17,18,20,27,16,16,16,20,20,18,17,16 
CONT Xdaz1: 25,25,23,31,26,31,30,24. 
XPAT Xdaz1: 30,31,31,28,31,22,27,27,33,28,26,22,34,33,28,31,28, 
30,29,31,29 
CONT DEADSouth: 30,23 
XPAT DEADSouth: 22,21,17,19,22,20,21,21,22,19 
CONT XpatORF: 35,25,33,31,30,31,30,22,20,27,24,27,29,23,25,26,23, 
23,30,26 
For Section 3.6 
Diameters of Xcat-2 RNA expression domain in stage VI Xenopus oocytes. 
GFP= oocytes injected with GFP, XGeq= oocytes expressing XPAT-GFP equatorially 
in particles, XGgran= oocytes expressing XPAT-GFP in granules at the vegetal pole. 
GFP: 22,23,30,20,24,18,15,20,22,22,19,18,21,19. 
XGeq: 19,22,18,17,19,15,15,20,14,18,20 
XGgran: 14,15,12 
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Appendix 2 
14, 
Sec uences of XPAT in deletion variants of XPAT-GFP 
The numbers correspond to the amino acid residue positions in wild-type XPAT. 
A) XPAT-GFP 
MALKAEDSFD IYSQLIQSFC RYAENTTVSE SQSPAFNAQK EFQTCQDHAC CTHSEAHTHI 60 
LMQQWQLLEE QWEYIDHLKT DVAALKQLLH GFMNSLSGTD SGMEGTNHFL PPHQNPTLLK 120 
DEEIVASALN RPSVDINGFE ENITTGAQIH AAFTKSPKKM PATSTPRKSE VLWSCSPTLA 180 
TDGYFMLPDI ILNPLDGKKL VSMLRSSNYE PHRFAELLFQ HHVPHSLFQL WANKVNFDGS 240 
RGKLGLPRNL MIDILHQTSK RFVLGPKEKR KIKTRLNLLL RTRQDRAWWD VGL 
B) AN! 
MQQWQLLEE QWEYIDHLKT DVAALKQLLH GFMNSLSGTD SGMEGTNHFL PPHQNPTLLKD 121 
EEIVASALN RPSVDINGFE ENITTGAQIH AAFTKSPKKM PATSTPRKSE VLWSCSPTLAT 181 
DGYFMLPDI ILNPLDGKKL VSMLRSSNYE PHRFAELLFQ HHVPHSLFQL WANKVNFDGSR 241 
GKLGLPRNL MIDILHQTSK RFVLGPKEKR KIKTRLNLLL RTRQDRAWWD VGL 
Q AN2 
MNSLSGTDSG MEGTNHFLPP HQNPTLLKDE EIVASALNRP SVDINGFEEN ITTGAQIHAA 152 
FTKSPKKMPA STPRKSEVLW SCSPTLATDG YFMLPDIILN PLDGKKLVSM LRSSNYEPHR 212 
FAELLFQHHV PHSLFQLWAN KVNFDGSRGK LGLPRNLMID ILHQTSKRFV LGPKEKRKIK 272 
TRLNLLLRTR QDRAWWDVGL 
D AN3 
MPATSTPRKS EVLWSCSPTL ATDGYFMLPD IILNPLDGKK LVSMLRSSNY EPHRFAELLF 219 
QHHVPHSLFQ LWANKVNFDG SRGKLGLPRN LMIDILHQTS KRFVLGPKEK RKIKTRLNLL 279 
LRTRQDRAWW DVGL 
E OC1 
MALKAEDSFD IYSQLIQSFC RYAENTTVSE SQSPAFNAQK EFQTCQDHAC CTHSEAHTHI 61 
LMQQWQLLEE QWEYIDHLKT DVAALKQLLH GFMNSLSGTD SGMEGTNHFL PPHQNPTLLK 121 
DEEIVASALN RPSVDINGFE ENITTGAQIH AAFTKSPKKM PATST 
218 
,' 
